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Abstract 
This thesis, completed  in collaboration  with  Purification  Process  Development  of  Pfizer 
Biotherapeutics,  is  concerned  with  how  mechanistic  models  of  chromatographic 
bioseparations can be applied in industry to accelerate development and increase robustness 
of industrial protein purification processes, whilst also realising the benefits of a systematic 
development approach based on fundamental process and product understanding.  
 
The first results chapter considers the application of mechanistic models to provide a link 
between high throughput screening (HTS) and scouting runs conducted during early process 
development.  The  chapter  focuses  on  an  anion  exchange  (AEX)  weak  partitioning 
chromatography  (WPC)  polishing  step  in  a  platform  monoclonal  antibody  purification 
process.  Adsorption  isotherms  are  formulated  from  experimental  multicomponent  batch 
adsorption studies of monomer – aggregate. A new approach is taken where the adsorption 
equilibria is characterised as a function of the product partition coefficient, enabling the 
model  to  be  applied  to  new  candidate  monoclonal  antibodies  without  additional 
experimental  effort.  Stochastic  simulations  conducted  at  an  early  stage  of  process 
development  identify  promising  operating  parameter  ranges  for  challenging  separations, 
directs optimal performance, and reduces development times. A detailed analysis of model 
predictions  increases  fundamental  knowledge  and  understanding  of  the  complex  WPC 
multidimensional  design  space,  which  enables  better  informed  process  development  at 
Pfizer. 
 
Resin fouling over a chromatography columns lifetime can cause significant (undesired) 
changes  in  process  performance.  A  lack  of  fundamental  knowledge  and  mechanistic 
understanding of fouling in industrial bioseparations limits the application of mechanistic 
models in industry. An experimental investigation was conducted into fouling of the AEX 
WPC  considered  in  the  first  results  chapter.  Analysis  of  fouled  resin  samples  by  batch 
uptake experiments, scanning electron microscopy, confocal laser scanning microscopy and 
scale down column studies, indicated significant blockage of the pores at the resin surface 
occurred that after successive batch cycles. Mass transport into resin particles was severely 
hindered, but saturation capacity was not affected. The increased understanding of resin 
fouling  can  direct  future  efforts  to  mitigate  this  detrimental  phenomenon  and  maintain 
process performance, whilst providing a basis for the development of new fouling models. 
 
The third results chapter considers an industrial hydrophobic interaction chromatography 
(HIC) separation at a late stage of process development. Resin lot variability, combined with 4 
 
 
a variable feed stream, had resulted in serious performance issues during the purification of a 
therapeutic protein from crude feed material. The traditional approach to tackling this type of 
problem involves defining a design space based on an extensive experimental effort directed 
by factorial design of experiments conducted at great cost. The result is a fixed, inflexible 
manufacturing  process,  with  a  control  strategy  based  on  reproducibility  rather  than 
robustness,  and  little  fundamental  understanding  of the  source  of  the  issue.  In  the third 
results chapter, the application of mechanistic models to identify robust operating conditions 
for the HIC is considered. A model is developed, validated experimentally, and used to 
generate probabilistic design spaces accounting the historical variability in the resin lots and 
load  material.  The  stochastic  simulation  approach  is  extended  to  explore  the  impact  of 
reducing  variability  in  the  load  material  on  the  design  space.  With  historical  process 
variability,  no  operating  condition  was  found  where  the  probability  of  meeting  product 
quality specifications remained > 0.95 for all resin lots. Model simulations indicated that 
adopting an adaptive design space, where operating conditions are changed according to 
which resin lot is in use, is favorable for ensuring process robustness, which is a step change 
concept for bioprocessing. 
 
The conclusions and outcomes resulting from the application of mechanistic models to the 
two industrial systems in this thesis, provides a basis for the next generation purification 
process development platform. 
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Chapter 1. Introduction 
 
Therapeutic proteins are well established as a clinically and commercially important class 
of therapeutics. The key consideration when bringing a product to market remains the need 
to launch as early as possible. There is also increasing desire in industry to move to a more 
systematic  approach  to  bioprocess  development  and  operation  based  on  fundamental 
process and product understanding. Innovation and engineering approaches based on first 
principles modelling have been proven in a variety of processing industries (e.g. refining, oil 
and gas, chemicals, energy). However, mechanistic models derived from first principles are 
seldom utilized in the biopharmaceutical sector. There remains a need to determine how to 
apply mechanistic models in industry, where production of a product of consistent quality in 
amounts satisfying demand remains the primary concern of bioprocess engineers, rather 
than  traditional  processing  objectives.  This  engineering  doctorate  thesis,  completed  in 
collaboration  with  Purification  Process  Development  of  Pfizer  Biotherapeutics,  is 
concerned with how mechanistic models of chromatographic bioseparations can be applied 
in  industry  to  accelerate  development  and  increase  robustness  of  bioseparations,  whilst 
realising benefits of an approach based on fundamental process and product understanding.  26 
 
 
1.1. Recombinant proteins market considerations 
Proteins are now used in a broad range of important clinical applications (Waldmann, 2003, 
Descotes and  Gouraud,  2008), and are  recognised as  a commercially  important  class of 
therapeutics. Annual revenues for 2012 estimated to total in excess of $50 billion of the 
$600billion  global  pharmaceutical  market  (Walsh,  2010).  Increasing  incidence  of  many 
diseases due to aging populations, rising living standards and fast developing geographical 
markets  (China  and  India  have  estimated  markets  approaching  $10  and  $2  billion, 
respectively) have provided strong drivers for this growth, which is predicted to continue in 
the future (Walsh, 2010). This is evident in industry with several hundred clinical candidate 
proteins  currently  estimated  in  company  pipelines  (Kelley,  2009),  of  which  many  serve 
significant unmet medical needs (Shukla et al., 2007). 
 
Until  recently,  the  biopharmaceutical  industry  has  relied  primarily  on  blockbuster  drug 
products such as Infliximab and Etanercept (Khanna, 2012). These are drugs with annual 
revenues in excess of $1billion which are highly desirable for companies as they provide 
consistent high revenues over long periods of time (>10 years). The desire to bring new 
blockbuster  drugs  to  market  remains  strong.  However,  although  there  are  numerous 
candidate biopharmaceuticals in development, few are predicted to reach blockbuster status 
as many target rare or orphan indications (Walsh, 2010). In addition, many first generation 
drugs have now reached or are reaching the end of patent protection, and their market value 
renders them attractive targets for biosimilars. This brings challenges for industry, both for 
companies trying to break into established markets, and for primary innovators protecting 
their investment in off patent products. 
 
Traditionally, the key considerations when bringing a newly discovered molecule to market 
have been: (i) the need to launch as early as possible in order to maximise the period of 
patent protection (which lasts 20 years), and (ii) the need to get the product first to market 
when companies are launching similar products, since this often results in better recognition 
from  customers  and  increased  sales.  Both  are  significant  challenges  as  development  is 
typically long and costly. The average time to market is 10 years at a cost of $1billion (Di 
Masi et al., 2003, Di Masi and Grabowski, 2007). There is a high risk of clinical failure 
(82% of newly discovered molecules are estimated to fail). New drugs must follow strict 
regulatory  pressures,  and  biopharmaceutical  manufacturing  processes  are  inherently 
complex. In addition, the increasing prevalence of biosimilars means that manufacturing 
efficiency and the reduction of cost are becoming additional considerations, and companies 
must strive to find a competitive edge which gives them an advantage over their rivals.  27 
 
 
1.2. Production of recombinant proteins 
The  aim  of  production  is  to  consistently  produce  a  quality  product  which  delivers  its 
intended performance (ICH, 2008). Protein therapeutics are typically required in amounts 
reaching  several  hundred  kilograms  of  bulk  drug  substance  per  annum  (Kelley,  2007). 
Consequently,  compared  to  early  biopharmaceutical  products,  large  scale  production 
processes  are  now  necessary  with  manufacturing  processes  producing  many  tens  of 
kilograms of product per batch (Aldington and Bonnerjea, 2007).  
 
Although varied, therapeutic protein production processes can typically be divided into cell 
culture/fermentation, cell harvesting, primary recovery and purification sections, which are 
often  grouped  into  the  upstream  processing  (cell  culture/fermentation)  and  downstream 
processing  sections  (DSP)  (cell  harvesting,  primary  recovery  and  purification)  of  the  
manufacturing process (Shukla and Thömmes, 2010). Each is comprised of a number of unit 
operations that are selected and optimised according to the product being produced.  
 
The primary aim of cell culture and fermentation is a high productivity, low cost production 
of the therapeutic protein, whilst enabling a facile and inexpensive DSP (Chu and Robinson, 
2001). This is achieved by a combination of cell line development and process optimisation 
(Wurm, 2004, Costa et al., 2010). The goal is to grow the expression system to high cell 
densities, thus producing a large amount of product per unit volume per unit time with 
minimal production of contaminants to be removed. 
 
Material  is  passed from  cell  culture/fermentation  to  the  primary  recovery  section  of  the 
manufacturing process. Here, cells and cell debris are removed from the culture broth, and 
cell  culture  supernatant  that  contains  the  product  of  interest  is  clarified  for  subsequent 
purification. Primary recovery may also involve the extraction of product from the host cell 
if the product is expressed intracellularly. Primary recovery is generally achieved through 
use of microfiltration, centrifugation, depth filtration and flocculation/precipitation (Roush 
and Lu, 2008). 
 
Material  is  then  passed  to  the  purification  section,  where  the  objective  is  to  achieve 
acceptable product purity. Other important considerations include yield/recovery, process 
throughput  and  manufacturability  criteria  (e.g.  robustness,  reliability  and  scalability). 
Membrane  filtration,  crystallisation  and  liquid  extraction  see  some  use,  however, 
chromatographic separations are currently the dominant technology for the purification of 
therapeutic proteins, as their very high selectivity is well suited to separating the product 28 
 
 
from the heterogeneous mix of impurities present in biologically derived material (Kelley, 
2007).  
 
1.3. Chromatography 
In chromatography, a mobile phase (liquid or gas) moves through a bed of particles known 
as the solid or stationary phase. Species in the mobile phase are separated as they interact 
with the solid phase to different degrees via molecular interactions or chemical bonds. Many 
different configurations are available to bring the mobile phase into contact with the solid 
phase, including packed beds, stirred tanks and expanded beds. Radial flow packed beds and 
simulated moving beds are available, but most commonly the solid phase is packed into a 
column  and  the  mobile  phase  flows  along  the  axial  dimension  with  material  applied  in 
batches. 
 
1.3.1. Operating modes 
Chromatographic separations can be operated in a number of different modes. The most 
commonly used are bind and elute mode (B/E), and flowthrough mode (FT). More recently, 
a third type designated weak partitioning (WPC) has been developed at Pfizer by Kelley et 
al. (2008). Further distinction is made between separations that occur with constant mobile 
phase conditions (i.e. pH, ionic strength, buffer composition) which are known as isocratic 
operation,  or  separations  where  the  mobile  phase  conditions  are  changed  during  the 
separation either stepwise or continuously which are known as gradient elution. 
 
The key feature of B/E mode is that the protein product is strongly bound to the solid phase 
and impurities flow through to waste. Each batch is divided into distinct phases, which 
include column  equilibration  (where  the  column  mobile  phase  is  brought  to the  desired 
conditions), column loading (where the material to be purified is applied to the column), one 
or more wash steps (where mobile phase buffer without protein material is applied to the 
column  in  order  to  push  out  remaining  impurities),  elution  (where  the  mobile  phase 
conditions  are  changed  to  promote  desorption  of  any  bound  material  for  collection), 
sanitisation (where the column is cleaned of any remaining material) and storage (where the 
column is put in mobile phase which preserves the resin bed for future use).  
 
In FT mode the opposite occurs, and the impurities are strongly bound to the solid phase, 
whilst the protein product flows through and is collected for further processing. The phases 
of FT include column equilibration, column loading, one or more wash steps, column strip 29 
 
 
(where the mobile phase conditions are changed so that the bound impurities are eluted from 
the column to waste), sanitisation and storage.  
 
In WPC, the strength of the product binding is between those observed in B/E and FT mode. 
Although similar to FT as impurities bind to the resin and the protein of interest flows 
through to be collected as product, WPC is distinct, as it is performed under mobile phase 
conditions where in addition to impurities a significant amount of product also binds to the 
resin. The more stringent binding conditions improves removal of impurities, and any loss in 
yield due to adsorption of the product can be restored by extending the load challenge and 
conducting a wash step at the end of the load phase. Typically WPC employs equilibration, 
load, wash, strip, sanitisation and storage phases, respectively (Kelley et al. 2008a). 
 
1.3.2. Solid phase 
The solid phase in chromatographic separations is composed of particles known as resins. 
Their properties are highly customisable and have important implications as summarised in 
Table 1.1. Resin particles are made from polymerisation of various materials (e.g. agarose, 
methacrylate etc), and can be porous or non-porous. Particles are often modified with the 
addition of specialised functional groups in order to confer additional properties such as 
better mechanical properties or selectivity. Functional groups that are designed to directly 
interact with species in the mobile phase are known as ligands. 
 
Ligands are normally attached to the resin base matrix via covalent bonding. As molecules 
of interest propagate through a resin bed, the surface of the molecule interacts with the 
surface of the ligand, which forms the basis for separation.  Many different ligands are 
available and can be grouped according to the type of interaction they offer as summarised 
in Table 1.2. This variety makes orthogonal sequences of chromatographic bioseparations 
possible, where species are separated according to a different type of interaction in each 
column, giving unmatched selectivity. The main ligands related to this work are affinity, 
anion exchange and hydrophobic interaction. 
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Table 1.1. Chromatography resin properties and their implications (Hagel et al., 2007). 
Resin property  Implication 
Mechanical properties  Throughput, scale up, maximum flow rates 
Ligand density and distribution  Binding capacity, selectivity, recovery 
Pore size distribution  Dynamic binding capacity 
Particle size distribution  Resolution, product recovery, impurity removal, dynamic binding capacity 
Chemical stability  Lifetime, reusability 
Hydrophilicity/hydrophobicity  Product recovery, cleanability 
 
 
Affinity ligands are specially designed to strongly  bind to the target of interest through 
multiple molecular interactions giving unmatched selectivity (Fahrner et al., 1999). They are 
commonly utilised in the first step of chromatographic purification sequences (Ayyar et al., 
2012). The chromatography is typically operated in bind and elute mode, thus, the protein of 
interest binds to the resin and impurities flow through to waste. The protein is released from 
the affinity ligand to be collected for further purification by changing the mobile phase 
composition (usually by lowering the pH). Affinity separations yield very pure product, 
however, the resins are expensive and ligand leakage and the harsh conditions used for 
elution can introduce additional impurities that must be removed (Pollock et al., 2013). An 
example of an affinity ligand is Protein A, which binds to the Fc region of monoclonal 
antibodies, and is used extensively throughout the biopharmaceutical industry. 
 
Ion exchange chromatography separates molecules based on solute charge (Vermeulen et al., 
1984, Yamamoto, 1988). In anion exchange chromatography, ligands are positively charged 
and thus bind negatively charged solutes. Conversely, in cation exchange chromatography, 
ligands are negatively charged and therefore bind positively charged solutes. The charge on 
a protein is a function of the proteins’ isoelectric point (pI) and the pH of the mobile phase. 
At a pH below their pI, proteins carry a net positive charge. At a pH above their pI, proteins 
carry a net negative charge. Hence, the pH and the concentration of competing ions in the 
mobile  phase  (known  as  counterions)  can  be  manipulated  in  order  to  selectively  bind 
components in the feed material, and allow others to pass unhindered through the column. 
Anion  exchange  steps  are  commonly  used  as  the  second  stage  within  chromatographic 
sequences,  where  positively  charged  product  flows  through  the  column  unhindered,  and 
negatively  charged  impurities,  such  as  host  cell  proteins,  nucleic  acids,  DNA  and 31 
 
 
endotoxins, are bound to the column (Shukla and Thömmes, 2010). Cation exchange steps 
are most commonly employed as polishing steps after the bulk of the purification has been 
completed to remove any remaining aggregated product and leached affinity ligand (Shukla 
and Thömmes, 2010). 
 
 
 
Table 1.2. Types of ligand chemistries used in the purification of therapeutic proteins. 
Type  Examples of ligands  Retention mechanism 
Affinity  Protein A/G 
Glutathione 
Heparin 
Dye 
Antibody 
Recombinant protein 
Lectin 
Immobilised metal affinity 
Biospecific interaction, cooridination 
complex formation 
Anion exchange  Diethylaminoethylene (DEAE) 
Quaternary aminoethyl (QAE) 
Quaternary ammonium (Q) 
Electrostatic interaction 
Cation exchange  Sulfopropyl (SP) 
Methylsulfonate (S) 
Carboxymethyl (CM) 
Electrostatic interaction 
Hydrophobic interaction  Phenyl- 
Butyl- 
Octyl- 
Hydrophobic complex formation 
Hydroxyapatite  (Ca5(PO4)3OH)2  Cation exchange and coordination 
bonds (Between Ca
2+ and 
carboxyl/phosphoryl groups) 
Mixed mode  N-benzyl-N-methyl-ethanoline 
4-mercapto-ethyl-pyridine 
Phenylpropylamine 
Hydrophobic interaction and ion 
exchange 
Reversed phase  4-carbon alkyl (C4) 
18-carbon alkyl (C18) 
Hydrophobic complex formation 
Size exclusion  N/A (porous inert base matrix)  Size exclusion 
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Hydrophobic interaction ligands contain exposed hydrophobic groups (often Butyl or phenyl 
groups) which interact with hydrophobic groups present on the surface of proteins. A series 
of publications by To and Lenhoff provide a useful introduction to hydrophobic interaction 
chromatography (To and Lenhoff, 2007a, 2007b, 2008). The strength of the protein – ligand 
interaction is a function of the salt used, and the salt concentration in the mobile phase, 
commonly classified according to the Hoffmeister series. A decrease in salt concentration 
results in an increase in the exposure of hydrophilic regions of protein molecules, which 
leads to solute elution based on the order of decreasing hydrophobicity. HIC is used both as 
an  intermediate  and  a  polishing  chromatographic  step.  In  flow  through  mode  HIC  can 
remove product aggregates, and in bind and elute mode both process and product related 
impurities can be separated from the product. 
 
1.4. Purification Process Development  
The development of a chromatographic bioseparation that isolates a protein of interest as 
part of the DSP is known as purification process development (PPD). An optimal, safe and 
economic purification process which consistently delivers the desired product purity and 
yield must be found quickly, somewhere in an extremely large parameter space (Lightfoot 
and  Moscariello,  2004).  The  amount  of  material  available  to  work  with  during  process 
development is often limited, and the work must be completed within constricted timelines 
to meet time to market constraints (Steinmeyer and McCormick, 2008).  
 
US  Food  and  Drugs  Administration  (FDA)  regulations  require  that  the  basic  separation 
scheme is fixed prior to clinical trials, i.e. early on in the overall development process (ICH, 
2008a, 2008b). In addition, there are further complexities that must be accounted for, such as 
the inherent variability in biopharmaceutical manufacturing due to the biological nature of 
the  materials  used,  and  the  high  end  product  purity  constraints  due  to  the  sensitive 
therapeutic nature of the products. The purification section is also the most expensive part of 
the manufacturing process, and often the processing bottleneck (Kelley, 2007). Against this 
background, purification process development is a very challenging prospect. 
 
The  development  of  a  chromatographic  bioseparation  in  industry  relies  heavily  on 
experienced engineers and scientists drawing from experience and heuristics to derive a 
skeleton process. An extensive experimental program is conducted to optimise the process 
which is usually conducted following a design by experiment (DOE) type approach. Process 
development involves experimentally testing a range of possible operating conditions using 
the minimal amount of time and material possible, until a combination is found which can 33 
 
 
achieve  adequate  product  quality.  As  confidence  in  the  products  clinical  success  grows 
through successful toxicology studies and clinical trials, the process is scaled up and further 
optimisation occurs via experimental studies conducted at laboratory and pilot scale. Final 
acceptance is achieved via the successful completion of three validation runs of the full sized 
manufacturing  process  (Jakobsson  et  al.,  2005).  Platform  approaches,  ultra  scale  down 
experimentation and statistical design of experiments are all key methodologies that are used 
in industry to ensure a satisfactory process is found in the limited time available for process 
development. 
 
1.4.1. Platform approaches 
Therapeutic proteins often have common biochemical structures, the obvious example being 
monoclonal antibodies which contain a fixed Fc region. This enables platform approaches, 
where  generic  purification  processes  are  employed  for  similar  molecules  (Shukla  et  al., 
2007, Kelley, 2007). Molecules still have different physiochemical properties. Therefore, the 
exact operating conditions will differ from molecule to molecule. However, the platform 
strategy  serves  as  a  guidance  that  defines  the  overall  scheme  of  operations,  and  often 
provides  a template  for  process  development  to  use  when  identifying  specific  operating 
conditions. 
 
The key advantage of a platform approach is that they greatly reduce the time and resources 
needed for process development (Nfor et al., 2009). Further wide ranging benefits include (i) 
better alignment between company business units with process development such as quality 
and manufacturing, where template documents can be integrated into systems to streamline 
communications  and  technology  transfer,  (ii)  greater  expertise  and  understanding  of  all 
parties concerned with associated benefits from extensive experience using the platform, (iii) 
a reduction in the number of raw materials required allows better deals can be negotiated 
with vendors, (iv) critical raw materials can be sourced from multiple vendors reducing 
organisational risk, (v) a common aligned philosophy can be adopted by multiple process 
development  sites  enabling  better  core  focus,  (vi)  a  site  independent  process  can  be 
developed  that  is  straightforward  to  transfer  between  multiple  manufacturing  sites  as 
business needs dictate, and (vii) easier planning across the entire organisation as it lays down 
a common set of expectations (Shukla et al., 2007). The disadvantages of using a platform 
approach  are  (i)  they  may  hinder  the  long  term  improvement  of  biopharmaceutical 
production, as there is less desire to innovate and greater focus on utilizing the current 
platform for as many molecules as possible, (ii) if not guarded against, platform approaches 
can favour design based upon heuristic knowledge, rather than from process understanding 34 
 
 
and fundamental knowledge, with a loss of the associated benefits, resulting in (iii) sub 
optimal processes, and (iv) difficulties when the platform does not perform as expected. 
 
1.4.2. Ultra scale down 
The  limited  availability  of  material  and  stringent  time  constraints  during  process 
development  has  given  rise  to  ultra-scale  down  (USD)  approaches  to  process 
characterisation (Chhatre et al., 2009, Li et al., 2012, Lau et al., 2013). Experimental data is 
generated with millilitre to microlitre scale devices and very small amounts of material. The 
data is then used to predict the performance of industrial scale unit operations (> 10 – 500 
L). In addition to chromatography, USD has been successfully utilised for many different 
unit operations such as centrifugation and depth filtration. In chromatographic separations, 
the  most  popular  USD  devices  are  micro  columns  in  pipette  tips  and  micro  plate 
technologies  (Bhambure  et  al.,  2011).  However,  there  is  a  continuing  effort  to  develop 
devices  that  require  smaller  volumes  of  material  which  means  that  new  technologies 
continue to appear.  
 
High throughput screening (HTS) is an approach to purification process development that 
makes use of USD through micro titre plates and robotic platforms (Coffman et al., 2008, 
Kramarczyk et al., 2008, Wensel et al., 2008, Kelley et al., 2008a). In this approach, each 
well in a 96 well micro titre plate represents an independent experiment. This enables a 
systematic  exploration  of  many  different  combinations  of  operating  conditions  and 
processing strategies in parallel to predict trends in larger scale column performance. This 
approach  enables  unattended,  rapid  and  automated  process  screening  that  significantly 
reduces  material  requirements  and  accelerates  development  times.  Combinations  and 
strategies that are undesirable can be quickly disregarded whilst those of interest can be 
taken forward to subsequent scale down column scouting runs. 
 
1.4.3. Statistical design of experiment methods 
Despite  their  success,  significant  differences  still  exist  between  USD  predictions  and 
chromatographic performance at an industrial scale. For example, USD devices by their 
nature have different hydrodynamic properties compared to the large scale columns they 
seek to predict, which results in differences in the quality of packed beds at different scales. 
These differences necessitate the use of qualified laboratory scale down column studies (i.e. 
that have been experimentally validated as representative of manufacturing scale), and the 
application of conventional scale up rules for final process characterisation, optimisation and 
validation, prior to biological license application submission. This experimental effort is 35 
 
 
commonly conducted according to a multivariate statistical design of experiment (DOE) 
type approach (Ferreira et al., 2007, Dejaegher and Heyden, 2011, Hibbert, 2012), using 
factorial  design  to  consider  interactions  between  variables,  in  contrast  with  univariate 
studies, which are limited as they only optimise one factor at a time. The DOE approach 
uses  a  statistical  regression  model  to  generate  a  response  surface  that  maps  process 
performance  over  the  complete  range  of  conditions  considered.  Parameter  estimation  is 
based on a limited number of experiments conducted at specific combinations of variables, 
directed  by  the  chosen  factorial  design  (Ferreira  et  al.,  2007).  DOE  approaches  reduce 
experimental effort required to identify favourable operating conditions, whilst still using a 
system  that  has  been  qualified as representative  of the large  scale  process. The  type of 
factorial design and the range and number of operating variables selected for studies are 
important considerations, as the right balance must be found between experimental burden 
and the resolution and range of the generated response surface (Ferreira et al., 2007). In 
order to reduce the experimental effort, multiple DOE studies can be conducted in sequence, 
where initial scouting studies explore a wide range of process conditions in order to identify 
variable ranges for more detailed studies as the purification process approaches maturity.  
 
1.4.4. Key outstanding issues 
Although the modern approach to the development of chromatographic bioseparations is 
able to produce products of the desired quality, it is often at great time, effort and cost. 
Processes  are  developed  and  validated  following  an  empirically  driven  experimental 
approach that results in a fixed, inflexible manufacturing process, a control strategy based on 
reproducibility  rather  than  robustness,  and  end  product  testing  via  offline  analysis.  The 
approach  to  problems  in  manufacturing  and/or  deviations  from  the  required  product 
specification is reactive and done on a case by case basis. As a result, for many products, 
manufacturing efficiency is low, waste is high, and it is difficult to analyse and understand 
reasons for batch failures. The consequences of this are: (i) higher costs for products, (ii) a 
risk of drug shortages, (iii) a lack of improvements based on new technologies and (iv) a 
need for intensive regulatory oversight, resulting in (v) little flexibility in the regulatory 
process  and  thus  little  flexibility  in  manufacturing,  (iv)  problems  with  regulatory 
consistency, (vii) increasing and sometimes irrelevant information required in submission 
documentation, (viii) hindrance of innovation from manufacturers because of the need for 
time consuming and costly additional supplements, and (ix) slowed time to market (ICH, 
2005, 2008a, 2008b). 
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1.4.5. Proposed solution 
For  these  reasons,  there  has  been a  sustained  effort  in  recent  years  to  move  to  a  more 
systematic approach based upon the principles of Quality by Design (QbD), which starts 
with  predefined  objectives,  emphasise  development  based  on  product  and  process 
understanding,  and  encourages  process  control  based  on  sound  science  and  quality  risk 
management. The objective of this initiative is to reach a desired state of biopharmaceutical 
development  similar  to  that  defined  by  Janet  Woodcock  (Director,  Centre  for  Drug 
Evaluation and Research, FDA,) as, “a maximally efficient, agile, flexible pharmaceutical 
manufacturing sector that reliably produces high quality drug products without extensive 
regulatory oversight’’. The recommended systematic approach can be broken into different 
elements. The guidance issued for industry from the FDA is as follows: (ICH, 2005, 2008a, 
2008b). 
 
Identification of the quality target product profile (QTPP) 
As soon as a molecule has been identified as a viable candidate for commercialisation, the 
ideal quality characteristics of the drug product that ensure the safe implementation of the 
desired therapeutic effect should be established. This includes (i) dosage form, (ii) route of 
administration, (iii) bioavailability, (iv) pharmokinetic characteristics and (v) quality criteria 
such as sterility and purity. (ICH, 2005, 2008a, 2008b) 
 
Identification of critical quality attributes (CQA) 
Once the quality target product profile (QTPP) has been defined, the next step is to identify 
the physical, chemical, biological or microbiological properties or characteristics that should 
be within an appropriate limit, range or distribution to ensure the desired product quality, i.e. 
that  the  QTPP  is  met.  These  properties  and  characteristics,  known  as  critical  quality 
attributes (CQA), are initially derived from the QTPP and/or prior knowledge, and are used 
to  guide  process  development.  Commonly  observed  classes  of  CQA’s  and  the  quality 
attributes  associated  with  them  include  (i)  identity  (primary  amino  acid  sequence),  (ii) 
potency,  (iii)  host  cell  modifications  (e.g.  glycosylation,  phosphorylation,  truncation, 
glycation,  methylation  and  isomerisation),  (iv)  process  modifications  (e.g.  PEGylation, 
aggregation, oxidisation, deamidation, C-termial lysine and misfolding), (v) host cell related 
impurities  (e.g.  host  cell  proteins  (HCP),  DNA  and  andotoxins),  and  (vi)  other 
characteristics  (e.g.  appearance,  colour,  particles,  pH,  osmolarity,  effector  function  and 
concentration). (ICH, 2005, 2008a, 2008b) 
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Process development 
In a QbD type approach, process development is conducted with the aim of designing a 
manufacturing process and control strategy to consistently meet the defined critical quality 
attributes,  thus  assuring  product  quality  (ICH,  2008a).  This  should  follow  a  systematic 
procedure where manufacturing options are evaluated and subsequently refined based on: (i) 
first  identifying  the  material  attributes  and  process  parameters  associated  with  each 
manufacturing  option  that  effects  the  product  CQA’s,  (ii)  determining  the  functional 
relationship that links those material attributes and process parameters to the product CQA’s, 
and  (iii)  using  enhanced  product  and  process  understanding  combined  with  quality  risk 
management to identify appropriate control strategies. Both the CQA’s and manufacturing 
process are modified and refined as product knowledge and process understanding increase 
throughout development, utilizing a combination of design of experiments, mathematical 
models,  and  studies  that  lead  to  mechanistic  understanding.  The  outcome  of  process 
development is a product design space and a process design space. (ICH, 2005, 2008a, 
2008b) 
 
Product design space 
During the development effort, the criticality of product attributes should be determined 
such that a product design space can be created and documented in the regulatory filing that 
defines the acceptable variability in CQA’s. The size of this space will depend on a range of 
factors including: (i) process robustness or capability, (ii) stability of the drug substance or 
drug product, (iii) clinical data for the product or other similar platform products, (iv) non 
clinical data for the product or similar platform products e.g. binding assays, cell based 
assays and in vitro assays, (v) the capability of analytical methods, and (vi) the level of 
understanding on the impact of each CQA on the safety and efficacy of the product.  (ICH, 
2005, 2008a, 2008b)  
 
Process design space 
The relationship   between the material attributes and process parameters with product critical 
quality  attributes  is  described  in  the  process  design  space.  This  is  defined  by  the 
International  Conference  on  Harmonisation  (ICH)  guidance  document  as  “the 
multidimensional combination and interaction of input variables and process parameters that 
have been demonstrated to provide an assurance of product quality” (ICH, 2008a). This can 
be  shown  in  terms  of  parameter  ranges,  or  more  complex  mathematical  relationships, 
including time dependent functions, scale up factors, and combinations of variables, e.g. 
models. Not all process parameters and material attributes need be included in the design 38 
 
 
space, as the increased understanding and knowledge gained during process development 
combined with quality risk management can provide the rational for inclusion or exclusion 
from  the  design  space,  which  should  be  documented  in  the  regulatory  submission. 
Independent design spaces for each individual unit operation, or design spaces that span 
multiple unit operations, are both acceptable options. While single unit design spaces are 
simpler to develop, a design space that spans the entire process can provide more operational 
flexibility. (ICH, 2005, 2008a, 2008b) 
 
Control strategy 
Equally important to the development of the process is the development of how that process 
is controlled. The control strategy should be designed as part of the overall development of 
the therapeutic protein production process. Sources of variability that impact quality should 
be  identified,  appropriately  understood,  and  subsequently  controlled.  Understanding  the 
variability and its impact on product quality in combination with quality risk management 
can  support  the  control  of  the  process,  such  that  variability  is  compensated  for  in  an 
adaptable manner. This enables the attractive possibility that variability can be less tightly 
constrained, and instead, unit operations are responsive to the process input. In addition, 
enhanced understanding of how process performance relates to product quality can justify 
the use of alternative approaches to determine that process streams are meeting the desired 
quality attributes, supporting real time testing and resulting in an increased level of quality 
assurance compared to the traditional end product testing. (ICH, 2005, 2008a, 2008b) 
 
Process validation and filing 
After the process design space and the control strategy has been defined, process validation 
studies  are  performed  to  demonstrate  that  the  process  does  indeed  deliver  a  product  of 
acceptable quality. The regulatory filing is then compiled including the acceptable operating 
parameter ranges specified in the process design space, in addition to the product design 
space, the control strategy, the outcome of the validation studies and a plan for ongoing 
process monitoring. (ICH, 2005, 2008a, 2008b) 
 
1.4.6. Advantages of a systematic approach  
The expected benefits of a systematic approach following QbD principles are numerous, and 
include: (i) better design of products, (ii) less problems in manufacturing, (iii) a reduction in 
the number of manufacturing supplements required for post market changes, (iv) increased 
understanding  of  the  process risk  bringing  improved  risk  mitigation, (v)  greater process 
robustness, (vi) enabling the implementation of new technologies to improve manufacturing 39 
 
 
without regulatory scrutiny, (vii) increased process efficiencies and reduced waste resulting 
in reduction in the overall cost of manufacturing, (viii) continuous improvement possible in 
products and in manufacturing processes, (ix) manufacturing is related to the clinic through 
design, (x) better coordination, consistency, quality and flexibility across the full regulatory 
process (review, compliance and inspection) resulting in (xi) less haggle during regulatory 
review and (xii) quicker approvals. The key differences between the QbD and traditional 
approach are summarised in Table 1.3 (ICH, 2005, 2008a, 2008b). 
 
1.5. Issues with QbD 
Although  the  proposed  systematic  approach  to  process  development  and  operation  has 
important  benefits  to  be  released,  in  practice,  there  will  be  significant  upfront  costs,  as 
fulfilling regulatory guidelines requires substantial additional effort by purification process 
development. There is a serious concern that this may hinder the effort to launch products as 
early as possible whilst maximising efficiency and reducing costs when bringing a product 
to  market.  This  is  a  very  important  consideration  in  an  increasingly  competitive 
biopharmaceutical market. Therefore, approaches that can aid or provide an alternative to the 
existing  experimental  approach  in  a  quality  by  design  development  paradigm  are  of 
increasing interest in industry. 
 
1.6. First principles models for QbD 
Innovation and engineering approaches based on first principles modelling have been proven 
in a variety of processing industries (e.g. refining, oil and gas, chemicals, energy). However, 
mechanistic models derived from first principles have so far been seldom utilized in the 
biopharmaceutical sector. Regulatory guidance regarding the implementation of Quality by 
Design has proposed greater use of mechanistic models (ICH, 2008a), and they have great 
potential for generating value and for reducing costs. Their use as an aid or an alternative to 
experimentation  may  provide  a  means  for  implementation  of  a  Quality  by  Design 
development approach without increasing costs and development times. 
 
One of the most straightforward ways that mechanistic models can help to implementation 
of a Quality by Design without increasing costs and development times is by reducing the 
amount of drug substance used for experimentation. A reduction can be achieved by directly 
replacing experiments with model simulations or by leveraging increased knowledge and 
fundamental understanding from the model in order that fewer but more useful experiments 
are  conducted  during  process  development.  The  model  may  facilitate  better  informed 40 
 
 
heuristics,  or  be  used  for  more  advanced  mathematical  methods  such  as  optimisation 
(Avraam et al., 1998), or experimental design. 
 
A  reduction  in  the  amount  of  drug  substance  used  for  experimentation  enables  process 
development  to  become  less  dependent  on  the  generation  of  material,  which  is  usually 
deliberately kept small so that losses are reduced in the event that a molecule fails. This is 
very useful as in industry, if the amount of drug substance available for an experimental 
programme is insufficient, the result can be substantial costs and delay whilst new material 
is generated, or significant risk may be incurred by continuing development on the basis of 
limited information.  
 
A reduction in the size of the required experimental programme during process development 
also reduces direct costs associated with laboratory facilities and personnel. This does not 
necessarily  result  in  a  reduction  in  the  number  of  personnel  employed,  as  reducing  the 
number of experiments required per molecule may increase the number of drugs that can be 
studied.  Thus,  the  inclusion  of  mechanistic  models  in  a  systematic  approach  to  process 
development  can  bring  associated  benefits  in  the  opportunities  that  biopharmaceutical 
companies can exploit. 
 
The speed and efficiency with which model simulations can be conducted can enable the 
exploration  of  the  process  design  space  in  ways  that  experimentation  cannot,  since 
experiments  will  always  be  limited  by  the  amount of  material  and  time  that it takes to 
conduct them. Unlike experimentation, model simulations can be conducted quickly, and 
advances in process modelling technology mean that model deployment in industry is now 
straightforward (Pantelides and Urban, 2005). Models give more control when examining 
process  sensitivity  compared  to  experiments  via  techniques  such  as  global  sensitivity 
analysis,  and  the  ability  to  quantify  process  risk  using  a  model  can  help  bring  greater 
assurance of product quality than traditional qualitative approaches (e.g. failure mode effects 
analysis) can provide on their own. 
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Table 1.3. Key differences between the QbD and traditional approach (ICH, 2005, 2008a, 2008b) 
Aspect  Traditional approaches  Enhanced, Quality by Design approaches 
 
Overall pharmaceutical 
development 
 
￿  Mainly empirical 
￿  Development research often conducted one variable at a 
time 
 
￿  Systematic, relating mechanistic understanding of material attributes and process parameters to 
drug product critical quality attributes 
￿  Multivariate experiments to understand product and process 
￿  Establishment of design space 
￿  Process Analytical Technology tools utilised 
 
Manufacturing process  ￿  Fixed 
￿  Validation primarily based on initial full scale batches 
￿  Focus on optimisation and reproducibility 
￿  Adjustable within design space 
￿  Lifecycle approach to validation and ideally, continuous process verification 
￿  Focus on control strategy and robustness 
￿  Use of statistical process control methods 
 
Process controls  ￿  In process tests primarily for go/no go decisions 
￿  Off line analysis 
 
￿  PAT tools utilised with appropriate feed forward and feedback controls 
￿  Process operations tracked and trended to support continual improvement efforts post approval 
Product specifications  ￿  Primary means of control 
￿  Based on batch data available at time of registration 
￿  Part of the overall quality control strategy 
￿  Based on desired product performance with relevant support data 
 
Control strategy  ￿  Drug product quality controlled primarily by intermediates 
(in process materials) and end product testing 
￿  Drug product quality ensured by risk based control strategy for well understood product and 
process 
￿  Quality control shifted upstream, with the possibility of real time release testing or reduced end 
product testing 
 
Lifecycle management  ￿  Reactive (i.e. problem solving and corrective action)  ￿  Preventive action 
￿  Continual improvement facilitated 
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First principles modelling approaches surpass Design of experiments (DOE) and response 
surface models (RSM) for quality by design related tasks such as design space identification 
due  to  the  increased  process  understanding  gained  during  model  development  and 
application.  Increased  process  understanding  not  only  enables  a  reduction  in  the 
experimental  programme  and  amount  of  material  required  during  process  development 
(which is also achieved through the use of DOE and RSM), but is very useful for answering 
operating questions during manufacturing. Testing hypotheses is greatly simplified with a 
predictive  model  enabling  answers  to  be  found  in  hours  rather  than  days  which  is  not 
possible with an empirical RSM which is limited to the data used for parameter estimation.   
 
More advanced applications of first principle models may also allow operators to intervene 
before unexpected deviations occur, as models can extract more information from laboratory 
and plant data. Processes can be monitored for key performance indicators by using model 
based soft sensing tools (de Assis and Filho, 2000), so that batch processes that are likely to 
fail  can  be  terminated  at  an  early  stage  of  the  batch,  reducing  the  impact  on  the 
manufacturing  campaign.  When  combined  with  process  control,  soft  sensing  allows  for 
adjustments to manipulated variables in order to reduce the number of batch failures.  
 
Lastly, at a higher level, models allow companies to safeguard, develop and exploit their 
intellectual  property  to  maximum  advantage.  Company  knowledge  can  be  captured  and 
organised  independently  of  employees  in  such  a  way  that  when  key  employees  leave, 
knowledge is retained. This is can be extremely important in a biopharmaceutical sector 
where many companies utilise similar processes, and personnel regularly  move between 
jobs.  
 
Concluding remarks 
Innovation and engineering approaches based on first principles modelling have been proven 
in a variety of processing industries (e.g. refining, oil and gas, chemicals, energy). However, 
mechanistic models derived from first principles have so far been seldom utilized in the 
biopharmaceutical sector. With the emergence of the quality by design initiative and the 
desire  to  move  to  a  more  systematic  approach  to  process  development,  there  are  new 
opportunities  for  mechanistic  modelling  approaches  in  the  biopharmaceutical  industry. 
Regulatory  guidance  regarding  the  implementation  of  Quality  by  Design  has  proposed 
greater use of mechanistic models (ICH, 2008a), and they have great potential for generating 
value and for reducing costs, and research into this area is of great importance. 
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1.7. Summary 
Therapeutic proteins are now well established as a clinically and commercially important 
class of therapeutics (Leader et al., 2008) and they have played a key role in major advances 
in healthcare over the last quarter century (Waldmann, 2003). Their high specificity and 
relatively low immunogenicity means they are useful as therapeutic agents in the treatment 
of  various  disorders  and  diseases  (Walsh,  2010,  Carter,  2011).  Annual  revenues  from 
therapeutic protein sales are now estimated to total in excess of $50 billion, nearly 10% of 
the  $600  billion  pharmaceutical  market  (Walsh,  2010).  Continuing  growth  is  evident  in 
industry, with several hundred clinical candidate proteins currently in company pipelines 
(Kelley, 2009), of which many serve significant unmet medical needs (Shukla et al., 2007).  
 
The key considerations when bringing a product to market are launching as early as possible 
whilst  maximising  efficiency  and  reducing  costs.  The  downstream  section  of  the 
manufacturing process traditionally constitutes a significant proportion (50 – 80 %) of the 
total manufacturing costs (Lightfoot and Moscariello, 2004), and is now considered to be the 
manufacturing  bottleneck  (Nfor  et  al.,  2009).  Chromatographic  purification  is  the 
predominant  unit  operation  used  in  downstream  processing,  but  developing  a 
chromatographic bioseparation is a hugely complex task (Lightfoot and Moscariello, 2004). 
Process development must be completed within very constricted timelines (Steinmeyer et al., 
2008), and is both technically and economically challenging. 
 
The  traditional  approach to  developing  and  operating  biopharmaceutical processes relies 
heavily on empirical methods and experimentation guided by heuristics. However, in recent 
years, there has been a sustained effort to implement a more systematic approach based upon 
the  principles  of  Quality  by  Design  (QbD)  (ICH,  2005,  2008a,  2008b).  The  goal  is  to 
develop a more efficient, agile, and flexible sector that can reliably produce high quality 
drug  products  without  extensive  regulatory  oversight  (Woodcock,  2005).  The  desired 
approach  starts  with  predefined  objectives,  and  emphasizes  product  and  process 
understanding, and process control, based on sound science and quality risk management 
(Rathore and Winkle, 2009, Rathore, 2009). 
 
Model  based  innovation  and  engineering  approaches  have  been  proven  in  a  variety  of 
processing industries (e.g. refining, oil and gas, chemicals, energy), but are seldom utilized 
in  the  biopharmaceutical  sector.  Regulatory  guidance  regarding  the  implementation  of 
Quality by Design has proposed greater use of mechanistic models (ICH, 2008a). Predictive 
chromatography  models  can  help  increase  process  understanding  and  fundamental 44 
 
knowledge, whilst the speed and efficiency with which model simulations can investigate 
design  alternatives,  means  they  can  help  accelerate  process  development  and  increase 
process robustness. Mechanistic models therefore have great potential for generating value, 
and  reducing  costs  in  biopharmaceutical  industry.  As  a  consequence,  biopharmaceutical 
companies  are  now  increasingly  interested  in  the  development  and  application  of 
mechanistic models of industrial chromatographic bioseparations, and research into this area 
is of great importance. 
 
1.8. Aim of this thesis 
Motivated  by  the  desire  to  accelerate  the  development  and  increase  the  robustness  of 
industrial protein purification processes whilst also realising the benefits from following a 
systematic QbD approach to process development and operation, the aim of this thesis is to 
derive fundamental process understanding of specific industrial chromatographic separations 
currently in development or operation at Pfizer, via the development and application of 
mechanistic models chromatography. 
 
1.9. Organisation of this thesis 
An  introduction  to  the  relevance  of  developing  mechanistic  models  of  industrial 
chromatographic bioseparations has been given, and the general aim of the project has been 
set out. The rest of the thesis is divided into five chapters. Chapter two provides a literature 
review of first principles modelling of chromatographic purification of therapeutic proteins 
with regard to model formulation, calibration and application.  
 
Chapter  three  considers  the  development  and  application  of  an  anion  exchange  weak 
partitioning  chromatography  model  at  an  early  stage  of  process  development  for  the 
purposes of; (i) increasing process understanding by providing a more informative method 
for exploring how process parameters can be controlled in order to raise product recovery to 
acceptable  levels  whilst  maintaining  impurity  clearance,  and  (ii)  accelerating  process 
development by providing a link between high throughput screening and scale down column 
experiments.  
 
Chapter four addresses a lack of fundamental knowledge on the mechanistic impact of resin 
fouling  experienced  during  the  purification  of  a  monoclonal  antibodies  in  the  anion 
exchange weak partitioning chromatography process considered in chapter three. A selection 
of  experimental  methods  are  used  to  characterise  the  fouling,  which  include,  scanning 45 
 
electron microscopy, confocal laser scanning microscopy, batch adsorption and scale down 
column studies. 
 
The fifth chapter considers the development and application of a model of a hydrophobic 
interaction chromatography process at a late stage of development for the purposes of (i) 
increasing process understanding by determining the mechanistic effect of resin lot to lot 
variability  that  was  resulting  in  serious  performance  issues,  and  (ii)  increasing  process 
robustness via the application of stochastic simulation to generate probabilistic design spaces 
that  identify prospective operating conditions that assure product quality. 
 
The sixth chapter summarises the findings and conclusions from each part of the project.  A 
number of areas for future work are discussed. The chapter focuses in particular on the 
broader  implications  for  the  use  of  mechanistic  models  of  chromatography  in  the 
biopharmaceutical industry.  
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Chapter 2. Literature Review 
 
This chapter provides a review of the current state of the art in first principles modelling of 
chromatographic  bioseparations,  categorised  and  discussed  according  to  model 
formulation, model calibration and model applications. It will be shown that there is a 
fundamental  lack  of  mathematical  descriptions  and  approaches  to  characterise  and 
calibrate  relevant  model  parameters  for  describing  the  non-ideal  phenomena  and 
challenging  feed  material  compositions  experienced  in  industrial  chromatographic 
separations.  In  addition,  not  enough  consideration  has  been  given  to  how  to  apply 
mechanistic models of chromatography (e.g. model calibration, optimisation, design space 
generation etc.) in an industrial environment with limited time and material.  
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2.1. Introduction  
The background presented in chapter 1 suggests first principles models of chromatography 
may have an important role to play in the systematic development and operation of industrial 
chromatographic  bioseparations  based  on  fundamental  process  understanding.  However, 
before  first  principles  modelling  approaches  are  adopted  by  industry,  a  critical  mass  of 
evidence needs to be built demonstrating the unique advantages mechanistic models can 
give industry compared to a purely experimental approach. 
 
2.2. Model formulation  
Model  formulation  consists  of  deriving  or  selecting  suitable  descriptive  equations  that 
mathematically  describe  the  physical  phenomena  encountered  in  chromatographic 
bioseparations, in order to meet the objectives of a modelling project. A wide range of 
options  are  available  and  have  been  presented  in  the  literature.  Two  types  of  physical 
phenomena  dominate  chromatography;  movement  of  solutes  through  the  packed  bed  of 
porous particles via mass transfer mechanisms, and adsorption based on the fundamental 
thermodynamic interactions between migrating solutes and the stationary phase. Equations 
used to describe these phenomena are discussed in section 2.2.1 and 2.2.2, respectively. 
Chromatographic  bioseparations  where  heat  effects  play  a  role  are  extremely  rare,  but 
exceptional cases are discussed in section 2.2.3. Very few chromatographic bioseparations 
have been designed where desired reactions occur whilst the species are separated. However, 
undesired  isomerisation,  association,  aggregation  of  species,  resin  fouling  and  ligand 
leaching are commonly observed in practice, and are discussed in section 2.2.4.  
 
2.2.1. Mass conservation 
Mass conservation equations describe the movement of load material components through 
the packed bed. The main phenomena that can contribute to this are illustrated in Figure 2.1, 
and  include convection,  axial  dispersion, diffusion  through  an external film  surrounding 
resin particles, and intraparticle diffusion through the stagnant mobile phase within particle 
pores. Diffusion along the surface of pores may play a role in some cases, but is usually 
insignificant and therefore generally ignored (Guiochon et al., 2006). A range of different 
mass transport models have been published and are summarised in Table 2.1. 
 
The general system of equations used to describe the main mass transfer phenomena consist 
of two sets of partial differential mass conservation equations. One describes the bulk fluid 
phase across the column axial dimension, and contains terms for accumulation in the mobile 
phase, accumulation in resin particles, convection, and dispersion. The other describes the 48 
 
intraparticle  fluid  phase  across  the  radial  particle  dimension,  which  includes  terms  for 
accumulation  in  the  intraparticle  fluid  phase,  accumulation  in  the  solid  phase,  and 
intraparticle diffusion. In addition to the two partial differential mass balances, a kinetic 
expression is used to describe diffusion through a stagnant film surrounding resin particles 
(Guiochon et al., 2006). When these equations are combined with an appropriate adsorption 
equation (which will be discussed in section 2.2.2), the model is known as a general rate 
model. 
 
The mass balance equations used in modern day general rate models are still similar to the 
original systems of partial differential equations derived in 1920 (Bohart and Adams, 1920), 
and  again  in  1939  (Wicke,  1939,  1940),  used  as  a  basis  for  the  fundamental  work  on 
modelling of chromatography (Wilson, 1940, DeVault, 1943, Lapidus and Amundson, 1952, 
van Deemter et al., 1956). Mass transport equations almost always assume Fickian diffusion, 
although  Maxwell  –  Stefan  equations  have  also  been  used,  in  particular  where  surface 
diffusion has been found to have an important contribution to a separation (Kaczmarski et 
al., 2002, 2003, Sun and Yang, 2007). 
 
The fundamental assumptions made when deriving the mass conservation equations of the 
general  rate  model  are  universal  for  all  its  subsequent  simplifications,  and  have  been 
discussed in detail by Guiochon et al., (2006). They include; the incompressibility of the 
mobile phase, concentration independence of the mass transfer parameters, constant mobile 
phase viscosity, and constant molar volumes between species in the mobile and stationary 
phase. The column is assumed to be one-dimensional (radially homogeneous), and evenly 
packed with spherical, uniformly porous, constant sized particles. As a result, the radial 
column dimension is usually ignored (Guiochon et al., 2006). 
 
Table 2.1. Summary of common mechanistic mass transfer models of chromatography 
Model Name  Convection  Axial 
Dispersion 
Mass Transfer 
through external film 
Intra-particle 
diffusion 
General Rate Model  YES  YES  YES 
YES 
(Heterogeneous 
particle) 
Lumped Kinetic 
Model  YES  YES  YES  NO 
Equilibrium 
Dispersive Model  YES  YES  NO  NO 
Ideal Model  YES  NO  NO  NO 
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Figure 2.1. Sources of mass transfer in packed bed chromatography.   
Column Inlet  Column Outlet 
i. Convection: Bulk flow of mobile 
phase through the column 
ii. Axial Dispersion: Diffusion of 
components within mobile phase in the 
direction away from high concentration. 
iii. Mass transfer through 
external film: Movement of 
components through a stagnant 
film of mobile phase 
surrounding the resin particles. 
iv. Intra-particle diffusion: 
Diffusion of components 
through the stagnant mobile 
phase within the resin pores. 
v. Surface diffusion: 
Diffusion of components on 
the surface of resin pores 50 
 
In practice, packed beds are almost always heterogeneous (Farkas et al., 1996, Shallikera et 
al., 2003), and particle size varies. However, it is commonly cited that any resulting radial or 
axial heterogeneity in concentration and velocity averages out when the ratio of column to 
particle  diameter  is  high  (typically  greater  than  30),  as  is  true  for  most  laboratory  and 
manufacturing  scale  chromatography  processes  (Guiochon  et  al.,  2006).  For  industrial 
systems, this assumption is dubious. Although bed consistency is checked by ensuring that 
the  column  asymmetry  and  plate  height  are  within set ranges,  often the ranges  deemed 
acceptable are set very wide because tighter ranges result in many repacks wasting time and 
money. Therefore, packing quality can vary considerably. Wall effects, the low density of 
resin particles, variability in the particle diameter, the length of time that resin is left to 
settle, changes during scale up (McCue et al., 2007), and differences in the packing method 
can all play a role.  
 
For  microscale  devices  in  particular,  hydrodynamic  effects  caused  by  non-ideal  bed 
properties are dominant e.g. in microfluidic columns, microcolumns and microtips (Abia et 
al., 2009). Using a standard model which assumes homogeneous bed and particle structure 
will therefore result in inaccurate model predictions. An approach for simulation of micro 
scale devices has been demonstrated, which utilises a model based on computational fluid 
dynamics  that  is  able  to  account  for  heterogeneity  in  particle  and  packed  bed  structure 
(Gerontas et al., 2013). However, the approach is not suitable for large scale systems, as the 
high level of discretisation required results in extremely long solution times. 
 
Another  issue  for  bioseparations  in  particular,  is  assuming  a  uniformly  porous  resin 
structure.  Chromatography resin particles are known to exhibit a range of pore sizes with 
normal-like distribution (dePhillips and Lenhoff, 2000, Yao and Lenhoff, 2006). This is not 
an issue when all species are significantly smaller than the smallest pore size, as all species 
have equal access to resin binding sites. However, as the size of biomolecules often falls 
within the pore size distribution (i.e. biomolecule and particle pore sizes are similar), pore 
accessibility  becomes  dependent  on  component  size.  This  can  impact  mass  transfer 
performance, as there is more competition for binding sites in the larger pores which are 
accessible to all components, than in smaller pores where few species can enter. In addition, 
as adsorbed proteins occupy a finite space, the adsorption process itself can modify the 
effective  pore  radius  as  bound  proteins  partially  obstruct  pores,  hindering  intraparticle 
diffusion (Boyer and Hsu, 1992, Susanto et al., 2007). This is especially true where tentacles 
are used within resin pores to increase resin capacity (Thomas et al., 2013). A change of 
tentacle  orientation  (which  can  occur  when  the  mobile  phase  composition  changes)  can 
result in large changes to pore accessibility of components. If the impact of changes to 51 
 
particle structure is large, then the more detailed distributed pore model can be used which 
accounts for the pore size distribution of the stationary phase, and pore shrinkage due to 
protein  adsorption  (de  Neuville  et  al.,  2013).  Alternatively,  diffusion  parameters  can  be 
calculated as a function of stationary phase concentration (Susanto et al., 2007).  
 
Despite the issues mentioned regarding model assumptions, the predictive capability of the 
general rate model is well proven. Older studies using the general rate model focused on 
increasing theoretical understanding of underlying phenomena such as displacement effects 
(Gu et al., 1990a), desorption (Gu et al., 1990b), restricted protein diffusion (Boyer and Hsu, 
1992),  scale  up  (Li  et  al.,  1998),  intraparticle  diffusion  (Susanto  et  al.,  2006),  and 
hydrophobic interaction mechanisms (To and Lenhoff, 2008). Later, the general rate model 
was  applied  to  process  development  tasks  such  as  process  design  (Melter  et  al.  2008), 
optimisation (Karlsson et al., 2004, Degerman et al., 2006, Lienqueo et al., 2009), design 
space exploration (Degerman et al., 2009) and scale up (Gerontas et al. 2010), albeit most 
often  using  well  known  proteins.  In  recent  years,  the  general  rate  model  has  been 
successfully  used  to  simulate  more  complex  chromatographic  processes  that  are  often 
nonlinear and contain streams with multiple species (Nagrath et al., 2011, Guélat et al. 2012, 
Osberghaus et al., 2012a, 2012b, 2012c). 
 
The problem with the general rate model is that it can be difficult to accurately estimate the 
large number of parameters required for simulations, and the model can take a long time to 
solve. This is of particular concern for industry, where minimising process development 
time is key, and processes are complex. In order to increase computational efficiency and the 
speed of model development, assumptions are commonly made to reduce model complexity 
by neglecting or lumping multiple phenomena into single terms. Successive simplification of 
the general rate model results in the lumped pore model, the lumped kinetic model, the 
equilibrium  dispersive  model  and  the  ideal  model,  listed  in  order  of  decreasing  model 
complexity (Kaczmarski et al., 2001). A summary of the main mass transport phenomena 
considered in each model is presented in Table 2.1. 
 
The lumped pore model simplifies the general rate model by assuming that particles are 
homogeneous. The  partial  differential  equation describing  intra  particular  mass  transport 
across the radial particle dimension is modified accordingly. The intraparticle mobile and 
stationary  phase  concentrations  are  replaced  with  average  concentrations,  and  the  intra 
particle diffusion term is replaced with a kinetic expression. The kinetic expression describes 
mass transfer between the column mobile phase and intra particular mobile phase via an 52 
 
overall mass transfer coefficient which is related to the external and internal mass transfer 
coefficients (Guiochon, 2002, Guiochon et al., 2006).  
 
Few studies have been conducted using the lumped pore model, as the lumped kinetic model 
provides identical solutions for experimental conditions typical of current chromatographic 
separations, but with greater computational efficiency, and less parameter estimation burden 
(Kaczmarski  et  al.,  2001).  The  model  achieves  this  by  replacing  the  partial  differential 
equation describing intraparticular mass transport with a kinetic expression, which links the 
column mobile phase concentration to the average intraparticular mobile phase concentration 
(Kaczmarski  et al.,  2001, Guiochon,  2002).  Hence, intraparticular  mass transport  is  still 
directly  accounted  for  within  the  model,  but  the  radial  distribution  domain  is  removed, 
which significantly reduces the number of equations.  
 
As  a  result,  the  lumped  kinetic  model  has  been  used  in  a  wide  range  of  studies,  most 
commonly considering process development tasks. These include process design (Mollerup 
et al., 2007), process optimisation (Chan et al., 2008, Teeters et al., 2009), design space 
exploration (Degerman et al., 2009, Gétaz et al., 2012), process control (Westerberg et al., 
2010), continuous chromatography (Muller – Spath et al., 2011), resin selection (Nfor et al. 
2011) and process synthesis (Nfor et al., 2013). There have also been studies where the 
focus was on increasing process understanding in areas such as hydrophobic interaction 
separations  (McCue  et  al.,  2008),  and  chromatographic  separations  involving  complex 
feedstocks (Bak et al., 2007, Gétaz et al., 2013).  
 
Simplifications made in the equilibrium dispersive model go even further than the lumped 
kinetic model, and assume that the mass transfer kinetics between the mobile phase moving 
through the column bed and the resin particles is infinitely fast. Thus, the concentration of a 
component in the extraparticular mobile phase is equal to the average concentration of that 
component in the intraparticular mobile phase, and the mass balance over particle pores can 
be neglected. The kinetic expression used in the lumped kinetic model is removed, and the 
axial dispersion coefficient is replaced with an apparent axial dispersion coefficient, which 
lumps the contribution from all sources of mass transfer associated with resin particles and 
axial dispersion (Kaczmarski et al., 2001, Guiochon, 2002, Guiochon et al., 2006). Despite 
its simplicity, the model still gives useful predictions (Chan et al., 2008, Susanto et al., 2008, 
Gu et al. 2013), and its high computational efficiency is particularly useful when model 
applications are computationally expensive, such as optimization (Degerman et al., 2007, Ng 
et  al.,  2012),  robustness  analysis  (Jakobsson  et  al.,  2005,  Westerberg  et  al.,  2012),  and 
exploring the effect of experimental uncertainty on parameter estimation (Borg et al., 2013). 53 
 
 
2.2.2. Adsorption 
Adsorption of proteins refers to the reversible adhesion of molecules from the liquid phase 
to  the  resin  surface,  dictated  by  the  fundamental  thermodynamic  interactions  that  occur 
when a load material component associates with a ligand or number of ligands covalently 
bound to the surface of the chromatographic adsorbent (Mollerup, 2008). The exact nature of 
the bonding between the resin ligand and molecule depends on the details of the species 
involved. The conformational entropy of proteins, hydrophobic interactions and electrostatic 
interactions  can  all  contribute  (Norde,  1998).  At  a  macroscopic  level,  the  mixture 
components distribute themselves between the stationary and mobile phase. 
 
Adsorption  of  therapeutic  proteins  and  other  molecules  found  in  chromatography  feed 
material is non-trivial. The application of models from theory alone is not yet possible due to 
many complicating factors. As explained in the review by Rabe et al., (2011): 
 
1.  Each  molecule  contains  many  electrostatic  and  hydrophobic  groups 
heterogeneously distributed throughout the entire protein structure, i.e. some are 
on the external surface while others are located inside the molecule. 
2.  Proteins  are  typically  asymmetric  and  so  representing  them  as  a  sphere  is 
unrealistic. 
3.  Proteins  often  simultaneously  interact  with  multiple  binding  sites,  using 
contributions from multiple groups. 
4.  Cooperative effects from proteins that are already adsorbed means that proteins 
are sometimes more likely to adsorb if there are pre-adsorbed proteins.  
5.  During adsorption and/or desorption proteins often unfold and change structure, 
potentially changing the groups exposed at the surface of the protein. 
6.  Due to the similar size of molecules to resin pore diameter, and the range of 
ionic strengths encountered, electrostatic force fields can interact causing the 
local conditions to vary. 
7.  Proteins  can  also  self-associate  (aggregate),  both  in  solution  and  on  the 
stationary phase, so interactions between components are very important. 
8.  Proteins often denature in extreme conditions or due to other components, e.g. 
proteases. 
9.  Overshooting  adsorption  kinetics  due  to  conformational  rearrangement  of 
adsorbed proteins on the resin surface have also been observed. 
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The complexity of protein adsorption means that adsorption equations are primarily based 
on  experimentally  correlated  equations  that  are  sometimes  derived  from  rigorous 
thermodynamic  principles  (Mollerup,  2008),  but  are  most  commonly  empirical  or  semi 
empirical (Guiochon et al, 2006). Models are composed of a generic function known as an 
adsorption  isotherm  which  describes  the  relationship  between  the  concentration  in  the 
mobile phase and the stationary phase of a chemical or biochemical species. There are many 
different adsorption isotherms available, which can be grouped into equilibrium models and 
kinetic models.  
 
Equilibrium isotherm models 
Equilibrium  models  predict  the  equilibrium  state  of  adsorption  (e.g.  the  bound  protein 
concentration  at  steady  state)  using  selected  parameters  such  as  unbound  protein 
concentration,  pH  and  ionic  strength.  Common  equilibrium  adsorption  isotherms  are 
summarised in Table 2.2. 
 
The simplest equilibrium model is the linear model, which assumes that the chromatography 
resin is under challenged and thus there are a large number of free binding sites (Guiochon 
et al, 2006). This is often the case in analytical chromatography where only small amounts 
of protein are applied to the chromatography column. However, this is rarely the case in 
industrial bioseparations, where columns are loaded as close to full capacity as possible in 
order to maximise productivity (Tugcu et al., 2007). Therefore, the ideal model has only 
been used in a few studies, where its simplicity was helpful in reducing the solution time of 
optimisation problems (Chan et al., 2008b, Ng et al., 2012). 
 
In  practice,  as  the  resin  becomes  increasingly  saturated,  it  becomes  more  difficult  for 
proteins to find free binding sites. After a certain amount of protein has been loaded onto the 
resin, all sites will be occupied and no more protein can bind. Many different isotherm 
models have been developed to represent this phenomena, such as Langmuir, steric mass 
action and quadratic isotherms (Foo and Hameed, 2010). Each isotherm makes a range of 
assumptions and often aims to address specific adsorption phenomena. 
 
The  Langmuir  isotherm  is  the  most  commonly  used  model,  and  assumes  monolayer 
adsorption  at  a  finite  number  of  equivalent  and  identical  binding  sites,  with  no  lateral 
interactions, steric hindrance, or migration of adsorbed molecules on the adsorption surface 
(Guiochon et al., 2006). Despite the idealistic nature of these assumptions, the Langmuir 
isotherm  has  been  used  in  a  number  of  different  studies.  Single  component  Langmuir 
isotherms are typically applied where simulation of a model chromatographic system is used 55 
 
to derive understanding of a particular feature or aspect of chromatography. For example, 
Gu  et  al.,  (1990)  used  a  single  component  Langmuir  when  considering  optimisation  of 
desorption chromatography, and Sun and Yang, (2007) used a single component Langmuir 
when studying the difference between mass transport models.  
 
The  dependence  of  adsorption  on  mobile  phase  modulators,  such  as  the  counter  ion 
concentration or pH, is often included in adsorption models if the model is intended for 
exploring  potential  operating  conditions  during  process  development.  The  Langmuir 
isotherm with mobile phase modulators has been used in numerous studies where models are 
used for process design and optimisation, considering a range of  molecules (IgG, BSA, 
insulin,  myoglobin  and  lactoferrin)  and  retention  mechanisms  (affinity,  ion  exchange, 
hydrophobic interaction and reversed phase chromatography) (Karlson et al., 2004, Melter et 
al., 2008, Degerman et al., 2009a, Westerberg et al., 2010, Gerontas et al., 2010, Ng et al., 
2012, Borg et al., 2013). 
 
Adsorption models can also be extended to deal with more than one component, including 
competition between components. In general, multicomponent adsorption isotherms are less 
rigorous  than  single  component  isotherms,  as  multicomponent  adsorption  is  not  well 
understood (Guiochon et al., 2006). For example, the multicomponent Langmuir isotherm is 
only thermodynamically correct when all components have identical saturation capacities, 
which is rarely the case for the extremely heterogeneous, multicomponent feed streams of 
industrial  processes.  Despite  this  limitation,  the  multicomponent  competitive  Langmuir 
isotherm is useful for systems with similar components, and has been used for hydrophobic 
interaction  chromatography  of  alpha  chymotrypsin  and  alpha  amylase  (Lienqueo  et  al., 
2009), IgG capture with cation exchange chromatography (Muller – Spath et al., 2011), and 
the separation of monoclonal antibody variants with ion exchange chromatography (Guélat 
et al. 2012).  
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Table 2.2. Common equilibrium adsorption isotherms 
Adsorption model  Equation  Notes  Reference 
Linear     =   ∙     Simplest isotherm available.  Guiochon et 
al., (2006) 
Langmuir 
  =
   ∙    ∙  
1 +    ∙  
 
where    is the saturation 
capacity and    is the 
equilibrium constant. 
Formulation assumes 
monolayer adsorption at a 
finite number of equivalent 
and identical binding sites, 
with no lateral interactions, 
steric hindrance and 
migration of adsorbed 
molecules on the adsorption 
surface.  
Gu et al., 
(1990), Sun 
and Yang, 
(2007) 
Bi – Langmuir 
  =
    ∙   ,  ∙  
1 +   ,  ∙  
+
    ∙   ,  ∙  
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Accounts for two different 
binding mechanisms. 
Kaczmarski 
et al., (2001) 
Competitive 
Langmuir     =
   ∙   ,  ∙   
1 + ∑  ,  ∙   
 
Langmuir isotherm where the 
adsorption of one component 
is influenced by all 
components in the system. 
Lienqueo et 
al., (2009), 
Muller – 
Spath et al., 
(2011) 
Steric mass action 
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where      is the equilibrium 
constant, Λ is the total ionic 
capacity of the stationary 
phase,   is the steric factor, 
and   is the characteristic 
charge. 
 
Brooks and 
Cramer, 
(1992), 
Natarajan 
and Cramer, 
(2000) 
Preferential 
interaction 
quadratic (PI
  Q) 
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where  	and   denotes the 
solutes,   
′ is the capacity 
factor,    is the number of 
components,      is the salt 
concentration,  ,   and   are 
retention factors, and  ,  ,  , 
and   are isotherm 
parameters. The model 
assumes competitive binding, 
equilibrium parameters 
independent of solute and salt 
concentration, no aggregation 
of conformal change, and a 
constant saturation capacity.   
Xia et al., 
(2003) 
 
 
The steric mass action (SMA) isotherm was developed based on the stoichiometric exchange 
of  components  between  the  stationary  and  mobile  phase  (Rounds  and  Regnier,  1984, 
Regnier and Mazsaroff, 1987), and steric hindrance of adsorption sites due to protein size 
(Velayudhan and Horvath, 1988, Brooks and Cramer, 1993). In the SMA model, competitive 
binding is described by mass-action equilibrium where electroneutrality on the stationary 
phase  is  maintained.  The  multipointed  nature  of  protein  binding  is  represented  by  an 57 
 
experimentally determined characteristic charge, and the steric hindrance of binding sites by 
adsorbed  molecules  is  represented  by  a  steric  factor  for  each  component  (Brooks  and 
Cramer,  1993).  The  obvious  application  of  the  SMA  isotherm  is  for  ion  exchange 
chromatography where salt and proteins are exchanged. The model has been successfully 
applied  to  a  range  of  systems,  including  alpha  chymotrypsinogen  A,  ribonuclease  A, 
nyomysin sulphate on a cation exchange system (Natarajan and Cramer, 2000), BSA on a 
strong  anion  exchanger  (Susanto  et  al.,  2006),  IgG,  BSA  and  myoglobin  on  an  anion 
exchanger  (Jakobsson  et  al.,  2005),  and  most  recently  Lysozyme,  ribonuclease  A  and 
cytochrome C on a cation exchanger (Osberghaus et al., 2012a, 2012b, 2012c). 
 
A more recent addition to the literature are the association isotherms (Mollerup et al, 2008a, 
Mollerup, 2008b), which are derived from thermodynamic principles. Association models 
include  a  primary  equation  used  regardless  of  adsorption  mechanism  which  relates  the 
bound and unbound component concentrations. A separate equation is used to describe an 
initial  slope  term  within  the  primary  equation  which  varies  according  to  retention 
mechanism. Protein adsorption is modelled as a reversible association between ligand and 
component. When the interactions are electrostatic, proteins displace counterions associated 
with  the  ligands.  If  the  interaction  is  hydrophobic,  then  adsorption  entails  a  reversible 
association  of  the  protein  with  the  ligand  to  form  a  complex  by  non-polar  interactions. 
Mollerup et al., (2007) used the model for ion exchange chromatography, and were able to 
successfully simulate the gradient elution of β-Lactoglobulin A and B, and the purification 
of four closely related components. 
 
Kinetic isotherm models 
Kinetic  isotherm  models  express  the  state  of  adsorption  through  rate  expressions  that 
describe relevant adsorption and desorption phenomena and mechanisms (Guiochon et al., 
2006).  Rate  expressions  can  be  added  or  removed  from  kinetic  models  as  needed,  to 
represent the different adsorption phenomena relevant to the separation in consideration. 
Therefore, a very large number of expressions are possible. A simplified and schematic 
summary of kinetic adsorption models that have been proposed has been presented by Rabe 
et al., (2011).  
 
The kinetic Langmuir isotherm is the most widely used kinetic model, and has been applied 
for modelling affinity (Bak et al., 2007), ion exchange (Susanto et al., 2008, Gerontas et al. 
2010), and reversed phase chromatography processes (Degerman et al., 2007). A second 
order  kinetic  binding  expression  was  used  when  modelling  IgG  elution  during  affinity 
chromatography  by  Sandoval  et  al.  (2012),  and  a  kinetic  expression  including  a  term 58 
 
describing conformational change on the resin surface during HIC was used by To and 
Lenhoff, (2008).  
 
A  useful  feature  of  kinetic  isotherms  is  that  the  kinetic  parameters  can  include  the 
contribution of mass transfer resistances taking place inside the pores of the adsorbents, 
when  an  explicit  particle  mass  balance  is  not  included  in  the  chromatography  model. 
Degerman et al., (2007) and Susanto et al., (2008) both took this approach when using the 
equilibrium dispersive mass transport model. Although these chromatography models give a 
good description of the experimental chromatograms, the kinetic parameters do not have 
physical meaning (Kaczmarski et al., 2001).  
 
2.2.3. Heat effects 
Heat  effects  have  little  consequence  for  conventional  chromatographic  columns,  and  no 
detectable  influence  of  the  heat  of  adsorption  on  the  migration  of  species  through  a 
chromatography column has been demonstrated (Gritti and Guiochon, 2007). High mobile 
phase  velocities  can  result  in thermal  heterogeneity  due to  mobile  phase decompression 
(Gritti,  and  Guiochon,  2007).  Therefore,  a  differential  heat  balance  for  the  mobile  and 
stationary phase may be useful when modelling high or ultra-performance chromatography 
(Guiochon et al., 2006).  In general, chromatographic separations are almost always assumed 
isothermal and adiabatic, thus the energy balance is usually entirely neglected without loss 
of model accuracy. 
 
2.2.4. Aging effects 
Fouling of chromatographic resin over operational lifetimes is a serious issue associated 
with industrial separations, attributed to repeated or prolonged exposure to the complex mix 
of components commonly seen in load material. This can result in significant reductions in 
binding  capacities,  and  therefore  altered  process  kinetics  (Staby  et  al.,  1998).  Although 
standard clean-in-place (CIP) procedures can help restore columns towards their original 
state, fouling by certain types of material is often irreversible under typical conditions (Jin et 
al., 2009), and this must be balanced by the fact that more stringent cleaning can cause 
degeneration of the resin pore structure and loss of ligands (Jiang et al., 2009; Muller-Spath 
et al., 2009). Studies have shown that the binding capacity of Protein A affinity resins can 
decrease between 20 – 40 % due to ligand leaching, depending on the volume of material 
applied to the resin over its lifetime (Pollock et al., 2013).   
 
Against  this  background,  aging  effects  are  very  important  phenomena  to  consider  in 
chromatographic models, but despite this, only one such study has been published, where a 59 
 
term for irreversible binding was included in the model (McCue et al., 2008). Indeed, there 
are  relatively  few  experimental  investigations  into  chromatography  column  aging  in  the 
literature.  
 
The impact of fouling on a range of performance indicators such as pressure drop profiles, 
dynamic  capacity  and  breakthrough  curves  have  been  measured  at  University  College 
London,  where  scaled  down  columns  were  repeatedly  loaded  with  fouling  material 
(Boushaba et al., 2011; Bracewell et al., 2008; Chau et al., 2006; Shepard et al., 2000). 
Rather than considering fouling directly, other studies have focused on resin lifetime issues 
and CIP procedures (Muller-Spath et al., 2009; Norling et al., 2005). More recently, confocal 
laser  scanning  microscopy  (CLSM),  a  tool  that  can  monitor  adsorption  processes  on  a 
particle  scale  by  observing  the  distribution  of  a  fluorescent  molecule  within  particles 
(Ljunglöf and Hjorth, 1996; Ljunglöf and Thömmes, 1998; Linden et al., 1999, Hubbuch et 
al. 2002), has been utilized to visualize fouling at the particle level (Jin et al., 2009; Siu et 
al., 2006, 2007). However, despite this progress, there remains only limited understanding of 
the mechanistic effect of aging phenomena, for example whether fouling impacts adsorption 
or  mass  transfer.  Therefore,  the  development  of  mathematical  descriptions  of  these 
phenomena is currently extremely difficult, which is a serious concern that needs to be 
addressed if models are to be used for process development in industry without resulting in 
unrealistic predictions.  
 
2.3. Model calibration 
Before  chromatographic  models  can  simulate  a  particular  chromatographic  separation, 
values for model parameters must be determined. In the following section of the chapter, 
methods to determine adsorption isotherm parameters, mass transfer parameters, and void 
volumes are reviewed. 
 
2.3.1. Methods to determine mass transfer parameters 
Mass transport equations are used to describe the movement of solutes through the packed 
bed of porous particles via mass transfer mechanisms. These equations include mass transfer 
coefficients and rate constants specific to each component. The methods used to determine 
these  mass  transfer  parameters  can  be  classified  into  three  groups,  correlations,  inverse 
methods, and experimental methods.  
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2.3.1.1. Correlations 
Due to intensive study in classical chemical engineering mass transfer research, there are a 
large  number  of  correlations  (summarised  in  Table  2.3)  available  that  attempt  to  relate 
dimensional  groups  (e.g.  the  Peclet  number  and  the  Biot  number)  and  mass  transfer 
parameters to fundamental properties of packed beds (e.g. porosity, tortuosity, pore size 
distribution)  and/or  molecules  (e.g.  size,  structure  etc).  Correlations  have  been  used  to 
determine all the major mass transfer parameters used in rate models, such as the apparent 
axial  dispersion  coefficient  (Charton  et  al.,  1994,  Ng  et  al.,  2012),  axial  dispersion 
coefficient (Kaczmarski et al., 2001), the film mass transfer coefficient (Kaczmarski et al., 
2001, Karlsson et al., 2004, Gerontas et al. 2010), and intraparticle diffusivity (Nagarath and 
Cramer, 2000, Gallant, 2004). The advantage of using a correlation is that it is then not 
necessary to determine the parameters experimentally, which is challenging and can give 
inaccurate values due to difficulties distinguishing between the effects of each parameter on 
the  shape  of  the  measured  chromatograms.  Conversely,  values  of  parameters  used  in 
correlations  can  themselves  be  unavailable  and  so  must  be  assumed,  and  mass  transfer 
parameter values determined using correlations are less specific to the system in question 
than parameters that are fitted to experimental data. Correlations are sometimes used in 
combination with other methods to ensure a good model fit to experimental data (Nagarath 
and Cramer, 2000, Teoh et al., 2001), and have been used to develop models for increasing 
process understanding (Li et al., 1998, Melter et al., 2008, Sandoval et al., 2012, Gu et al., 
2013), and assisting with process development tasks (Jakobsson et al., 2005, Degerman et 
al., 2006, Lienqueo et al., 2009, Nfor et al. 2011). 
 
2.3.1.2. Inverse methods 
Inverse methods can also be used to estimate the values of mass transfer parameters, and are 
similar to the method used when estimating adsorption isotherm parameters. An algorithm is 
used to minimize the error between experimental measurements and model predictions by 
changing the mass transfer parameter in question. The inverse method is usually applied to 
estimate parameters from a single phenomenon at a time, due to the difficulty separating the 
effects  of  mass  transport  and  adsorption  from  measured  chromatograms  (Natarajan  and 
Cramer, 2000, Kaczmarski et al., 2002, Borg et al., 2013). However, Gerontas et al., (2010) 
were  able  to  estimate  adsorption  and  mass  transport  parameters  simultaneously  using  a 
genetic algorithm combined with derivative based search algorithm to ensure the search 
algorithm did not become trapped in local optima.  
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Table 2.3. Correlations for mass transfer parameters (continued on the following page) 
Description   Correlation  Parameters 
The apparent dispersion 
coefficient (Guiochon et 
al., 2006). 
 
   =
  
2  
 
where   is the 
superficial velocity, 
  is the column 
height and   is the 
number of theoretical 
plates. 
 
The axial dispersion for 
liquid flow in packed 
beds with spherical 
particles (Ligny, 1970). 
 
    = 0.7   +
5   
1 + 4.4  /     
 
where    is the 
molecular diffusivity, 
   is the particle 
radius and   is the 
interstitial velocity. 
 
Axial dispersion 
coefficient (van Deemter 
1956) 
 
    =      +     
 
  
  where    and   are 
empirical 
constants,	   is the 
molecular diffusivity, 
   is the particle 
diameter,   is the 
interstitial velocity 
and    is the bed 
porosity. 
 
Axial dispersion (Chung 
and Wen, 1968). 
 
    =	
2     
0.2 + 0.011   .  			 10   <   
< 10   
where    is the 
particle radius,   is 
the interstitial 
velocity,    is the 
bed porosity and Re 
is the Reynolds 
number 
 
Molecular diffusivity 
(Polson, 1950). 
 
   = 2.74 × 10           ⁄   where    is the 
molecular diffusivity 
(cm
2/s) and   is 
the molecular weight 
of the solute. 
 
Molecular diffusivity 
(Young et al., 1980). 
 
   = 8.34 × 10   ×
 
       ⁄  
where   is the 
column temperature, 
  is the kinematic 
viscosity, and   is 
the molecular weight 
of the solute. 
 
 
 
 
 
 
 
 
 
 
   62 
 
Table 2.4. Correlations for mass transfer parameters (continued) 
Description   Correlation  Parameters 
Intraparticle 
diffusivity 
(Striegel et al., 
2009).  
 
  
=
      1 − 2.104   
  
  + 2.09   
  
 
 
− 0.95   
  
 
 
 
    
 
where    is the 
molecular diameter 
(Å ,    is the 
average particle 
macropore 
diameter (Å ,      
is the molecular 
coefficient, and 
     is the particle 
tortuosity (usually 
unavailable so 
assumed around 2-
6 for commercial 
porous solids). 
 
Molecular 
diameter for 
proteins in water 
(Gu et al., 1999). 
 
   = 1.44        ⁄   where     is the 
molecular weight 
of the solute. 
Film mass transfer 
coefﬁcient 
(Wilson and 
Geankoplis, 1966). 
 
  = 0.687     ⁄          ⁄  
     ⁄
  (0.0016 < Re < 55)  where   is the 
interstitial velocity, 
   is the particle 
radius, and    is 
the molecular 
diffusivity (cm
2/s). 
Film mass transfer 
coefficient 
(Kataoka et al., 
1972).  
  = 1.165     ⁄        ⁄  
     ⁄
  1 −        ⁄      ⁄ 				   
< 100  
where   is the 
interstitial velocity, 
   is the particle 
radius, and    is 
the molecular 
diffusivity (cm
2/s). 
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2.3.1.3. Experimental techniques 
A useful approach to estimating mass transfer parameters is to relate experimental data to 
empirical equations defining known relationships between experimental measurements and 
mass transfer parameters (Boyer and Hsu, 1992, Natarajan and Cramer, 2000, Persson et al., 
2006). This involves correlating the height equivalent to a theoretical plate (HETP) to the 
hydrodynamic  properties  of  a  column  through  the  plate  height  equation  (Gritti  and 
Guiochon,  2010).  In  this  methodology,  pulse  injections  of  the  molecule  of  interest  are 
conducted at linear adsorption conditions, and the retention time,   , and the peak width at 
half peak height,   . , are recorded as a function of superficial velocity and mobile phase 
conditions. This data is used to calculate the HETP using the following equation: 
 
        HETP =	
 
 .   ∙  
  . 
  
 
 
         [2.1]  
 
where   is the column length. The HETP is plotted against the superficial velocity. The 
HETP vs velocity data is compared with a plate height equation which is derived from 
moment analysis of the rate model being used. The derived equations are complex, and the 
derivation is tedious, involving successive differentiations of the Laplace transform solution 
of the chromatography model used (Guiochon et al., 2006). However, once the plate height 
equation has been formulated, it is straightforward to relate mass transfer parameters to the 
experimental data (Muller – Spath et al., 2011, Ng et al., 2012, Gétaz et al., 2013). 
 
2.3.2. Methods to determine adsorption isotherms 
Adsorption  isotherms  are  used  in  chromatography  models  to  describe  the  relationship 
between a component’s concentration in the mobile phase and in the stationary phase. The 
complexity of protein adsorption means that adsorption isotherm parameters must usually be 
fitted to experimental data. Methods that are used to generate suitable data can be grouped 
into static experimental methods, dynamic experimental methods, the inverse method, and 
the retention time method. A summary of the key features of each method is presented in 
Table 2.5 . 
 
2.3.2.1. Static experimental methods 
In static methods, the equilibrium state of adsorption is measured in multiple experiments 
conducted  over  a  range  of  material  compositions  and  protein  concentrations  (Seidel-
Morgenstern, 2004). The data is combined to create an experimental adsorption isotherm to 
which the isotherm model is fit. The most popular static method is ultra-scale down batch 
adsorption, where solutions of the component under investigation are brought to equilibrium 64 
 
in closed lots of low volumes of resin (< 1 ml). The mobile phase can be analysed and the 
concentration of protein bound to the resin determined by mass balance. Alternatively, the 
bound protein can be eluted and analysed directly.  
 
Ultra-scale down batch adsorption can be tedious, requiring labour intensive experiments, 
and can give inaccurate results. However, it only requires small amounts of protein and can 
be conducted in high throughput mode. In addition, automation by robotic liquid handling 
can greatly decrease the amount of time required whilst increasing accuracy due to better 
precision  (Seidel-Morgenstern,  2004).  The  method  has  been  used  successfully  in  the 
development of models for a range of systems (Susanto et al., 2006, Sun and Yang, 2007, 
Susanto et al., 2008, Gu et al. 2013), including with crude feed material (Bak et al., 2007).  
 
Another static method involves completely equilibrating a column with feed solution of 
known protein concentration. Again, the amount of bound protein can be determined either 
by  mass  balance,  or  by  eluting  all  bound  protein  and  measuring  the  amount  directly. 
However, unless the column volume used is very small, completely equilibrating the column 
at multiple compositions and concentrations is very material and labour intensive. Therefore, 
this method has been used in only very few studies, and only with widely available products 
such as pure IgG (Ng et al., 2012) and BSA (Gu et al. 2013). 
 
2.3.2.2. Dynamic experimental methods 
Dynamic methods are based upon the analysis of the dynamic response to defined changes 
in column inlet protein concentrations (Seidel-Morgenstern, 2004). It is assumed that the 
only source of mass transfer in the column is convection. The adsorption isotherm is then 
directly related to the shape of elution profiles and breakthrough curves. Although the data 
analysis  in  dynamic  experimental  methods  is  more  complex  that  static  experimental 
methods, dynamic experimental methods are popular as all experiments can be conducted on 
one column. The magnitude of the changes to column inlet concentration can be small, 
intermediate or large, and dictates the exact method to determine the adsorption isotherm i.e. 
the perturbation method, elution by characteristic points and frontal analysis, respectively 
(Lisec et al., 2001, Seidel-Morgenstern, 2004). Frontal analysis is commonly used due to its 
relative simplicity, and possible automation, although it requires large amounts of material. 
There  are  examples  of  the  methods  use  for  all  major  retention  mechanisms,  i.e.  anion 
exchange (Kaczmarski et al., 2001, Jakobsson et al., 2005, Gallant, 2004, Osberghaus et al., 
2012a),  cation  exchange  (Melter  et  al.  2008, Muller  –  Spath  et  al.,  2011),  hydrophobic 
interaction (Nagrath et al., 2011), and affinity separations (Ng et al., 2012). The perturbation 
method and elution by characteristic points method are described in the literature (Seidel-65 
 
Morgenstern,  2004),  but  are  rarely  used  as  they  are  difficult  to  apply  to  systems  with 
multiple components.  
 
2.3.2.3. The inverse method 
The inverse method involves using an algorithm to minimize the error between the measured 
elution profile from an experiment, and the profile calculated from the full chromatography 
model  by  varying  isotherm  parameters,  thus  determining  best  fit.  Advancements  in 
numerical methods used to solve parameter estimation problems have resulted in a large 
increase in the use of the inverse method over the past decade (Teoh et al., 2001, Chan et al., 
2008, Melter et al. 2008, Lienqueo et al., 2009, Westerberg et al., 2010, Gerontas et al. 2010, 
Muller – Spath et al., 2011, Osberghaus et al., 2012a, Gétaz et al., 2012), although problems 
have been reported where significant differences are observed in estimated parameter values 
depending on the choice of axial discretisation domain (Kaczmarski, 2007). Also, uncertain 
experimental data can result in large uncertainties in estimated parameter values (Borg et al., 
2013). 
 
2.3.2.4. Retention time methods 
Retention  time  methods  use  the  retention  time  of  components  of  interest  under  linear 
conditions  to  determine  the  initial  slope  of  isotherms  (Mollerup,  2008).  The  method  is 
particularly useful as pulse injections of components onto columns are straightforward to 
conduct, and can be used to explore the impact of mobile phase conditions on the isotherm 
quickly and efficiently. The advantage of using this methodology is that the influence of pH 
and counter ion concentration are captured without having to generate the complete isotherm 
at each unique operating point. In addition, detailed thermodynamic information may be 
determined via comprehensive analysis of the results, which can aid the development of 
isotherms  derived  from  fundamental  thermodynamic  principles  such  as  the  association 
models (Mollerup et al, 2008a, Mollerup, 2008b). However, the method does not give any 
indication of the maximum saturation capacity, and therefore further experiments must also 
be completed in order to complete the calibration of the adsorption isotherm. In addition, the 
methodology requires many experiments with different buffer compositions. In recent years, 
retention time methods have emerged as a popular tool and are now applied regularly in the 
literature because complex chromatographic problems are now being considered where the 
effect of mobile phase composition on adsorption is of key importance (Mollerup et al., 
2007, Melter et al. 2008, Muller – Spath et al., 2011, Nagrath et al., 2011, Nfor et al. 2011, 
Gétaz et al., 2012).  
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Table 2.5. Features of the different methods available for measuring adsorption isotherms, adapted from Seidel – Morgenstern, (2004).  
Method  Type  Material 
requirements 
Favourable features  Unfavourable features  Applicable to 
one solute 
Applicable to 
two solutes 
Applicable to more 
than two solutes 
Batch  Static  Small  Automation  Tedious, not accurate  Yes  Yes  Yes 
Adsorption – 
desorption 
Static  Small  Accurate, automation  Tedious  Yes  Yes  Yes 
Frontal analysis   Dynamic  Large  Easy automation  High material requirements  Yes  Yes  Yes 
Perturbation  Dynamic  Small  No detector calibration 
required 
Isotherm model required  Yes  Yes  Difficult 
Dispersed front 
analysis 
Dynamic  Intermediate  Small number of 
experiments 
High column efficiency 
required 
Yes  No  No 
Chromatogram 
fitting 
Dynamic  Intermediate  Small number of 
experiments 
Models for isotherm and 
mass transfer required  
Yes  Yes  Difficult 
Retention time 
method 
Dynamic  Small  Straightforward to apply 
to systems with variable 
mobile phase conditions 
Only applied at linear 
section of adsorption 
isotherm  
Yes  Yes  Yes 
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2.3.3. Methods to measure void volumes 
Bed voidage, particle porosity and total column porosity are important parameters that are 
related  to  the  bed  and  particle  structure  and  they  can  be  obtained  experimentally  by 
measuring the retention time of suitably sized unretained molecules. Molecules with very 
large molecular weight that do not penetrate particle pores, such as dextran blue, can be used 
to determine the bed voidage. Smaller molecules, such as sodium chloride or acetone, can be 
used to determine the total column porosity. With these values, a simple relation can be used 
to calculate the particle porosity.  
 
The  bed  voidage  has  been  determined  for  many  different  resins  and  systems  and  is 
commonly  around  0.37.  Particle  porosities  are  more  varied  (0.55  –  0.8),  and  are  often 
specified by the resin manufacturer. The effective void volume experienced by the specific 
component may vary depending on the component size, and amendments to models that 
account for this effect have been suggested (de Neuville et al., 2013). The effective porosity 
can be characterised experimentally by conducting inverse size exclusion chromatography 
(iSEC), where dextran standards of known size are used as probe molecules. The fraction of 
the total particle porosity available as a function of molecule size can then be determined 
from the retention time of the dextran standards. Alternatively, the void volumes of a large 
number of commercially available resins have been studied and published in the literature 
(dePhillips  and  Lenhoff,  2000,  Yao  and  Lenhoff,  2006),  which  can  be  used  directly  in 
models, or as a means of checking measured parameters. 
 
2.4. Model applications 
Models of chromatography can be applied to complete important process development tasks 
such as process optimisation, design space identification, robustness and sensitivity analysis, 
and scale up. In the following section the state of the art in the open literature in these areas 
is reviewed.  
 
2.4.1. Resin selection  
Many different chromatographic resins are now available. The most suitable resin must be 
identified from hundreds of potential candidates early in the development process to leave 
time  for  optimisation  and  validation  studies.  The  identification  is  usually  achieved  via 
experimental high throughput screening methodologies. Model based approaches have been 
proposed  which  may  provide  advantageous  as  resins  can  be  evaluated  at  their  optimal 
operating conditions with minimal experimentation required (Nfor et al., 2011). 
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2.4.2. Purification process synthesis 
Purification  process  synthesis  refers  to  the  task  of  selecting  the  optimal  sequence  of 
chromatography unit operations to purify the clarified crude material following fermentation 
and primary recovery. This is nontrivial as a large number of process alternatives are usually 
possible, especially when the process does not utilize affinity chromatography. Nfor et al., 
(2013) recently demonstrated a methodology for selecting the most optimal process scheme 
for the purification of a monoclonal antibody from a crude mixture, employing a systematic 
cycle of flow sheet synthesis, optimisation, evaluation and rational elimination of the least 
feasible  options  at  each  purification  step  based  on  the  specific  needs  of  that  step.  The 
process evaluation was based on the performance of optimized mechanistic models for each 
step, and thus provided a more accurate indication of the most favourable sequence when 
compared to alternate approaches. 
 
2.4.3.  Process optimisation 
There are useful examples of mathematical optimisation of the chromatographic purification 
of therapeutic proteins using mechanistic models of chromatography, where mathematical 
optimisation refers to minimising or maximising an objective function by varying decision 
variables subject to constraints (Degerman et al., 2006, 2007, Ng et al., 2012, Osberghaus et 
al., 2012b). Common factors to consider in the objective function include the yield and 
productivity  of  the  chromatographic  separation,  and  the  purity  of  the  product.  When 
considering multiple objectives, cost functions have been used which define the relative 
importance of each factor when optimising a particular process (Lienqueo et al., 2009). 
Alternatively,  multiple  optimisations  can  be  completed  where  the  objective  function  is 
changed each time so that each factor is weighted differently. The resulting optimal values 
can then be used to generate a Pareto front useful for exploring the trade-off between the 
different factors (Degerman et al., 2009, Gétaz et al., 2012).  
 
If the yield, productivity and purity are not included in the objective function, then they are 
usually included as a constraint. A wide range of decision variables are usually available in 
chromatographic separations. Column length, flow rate, volumes (wash, load and elution), 
buffer composition (e.g. ionic strength, pH) have all been considered. A recent study by 
Osberghaus et al. (2012a) compared mechanistic and empirical model based approaches for 
the optimisation of a three component separation, and concluded that for processes with low 
robustness,  the  performance  of  a  DOE  approach  was  significantly  inferior  to  the 
performance of a mechanistic model, resulting in inaccurate predictions and a sub optimal 
process. However, discussion of the advantages and disadvantages revealed useful synergies 
between the two approaches, which suggested process optimisation should start with the 69 
 
traditional  DOE  approach  in  order  to  comfortably  and  quickly  reveal  important  factors 
which will generate a basic understanding of the chromatography. Then the outcomes from 
this study can be used to direct the development of a mechanistic model, using data from 
DOE experiments for model calibration and validation. The mechanistic model can then be 
used  for  detailed  process  optimisation,  as  well  as  other  development  tasks  which  are 
discussed in this section.  
 
Despite the examples seen in the literature, mathematical optimisation of the sort described 
above does not see regular use in industry due to the large and frequent variance of inlet 
material,  uncertainties  in  controlled  process  parameters,  and  frequency  of  non-ideal 
phenomena such as resin fouling which promotes a focus on identifying the most robust 
operating conditions, rather than optimising for particular scenarios. 
 
 
2.4.4. Design space identification 
Mechanistic models are ideally suited to design space identification as they can explore 
different operating conditions and design parameters with greater efficiency and speed than 
an experimental approach, although few examples have been published in the literature. 
Degerman  et  al., (2009), used a  mechanistic  model  to identify  the  design  space for  the 
purification  of  IgG  from  BSA  by  gradient  elution  using  hydrophobic  interaction 
chromatography.  The  method  used  was  based  on  Pareto  optimisation  assuming  that  the 
process should only be run at optimal operating points, with Pareto fronts developed for 
different magnitudes of process disturbances which provide information that are used to 
determine  a  suitable  design  space. The  method  combines  both  process  optimisation  and 
design space determination whilst accounting for parameter uncertainty and operating point 
sensitivity. Although it requires a large number of simulations to be performed and does not 
provide information for non-optimal operating conditions, it is a very useful example of a 
model based approach to design space determination.  
 
Gétaz et al., (2013), use a similar approach to determine the design space for the purification 
of a 4.3 kDa polypeptide crude mixture via gradient elution using a Kromasil 100 A 10  m 
C8  (hydrophobic  interaction)  high  performance  liquid  chromatography  (HPLC)  column. 
Optimal operating conditions were determined by Pareto optimisation, and then the response 
of product critical quality attributes to variations in process parameters was plotted as a 
function of loading and elution volume in order to indicate the design space borders. Both 
examples highlight the importance of accounting for process variability in order to assure the 
registered  design  space  is  robust.  In  addition,  although  ideally  the  design  space  should 70 
 
contain a dimension for every process parameter, in practice due to the complexity of such a 
multi-dimensional design spaces, the number of parameters considered is limited to two.  
 
The issue  of  how  to  communicate  multidimensional  design  spaces  is  a  wider  challenge 
associated  with  design  space  identification  that  is  not  just  limited  to  model  based 
approaches, but is also a key challenge for experimental approaches, as it limits operating 
parameter  ranges  defined  in  regulatory  submissions  to  linear  combinations  of  process 
parameters, limiting design space size and excluding many feasible points of interest.  
 
2.4.5. Robustness and sensitivity analysis 
An  important  task  in  the  development  of  a  chromatographic  step  for  purification  of  a 
therapeutic protein is concerned with ensuring that the process can cope with bioprocess 
variability (Rathore, 2009). Maximising process robustness, and minimising sensitivity to 
disturbances, are key aspects of this effort. Model based approaches to these tasks have been 
considered in the literature (Jakobsson et al., 2005, Degerman et al., 2009, Westerberg et al., 
2012, and Gétaz et al., 2013).  
 
Jakobsson et al. (2005), conducted a full factorial study of six factors on the purity and yield 
of the ion exchange purification of BSA, myoglobin and IgG. Using the results the relative 
importance and effect of each process parameter was determined.  Degerman et al. (2009) 
used a model based approach to determine which process parameters were critical to control 
in order to assure process robustness for three case studies: (i) purification of IgG from BSA 
with  hydrophobic  interaction  chromatography,  (ii) purification  of  insulin  from  desamido 
insulin with reversed phase chromatography, and (iii) purification of IgG from BSA and 
myoglobin  with  hydrophobic  interaction  chromatography.  Parameters  were  ranked 
according  to  importance,  and  risk  of  batch  failure  was  determined  for  each  case  study 
accounting for uncertainty in a selection of process parameters. Gétaz et al. (2013) varied 
both process parameters (flowrate, loading, column length, feed concentrations, and buffer 
compositions)  and  model  parameters  (mass  transfer  coefficient  and  saturation  capacity) 
around the standard operating conditions that had been found via process optimisation. The 
results  were  used  to  determine  critical  process  parameters  depending  on  the position  of 
operation within the design space, and to determine correlated effects. All studies described 
found that process disturbances significantly decrease design space size, and illustrate the 
importance of process robustness in order to assure product quality. 
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2.4.6. Process scale up 
Scale up strategies currently employed in industry are based on keeping the bed height and 
linear  velocity  constant.  Process  development  experiments  must  therefore  be  conducted 
whilst keeping the bed height constant. This limits the minimum column volume that can be 
used for these experiments. Compared to a shorter bed height, the extra length of column 
means that experiments are more time consuming, and the extra volume means that larger 
amounts of material are required. As the mechanistic models of chromatography capture the 
underlying phenomena which are driving purification processes, they can provide useful 
information on alternative approaches to process scale up (Mollerup et al. 2007). Gerontas et 
al. (2010)  were able to demonstrate how a mechanistic model can be developed using scale 
down  columns  with  reduced  bed  heights  (and  thus  volumes),  and  then  the  validated 
mechanistic model can be used to predict process operation in columns at full bed height, 
thus  achieving  significant  savings  in  terms  of  time  and  material.  Despite  the  simplified 
composition of the feed material considered (BSA and lactoferrin were selected due to the 
difficulty in procuring the very large amounts of protein required to load the manufacturing 
scale columns), the study demonstrated how a relatively simple application of a mechanistic 
model can be of enormous value for industry where time and material constraints are of 
great importance. 
 
2.5. Concluding remarks 
In order for first principles modelling approaches to be applied in industry for the design and 
development of chromatographic processes for the purification of proteins, a large body of 
evidence  and  best  practices  must  be  developed  in  the  literature.  The  literature  review 
considered three key areas, model formulation, model calibration and model applications. 
The key findings are summarised in this section, and in Appendix A, which details the 
referenced studies, indicating the mode of chromatography, retention mechanism, molecule 
of  interest,  load  material  composition,  adsorption  model,  mass  transfer  model,  and  any 
subsequent model applications. 
 
A large number of well understood options are available for modelling the movement of 
solutes through the packed bed of porous particles via mass transport mechanisms. The exact 
choice  of  model  depends on  the  specific  objectives  of  the  modelling  project.  The  most 
frequently  used  model  is  the  general  rate  model,  which  describes  convection,  axial 
dispersion, diffusion through an external film surrounding resin particles, and intraparticlar 
diffusion through the stagnant mobile phase within particle pores (Guiochon et al., 2006). 
This is usually sufficiently accurate for most chromatographic separations. More complex 72 
 
models  are  available  if  required,  which  include  equations  describing  surface  diffusion 
(Kaczmarski et al., 2002, 2003, Sun and Yang, 2007), pore shrinkage (de Neuville et al., 
2013),  and  heterogeneity  in  particle  and  packed  bed  structure  (Gerontas  et  al.,  2013). 
Alternatively, simpler models such as the lumped pore model, lumped kinetic model, and 
equilibrium  dispersive  model  are  available  for  circumstances  where  high  computational 
efficiency or fast model development is important (Kaczmarski et al., 2001).  
  
Mass conservation equations are linked with equations describing adsorption to complete the 
chromatography model. Despite the wide range of options available, in practice, adsorption 
models  are  generally  restricted  to  what  is  experimentally  measurable,  and  the  ability  to 
distinguish between different adsorption phenomena is limited and difficult. In addition, it is 
desirable to keep the number of adjustable parameters to a minimum, as a higher complexity 
of model degrades the validity of the mechanistic meaning of the models parameters, i.e. the 
mechanistic model becomes more like a statistical model. As a result, the application of 
adsorption models has mainly been limited to simpler expressions, such as the Langmuir 
isotherm.  Additional  complexity  is  often  described mathematically  by  extending  simpler 
isotherms to account for competition, mobile phase modulators, and kinetic effects. In recent 
years,  increasingly  complex  chromatographic  systems  have  been  considered  (i.e. 
Osberghaus et al., 2012a, Guélat et al. 2012, Borg et al., 2013 etc), which has seen the 
utilisation of greater adsorption isotherm complexity such as the steric mass action (Bak et 
al., 2007), and association isotherms (Mollerup et al., 2008). However, the modelling of 
complex industrial systems is still extremely difficult because of the lack of options and 
approaches for describing heterogeneous, multi-component load material. 
 
One area that has so far seen little consideration in the chromatography modelling literature 
are  aging  effects  such  as  resin  fouling  and  ligand  leaching,  and  undesirable  reactions 
between material components during separations such as aggregation. These phenomena can 
seriously impact process performance (Staby et al, 1998, Jin et al., 2009). If first principles 
modelling approaches are to provide a true alternative to existing experimental approaches, 
mathematical descriptions must be formulated and integrated into chromatography models, 
otherwise there is a risk of dangerously optimistic performance predictions. In addition, the 
lack of discussion and emphasis on these undesirable phenomena in the modelling literature 
may result in many experimentalists disregarding and dismissing mechanistic modelling, 
without considering the benefits such an approach may bring. 
 
Model calibration involves determining values for model parameters. There are three main 
approaches for determining mass transfer parameters. The first involves the use of literature 73 
 
correlations. The second is known as the inverse method, where an algorithm is used to 
minimise the error between experimental measurements and model predictions by changing 
the mass transfer parameter in question. The third approach involves relating experimental 
data  to  empirical  equations  defining  known  relationships  between  experimental 
measurements  and  mass  transfer  parameters.  All  are  well  understood,  have  been  used 
extensively,  and  are  often  used  together  to  increase  confidence  in  estimated  parameter 
values.  
 
Similarly, adsorption isotherm parameters can be determined using a range of approaches. 
Static experimental methods include batch adsorption experiments conducted using scale 
down and laboratory scale systems. Dynamic experimental methods include frontal analysis, 
perturbation analysis and elution by characteristic points (Seidel-Morgenstern, 2004). Other 
methods include the inverse method where isotherm parameters are fit to chromatograms 
from column runs (Teoh et al., 2001, Kaczmarski, 2007), and retention time methods which 
can quickly determine the isotherm at linear adsorption conditions over a range of mobile 
phase  conditions  (Mollerup  et  al,  2008a).  As  with  the  estimation  of  mass  transfer 
parameters, although each method can be applied on its own, (Susanto et al., 2008, Gerontas 
et al. 2010, Ng et al., 2012), the complexity of protein adsorption means that in practice, 
multiple  methods  are  often  used  together  to  ensure  accurate  isotherm  parameters  (i.e. 
Jakobsson et al., 2005, Nfor et al. 2011, Muller – Spath et al., 2011, Osberghaus et al., 
2012a).  
 
Void volumes are usually determined experimentally by measuring the retention time of 
suitably sized unretained molecules, or taken from the published literature. Care must be 
taken  when  the  experimental  approach  is  used,  but  in  general  it  is  straightforward  to 
complete.  However,  assuming  uniformly  porous  resin  structure  can  result  in  prediction 
errors  due  to  dynamic  phenomena  such  as  hindered  diffusion.  In  this  case,  it  may  be 
necessary to use inverse size exclusion to characterise the pore size distribution.  
 
The application of chromatography models for process purification development has seen 
less  consideration  in  the  literature  than  model  formulation  and  calibration,  although  the 
introduction of quality by design has seen a sharp increase in interest in recent years. There 
have been publications demonstrating the use of models for a wide range of development 
tasks, such as resin selection, whole process synthesis, process optimisation, design space 
formulation and analysis, robustness and sensitivity analysis, and process scale up. All of 
these studies show the great potential for first principles modelling approaches. However, 
only a few consider real industrial systems where crude feed material is purified rather than 74 
 
well-known model proteins, and many proposed approaches require similar or greater time 
and material than alternative experimental approaches. 
 
In summary, the key areas that need addressing before first principles modelling approaches 
are accepted by industry as a feasible aid or alternative to experimental approaches are all 
related  to  the  practical  implementation  of  modelling  approaches  in  industry.  There  is  a 
fundamental lack of mathematical descriptions and approaches to characterise and calibrate 
relevant model parameters for describing the non-ideal phenomena and the challenging feed 
material compositions that are commonplace in industry. In addition, more often than not, 
little consideration is given to how to apply the relevant mathematical and experimental 
techniques described in this chapter in an industrial environment with limited time, material 
and money. More needs to be done to demonstrate how the advantages of a model based 
approach  can  be  leveraged  in  an  industrial  environment  to  generate  value,  when  there 
remains an established experimental alternative that is well understood by regulators and 
biopharmaceutical companies alike, which has been proven with many examples in the past. 
 
2.6. Aims of the thesis 
The aim of this thesis is to derive fundamental process understanding of specific industrial 
chromatographic  separations  currently  in  development  or  operation  at  Pfizer,  via  the 
development and application of mechanistic models chromatography, in order to accelerate 
the development and increase the robustness of industrial protein purification processes, 
whilst following guidance regarding the implementation of Quality by Design. A range of 
experimental and mathematical methods are used to achieve a number of objectives related 
to specific chromatography processes currently in development or operation at Pfizer: 
 
2.6.1. Chapter 3 - Weak partitioning chromatography 
Pfizer utilise an anion exchange chromatography step operated in weak partitioning mode as 
part of their two - step platform monoclonal antibody purification process (Kelley et al., 
2008a).  The  step  has  consistently  provided  excellent  clearance  of  impurities  whilst 
maintaining high step yields (> 90 %) for numerous proteins (Kelley et al., 2008, Iskra et al, 
2013). However, feed material with high levels of product aggregates can occasionally pose 
a purification challenge, where operating conditions need to be carefully chosen in order to 
assure impurity clearance. In extreme cases, additional chromatography columns may be 
required. The current experimental procedure used to identify operating conditions (high 
throughput batch binding studies (HTS) followed by scale down column studies), requires a 75 
 
significant amount of time and material for challenging feed material compositions, contrary 
to industrial objectives at an early stage of process development.  
 
Developing an exhaustive chromatographic rate model is unlikely to be feasible at an early 
stage  of  process  development  due  to  limited  time,  material  and  analytics.  Therefore,  a 
simplistic  ‘platform’  model  of  the  WPC  system  that  can  be  applied  irrespective  of  the 
particular molecule will be developed. The aim is to aid the existing experimental process 
development procedure by providing a link between HTS and scale down column studies. 
The model will provide a more informative means for exploring how process parameters can 
be controlled in order to raise product recovery to acceptable levels and maintain impurity 
clearance.  Stochastic  simulation  will  be  used  to  increase  understanding  of  process 
robustness, and to identify prospective operating conditions for further development that can 
assure product quality when purifying material with challenging compositions. 
 
2.6.2. Chapter 4 - Resin fouling 
Resin  aging/fouling  during  process  operation  can  significantly  decrease  anion  exchange 
chromatographic  performance  (Staby  et  al,  1998,  Jin  et  al.,  2009).  There  is  a  lack  of 
fundamental  knowledge  and  mechanistic  understanding  of  fouling  in  industrial 
chromatographic processes. Therefore, the application of mechanistic models to industrial 
chromatographic  processes  is  problematic,  because  model  predictions  are  restricted  to 
columns containing clean/new resin. Resin fouling of the anion exchange weak partitioning 
chromatography  step  considered  in  chapter  three  had  been  observed  during  purification 
process  development  of  a  monoclonal  antibody.  Significantly  earlier  breakthrough  of 
impurities  and  premature  loss  of  capacity  was  observed  during  experimental  studies 
conducted  by  Iskra  et  al.  (2013).  The  fouling  was  attributed  to  a  unique  quality  of  the 
particular feed stream.  
 
In this thesis, the location of the foulant will be revealed, and the effect of fouling on protein 
uptake kinetics and resin capacity will be determined. The knowledge gained can increase 
process understanding, and thus provide for better informed process development and model 
formulation. 
 
2.6.3. Chapter 5 - Resin lot variability 
Serious  performance  issues  were  observed  in  a  hydrophobic  interaction  chromatography 
(HIC) step at a late stage of development, which were attributed to resin lot variability. 
(Note that the HIC is part of a different process to the one considered in chapters three and 
four of this thesis). The HIC provides impurity clearance whilst producing a complex final 76 
 
product composed of six closely related variants of a dimer protein therapeutic (~30 kDa), 
with  their  monomer  subunits  in  a  specific  ratio.  Impurity  removal  is  well  understood, 
however, achieving the correct monomer subunit ratio poses a purification challenge. An 
extended range of resin lots had been obtained from the supplier for testing within normal 
process operating ranges. All resin lots were within the manufacturers’ specifications for 
ligand density and chloride capacity. Despite this, many resins failed to meet product quality 
specifications during testing, and would have incurred significant losses if used for the large 
scale manufacture of the product.  
 
A model is developed and used in a process scenario to allow specific variables critical to 
product  quality  to  be  studied.  Stochastic  simulation  is  used  in  order  to  identify  robust 
operating  conditions,  and  the  level  of  control  required  on  uncertain  process 
parameters/variables to bring process robustness to an acceptable level. 
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Chapter 3.  Weak Partitioning Chromatography 
A model based approach for linking experimental high throughput batch bind screens (HTS) 
and  scouting  runs traditionally  conducted  during  process  development is  proposed.  The 
approach is specific to a weak partitioning chromatography (WPC) anion exchange (AEX) 
polishing step that is part of Pfizer’s two-step platform monoclonal antibody purification 
process. The approach involves the development of a simplistic ‘platform’ model that can be 
applied to new candidate molecules based on the results of a standard HTS. This is achieved 
by characterising the equilibrium isotherms of three critical components (monomer, dimer 
and multimer) of the WPC separation, as a function of the product partition coefficient, 
rather  than  the  conventional  approach  of  pH  and  counterion  concentration.  Use  of  the 
model  is  limited  to  an  early  stage  of  process  development.  This  reduces  the  impact  of 
inaccuracies due to simplifications made when formulating the model. Important advantages 
are  realised  by  harnessing  the  models’  predictive  power  when  (1)  there  are  maximum 
degrees of freedom available for bioseparation design, and (2) minimal investment has been 
made in the product. The model can quickly identify operating parameter ranges that are of 
interest for the purification of load material with challenging compositions. When combined 
with  stochastic  simulation,  the  model  can  explore  the  impact  of  process  variability  on 
product  quality  and  process  performance.  This  approach  enables  the  purification  of 
previously  impossible  to  purify  feed  streams  using  the  two-step  platform  monoclonal 
antibody  purification  process.  It  also  identifies  promising  parameter  ranges  to  explore 
experimentally,  thus  accelerating  process  development  and  helping  optimise  column 
performance.  
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3.1. Introduction 
A  typical  platform  for  the  purification  of  monoclonal  antibodies  (mAb)  derived  from 
recombinant cell culture employs three chromatographic steps. Protein A capture is followed 
by  two  polishing  steps,  usually  anion  exchange  (AEX)  chromatography  in  flowthrough 
mode, and one of either cation exchange, ceramic hydroxyapatite or hydrophobic interaction 
chromatography. The Protein A capture step removes the bulk of the impurities, and the two 
polishing steps ensure clearance of host cell protein, DNA, high molecular mass species 
(HMMS - also known as aggregated product), virus and leached Protein A. 
 
Weak partitioning chromatography (WPC) is an isocratic mode of protein purification that 
enables  a  two  column  purification  process  (e.g.  Protein  A  affinity  and  AEX  weak 
partitioning chromatography), rather than the established three column process (e.g. Protein 
A affinity, AEX and HIC chromatography). By reducing the number of chromatographic 
steps, process development is accelerated, and development and manufacturing costs are 
reduced. Although similar to flowthrough (FT) mode where impurities bind to the resin and 
the protein of interest flows through to be collected as product, WPC is distinct, as it is 
performed  under  mobile  phase  conditions  where  in  addition  to  impurities  a  significant 
amount of product also binds to the resin. The more stringent binding conditions improve 
removal of impurities such that a third column is no longer required to assure impurity 
clearance,  and  any  loss  in  yield  due  to  adsorption  of  the  product  can  be  restored  by 
extending the load challenge and conducting a wash step at the end of the load phase to 
recover the product. 
 
The  weak  partitioning  mode  is  defined  by  the  product  partition  coefficient,  K ,  falling 
between 0.1 and 20, which is distinct from bind and elute (K  > 100) and flowthrough (K  < 
0.1)  modes  of  chromatography.  The  product  partition  coefficient  is  defined  as  the  ratio 
between the concentration of bound and unbound product in equilibrium in the linear region 
of the adsorption isotherm. In AEX, the product partition coefficient is modulated by the 
mobile phase pH and counterion concentration. Figure 3.1 overlays chromatograms from 
column runs at WPC (K  = 2) and FT (K  < 0.1) conditions. The chromatograms show that 
product breaks through later under WPC conditions, indicating higher protein adsorption 
during the load phase. The additional bound protein is recovered during the wash, without 
reducing impurity removal as illustrated by the larger WPC strip peak. 
 
WPC operating conditions can be rapidly determined using high throughput batch binding 
studies (HTS), where resin is brought to equilibrium with small amounts of protein solutions 79 
 
(<  5  g/L)  at  unique  combinations  of  pH  and  counterion  concentration.  The  protein 
concentration in the supernatant is measured and a mass balance is used to calculate the 
bound concentration and thus the partition coefficient. A response surface can be generated 
from the HTS data that plots the partition coefficient as a function of pH and counterion 
concentration. The response surface forms the basis for the development of a design space 
which provides sufficient clearance of impurities (e.g. host cell protein, DNA, HMMS, virus 
and leached Protein A). Initial ranges of pH and counterion concentration are defined for 
further characterisation by factorial design of experiment (DOE) studies on qualified scale 
down columns. 
 
Several clinical current good manufacturing practice cGMP processes at Pfizer have utilised 
AEX  in  WPC  mode,  which  has  consistently  provided  excellent  clearance  of  impurities 
whilst maintaining high step yields (> 90 %). Studies have shown that WPC is a robust 
polishing step over a wide range of operating conditions. However, feed material with high 
levels of high molecular mass species (especially product dimer) can occasionally pose a 
purification challenge, where operating conditions (e.g. pH, counterion concentration) need 
to  be  carefully  chosen  in  order  to  assure  impurity  clearance.  In  extreme  cases,  a  third 
chromatography column may be required. Scale down design of experiment studies in order 
to identify robust operating conditions for these challenging material compositions require a 
significant amount of time and material, contrary to industrial objectives.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.1. Overlay of chromatograms at flowthrough conditions (Solid line -     < 0.1) and weak partitioning 
conditions (dotted line -   = 2) adapted from Kelley et al., 2008a.   80 
 
A  model  based  approach  for  application  at  an  early  stage  of  process  development  is 
proposed to provide a link between HTS and scale-down column studies. The objective is to 
enhance experimental efficiency, reduce the number of column studies necessary for process 
definition,  and  increase  process  understanding.  The  approach  involves  formulating  a 
simplistic ‘platform’ model of the WPC containing a basic mass balance and a description of 
adsorption equilibrium. The key feature of the approach is that once the model has been 
developed, it can be applied to new candidate molecules based on the results of the standard 
HTS experiment conducted at the start of process development. This is achieved by prior 
characterisation  of  the  equilibrium  isotherms  of  three  critical  components  of  the  WPC 
separation, namely the product monomer, dimer and multimer, as a function of the product 
partition coefficient, K , rather than pH and counterion concentration. 
 
The approach is distinct, but complementary, to developing an exhaustive chromatographic 
rate  model  for  each  molecule,  which  may  not  be  feasible  at  an  early  stage  of  process 
development  due  to  limited  time,  material  and  analytics.  The  ability  to  quickly  and 
efficiently explore potential operating conditions is particularly useful for scenarios where 
challenging  feed  material  compositions  pose  problems  for  an  experimental  approach  to 
process development. The approach is equally useful for increasing understanding of weak 
partitioning chromatography, and can indicate where enhancements to the WPC platform 
can be made. The difference between traditional development and the proposed approach is 
illustrated in Figure 3.2. 
 
In this chapter, the platform model is developed and then tested. Ultra-scale down batch 
adsorption experiments are used to collect the data required to fit model parameters. Existing 
platform knowledge of how WPC operates, and molecule specific information provided by 
Pfizer, is used to choose relevant mobile phase conditions to characterise the equilibrium 
isotherms of the three critical components (monomer, dimer and multimer). The model is 
applied  to  two  case  studies  to  demonstrate  how  the  model  can  be  applied  during  early 
process  development.  In  addition,  an  in-depth  analysis  of  monomer  –  dimer  selectivity, 
maximum load challenge, recovery, and the impact of uncertainty in the AEX WPC system 
is conducted, supported by relevant experimental studies. The results show how a model 
based approach based on fundamental process understanding can be used at an early stage of 
process development for exploring how process parameters (e.g. partition coefficient, load 
challenge and load concentration) can be controlled in order to raise product recovery to 
acceptable levels, whilst maintaining robust impurity clearance. 
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Figure 3.2. The difference between a traditional and the proposed early stage development approach utilising 
simplistic ‘platform’ model of WPC to provide a link between high throughput screening experiments and scale 
down column studies 
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3.2. Experimental Materials and methods 
3.2.1. Materials 
Therapeutic protein and feed material 
Two  different  humanized  IgG1monoclonal  antibodies  (mAb  A  and  B)  are  used  in  this 
chapter. Both were produced in recombinant chinese hamster ovary (CHO) cells grown in 
serum free medium. Downstream processing prior to AEX WPC consisted of centrifugation 
and  depth  filtration,  followed  by  Protein  A  chromatography.  Load  material  used  in 
experiments was derived from Protein A peak pools generated during either scale down 
process development or pilot plant studies. The correct pH and counterion concentration was 
achieved in load material by buffer exchange and dilution/concentration. Protein A peak 
pool material typically contained the product of interest, host cell proteins, DNA, residual 
Protein  A  which  had  leached  from  the  affinity  capture  resin,  and  high  molecular  mass 
species (HMMS) comprised of dimer and multimer. 
 
Chromatography resin 
Fractogel® EMD TMAE HiCap (M) anion exchange resin was obtained from EMD Merck 
(Darmstadt, Germany). 
 
Equipment 
All  preparative  scale  laboratory  experiments  were  carried  out  using  an  ÄKTA  FPLC 
chromatography system from GE Healthcare (Uppsala, Sweden). Laboratory columns used 
for WPC were 0.5 cm in diameter and 15 cm in height. A Tosoh TSK – GEL G3000SWXL 
high performance liquid chromatography (HPLC) column was used for analytics. 
 
3.2.2. Experimental methods 
 
Depth filtration 
Depth filtration was used to reduce the amount of negatively charged species that were not 
considered in the model (HCP, DNA and leached Protein A) in neutralised Protein A peak 
pool material, prior to batch adsorption experiments. A XOHC depth filter was obtained 
from  EMD  Millipore  (Billerica,  MA).  26  cm
2  µPOD  format  filters  were  used  for  all 
experiments. The depth filter is based upon diatomaceous earth and is positively charged. It 
was  used to  reduce  the amount  of  negatively  charged  species  (HCP,  DNA  and  leached 
Protein  A)  in  neutralised  Protein  A  peak  pool  material,  prior  to  batch  adsorption 
experiments. Before loading, the filters were flushed with 100 L/m
2 RO water to remove 83 
 
preservative followed by 50 L/m
2 of equilibration buffer. Filters were loaded up to 200 L/m
2 
at 200 LMH. After loading, any remaining protein was blown out of the filter with air. 
 
High throughput screening for    contours 
High throughput screening had been conducted prior to this work by Pfizer for the two 
different  candidate  monoclonal  antibodies,  A  and  B.  The  data  was  used  to  estimate 
parameters of response surface models of the partition coefficient, K , as a function of pH 
and counterion concentration for each mAb. The response surface model was used to help 
choose relevant mobile phase conditions to characterise the equilibrium isotherms of the 
three critical components (monomer, dimer and multimer). The high throughput screening 
methodology  is  presented  in  detail  in  the  literature  (Kelley  et  al.,  2008a),  showing  the 
excellent fit (r
2 > 0.985), and high significance of parameters (p < 0.01), typically achieved 
during parameter estimation. The regression equations for mAbs A and B are presented in 
Table 3.1 and Table 3.2. Figure 3.3 shows the product partition coefficient as a function of 
pH and counterion concentration for monoclonal antibodies A and B generated using the 
response surface models (RSM) provided by Pfizer.  
 
Table 3.1. Monoclonal antibody A regression equation terms and estimate 
Term  Estimate 
Intercept  -6.99 
Total	Cl   - 0.015 
pH   0.90 
 pH − 8.3  ×  pH − 8.3    0.47 
 Cl − 45.23 ×  Cl − 45.23    0.00013 
 pH − 8.3  ×  Cl − 45.23    - 0.018 
 
Regression Equation: 
 
log	Kp = −6.99 +  Total	Cl × −	0.015  +  pH × 0.90  +   pH − 8.3  ×  pH − 8.3  ×
0.47  +   Cl − 45.23  ×  Cl − 45.23  × 0.00013  +   pH − 8.3  ×  Cl − 45.23  × −0.018  		  
 
 
 
 
Table 3.2. Monoclonal antibody B regression equation terms and estimate 
Term  Estimate 
Intercept  - 6.37 
Total	Cl   -0.013 
pH   0.91 
 pH − 7.74 ×  pH − 7.74    0.38 
 Cl − 50.25 ×  Cl − 50.25    0.000058 
 pH − 7.74 ×  Cl − 50.25    - 0.020 
 
Regression Equation: 
 
log	Kp = −6.37 +  Total	Cl × −	0.013  +  pH × 0.91  +   pH − 8.3  ×  pH − 8.3  × 0.38  +
  Cl − 45.23  ×  Cl − 45.23  × 0.000058  +   pH − 8.3  ×  Cl − 45.23  × −0.02  		  
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Figure 3.3. Monoclonal antibody A and B product partition coefficient, K , contours as a function of pH and 
counterion concentration. The contour plots were generated using response surface models generated from high 
throughput screening studies conducted prior to this work at Pfizer.  
 
 
Batch adsorption experiments 
Batch adsorption experiments were conducted using mAbs A and B to generate data for 
estimating isotherm parameters for monomer, dimer and multimer adsorption in the WPC 
AEX system. HCP, DNA and leached Protein A was removed prior to batch adsorption 
studies via depth filtration (mAb A) or WPC (mAb B). MAb A material contained 89% 
monomer, 8% dimer and 3% multimer. MAb B material contained 89% monomer, 2% dimer 
and 9% multimer. Response surface models (Table 3.1 and Table 3.2) provided by Pfizer 
were  used  to  select  pH  and  counterion  concentrations  (Table  3.3)  for  batch  adsorption 
experiments.  The  experiments  were  designed  in  order  to  ensure  broad  coverage  of  the 
mobile  phase  conditions  typically  explored  during  process  development.  Figure  3.4 
illustrates the breakdown of the experimental study. The concentration of monomer, dimer 
and  multimer  in  the  solid  and  liquid  phase  was  determined  for  three  product  partition 
coefficients (K  = 1, 3 and 10), at three unique counterion/pH combinations for each product 
partition  coefficient,  and  5  different  load  concentrations  ([C0]  =  0.2,  0.5,  1,  1.5  and  2 
mg/ml), with all experiments repeated in triplicate.  
 
The experiments were based on the work of Coffman et al. (2008), conducted in a 96-well 
800µl were round-well filterplates with 0.45 µm pore-size polypropylene membrane, and 
repeated in triplicate. 25µl of resin was taken from a bulk reservoir and dispensed by the 
robotic  liquid  handler  into  the  individual  wells  as  25%  (v/v)  slurry  in  the  appropriate 
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equilibration buffer. The plate was then centrifuged to evacuate excess liquid and leave 
damp resin. Subsequently, load material was added into wells containing the resin. The 
initial concentrations for each filter plate well were produced by mixing together protein 
from bulk solutions of known concentrations and compositions, with the appropriate amount 
of equilibration buffer from a bulk solution in order that the total volume of liquid dispensed 
into each well was 275µL (    ). The resin and solutions were then agitated on a platform 
shaker for 120 minutes. Studies have indicated that this incubation time was suitable for this 
system (Kelley et al. 2008a). Foil adhesive tape was used on the underside of the filter-plate 
to prevent liquid loss during shaking. 
 
 
 
Table 3.3. Mobile phase conditions used in batch adsorption isotherm experiments 
Target  K   Condition identifier  Ionic strength (mM)  pH 
1  A1  15  8.00 
1  A2  30  8.24 
1  A3  50  8.58 
1  B1  35  7.52 
1  B2  50  7.70 
1  B3  70  8.05 
3  A1  15  8.36 
3  A2  30  8.61 
3  A3  50  8.96 
3  B1  70  8.56 
10  A1  15  8.67 
10  A2  30  8.93 
10  A3  50  9.29 
10  B1  30  8.19 
10  B2  50  8.53 
10  B3  65  8.85 
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Figure 3.4. Breakdown of experimental batch adsorption studies used to characterise the adsorption equilibria of 
monomer, dimer and multimer 
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After incubation, a centrifuge evacuated the supernatant into a UV-transparent 96 well micro 
plate  which  was  stacked  beneath  the  filter  plate  for  analysis.  The  supernatant  was  then 
analyzed  by  a  96-well  UV  spectrophotometer  (SpectraMax  250,  Molecular  Devices, 
Sunnyvale,  CA)  to  determine  the  concentration  of  protein  in  the  supernatant,    
 .  Size 
exclusion  chromatography  (SEC)  high  performance  liquid  chromatography  (HPLC)  was 
used  to  determine  the  percentage  of  each  component  in  the  supernatant,    
 .  The 
concentration of the protein in the mobile phase is then calculated from Eq 3.1: 
 
  
  =
      ∙  
 
            [3.1] 
 
where   
  is the concentration of component   in the mobile phase in mg/ml,        is the 
measured  concentration  in  the  supernatant  of  the  micro  well  determined  by  UV 
spectroscopy, and   
  is the percentage of component   in the mobile phase as determined 
by SEC HPLC.  
 
An elution cycle was then conducted following the same methodology as the load cycle, 
where 275 µL of elution buffer was added to each well, the plate agitated on a platform 
shaker for 120 minutes and the supernatant subsequently collected as described previously 
and analysed using the spectrophotometer and SEC HPLC. The amount of protein adsorbed 
per unit volume settled resin,   , was calculated using Eq 3.2:  
 
   =		 
        
      
  ∙          ∙	 
  
       
           [3.2] 
 
where          is the concentration of the elution supernatant (mg/ml) determined by UV 
spectroscopy,   
        is the percentage of component   in the elution phase as determined 
by SEC HPLC,          is the volume of the elution supernatant (275 µl in this work), and 
       is the settled volume of resin in the microwell (25 µl in this work). 
 
Size exclusion HPLC 
Size exclusion HPLC was used to determine the relative percentages of monomer, dimer and 
multimer in samples (taken from both batch adsorption experiments and column runs). The 
size exclusion (SEC) HPLC assay utilises a Tosoh TSK – GEL G3000SWXL stainless steel 
column, 7.8 mm  ID  × 30 cm length, 5 μm  mean particle size. After equilibrating the 
column with 10 mM Sodium Phosphate, 500 mM Sodium Chloride at pH 7.3 for 90 minutes 
or until a stable baseline is established, 50 µl samples at approximately 3 mg/ml are injected 
onto  a  column  at  a  flowrate  of  0.5  ml/min.  The  separation  is  isocratic.  Molecules  are 88 
 
separated by their hydrodynamic volume, and elute in order of molecular size (largest first). 
Absorbance  at  280  nm  is  measured  at  the  column  exit.  Integration  of  the  resulting 
chromatogram  and  analysis  of  the  relative  percentage  area  of  each  peak  indicates  the 
percentage  of  each  component  in  the  sample.  The  total  time  to  run  each  sample  is  30 
minutes. 
 
Weak partitioning chromatography 
Column  runs  were  conducted  to  validate  model  predictions.  During  all  experiments  the 
columns were first equilibrated with buffer at the desired pH and counterion concentration. 
Load  material  at  the  desired  pH  and  counterion  concentration  was  then  applied  to  the 
column  at  150  cm/hr.    In  certain  experiments  the  load  was  followed  by  a  wash  of  the 
equilibration buffer. The load eluate (and wash if present) was collected as the process pool, 
and any remaining bound protein was removed using a 2 M NaCl strip buffer.  The columns 
were sanitized with 2 M NaCl, 0.5 M NaOH and stored in 16% ethanol, 150 mM NaCl, 50 
mM TRIS, pH 7.5. 
 
Summary 
In  order  to  characterise  the  adsorption  equilibria  of  the  two  monoclonal  antibodies  on 
Pfizer’s WPC AEX platform process, material was generated via column experiments, and 
prepared for batch adsorption studies by depth filtration, followed by buffer exchange and 
dilution/concentration. High throughput batch adsorption studies were then conducted. A 
robotic liquid handler deposited resin into 96 well plates, and protein was added to each well 
by hand. The liquid supernatant was collected for analysis via centrifugation following resin 
equilibration and resin strip. The total concentration and percentage of each species in the 
material were measured using UV spectroscopy and size exclusion high performance liquid 
chromatography, respectively. All experiments were repeated in triplicate, and the resulting 
data was used for estimating adsorption isotherm model parameters. In order to validate the 
model  and  test  the  proposed  approach,  multiple  column  studies  were  conducted.  In  all 
studies,  material  was  prepared  by  buffer  exchange  and  dilution/concentration,  and  the 
analytical techniques used for characterising flowthrough, wash and strip fractions collected 
during experiments were identical to those used in the batch adsorption studies. 
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3.3. Mathematical methods 
 
3.3.1. Chromatography model  
Adsorption isotherm 
Single  component  Langmuir  isotherms  were  used  to  describe  the  adsorption  of  the 
monomer,  dimer  and  multimer  species  in  the  AEX  WPC  system.  The  model  assumes 
monolayer adsorption at a finite number of equivalent and identical binding sites, with no 
lateral  interactions,  steric  hindrance,  migration  of  adsorbed  molecules  on  the  adsorption 
surface,  or  competition  for  binding  sites  between  species.  In  particular,  assuming  no 
competition  for  binding  sites  is  unrealistic  in  the  multicomponent  AEX  WPC  system. 
However, the experimental effort required to elucidate competitive phenomena is prohibitive 
at  an  early  stage  of  process  development.  The  impact  of  this  erroneous,  but  necessary, 
assumption on model predictions was minimised by: (i) fitting model parameters to data 
collected under competitive conditions typically experienced in the industrial process, where 
monomer accounts for 85-90 % of the load material, and (ii) restricting the application of the 
final  model  to  an  early  stage  of  process  development.  The  single  component  Langmuir 
adsorption  isotherm  was  extended  to  cover  the  mobile  phase  conditions  considered  in 
experimental studies by writing the adsorption isotherm parameters,    and   , as a function 
of the product partition coefficient, K , for monomer and dimer, and constant for multimer: 
 
      =		
  ∙  
    ∙  
										∀  = Monomer,dimer,multimer       [3.3] 
             =          ∙ 	K           [3.4] 
           =        ∙ 	K             [3.5] 
              =                      [3.6] 
             =	       ∙ K             [3.7] 
           =		       ∙ 	K  + γ          [3.8] 
              =                      [3.9] 
where 
 
   = Bound concentration of component i [mg/ml] 
   = Mobile phase concentration of component i [mg/ml] 
   = Adsorption constant of component i 
   = Adsorption constant of component i 
   = Adsorption constant of component i 
   = Adsorption constant of component i 
γ = Adsorption constant 
K  = Product partition coefficient 90 
 
Mass conservation 
A  simple  mass  balance  is  used  to  predict  the  amount  of  each  species  collected  in  the 
flowthrough  during  column  runs,  i.e.  the  capacity  of  the  column  for  each  species  (as 
predicted by the adsorption isotherm model) is subtracted from the amount of each species 
loaded  onto  the  column.  The  flowthrough  amounts  can  then  be  used  to  predict  column 
performance such as product recovery and purity.  
 
3.3.2. Adsorption isotherm parameter estimation 
The  ‘parameter  estimation’  entity  in  gPROMS
TM  is  based  on  the  SRQPD  sequential 
quadratic  programming  code,  and  was  used  to  estimate  parameters,	    and    ,  from  the 
empirical equations, which link the Langmuir adsorption isotherm parameters,    and   , to 
the  product  partition  coefficient,  K .  Parameter  estimation  was  based  on  the  maximum 
likelihood formulation,  which  determines  values  for  the uncertain physical  and  variance 
model parameters that maximise the probability that the model will predict measured values 
from  development  experiments  (Process  Systems  Enterprise,  2013).  Parameters  were 
estimated by fitting the single component Langmuir isotherm model to batch adsorption 
experimental data (section 3.3.2). 
 
3.3.3. Stochastic simulations 
Stochastic simulations were conducted to explore the impact of uncertainty/variability on 
process  performance.  Uncertainty  in  process  parameters  of  interest  is  accounted  for  by 
specifying  a  probability  distribution  function  with  appropriate  arguments  (e.g.  a  normal 
distribution defined by the average and standard deviation). During stochastic simulations, a 
built in function within gPROMS is used that returns a random value sampled from the 
probability distribution function. Each time a simulation is run, a different value is picked 
for the uncertain variable/parameter of interest. Multiple simulations are conducted (> 5000). 
Process performance parameters (e.g. recovery) and/or critical product attributes or interest 
(e.g.  purity)  are  recorded.  The  data  is  used  to  generate  process  performance  mean  and 
variance as a function of process parameter/variable mean and variance. The performance 
parameters  considered  in  this  chapter  are  the  monomer  recovery  and  purity  in  the 
flowthrough material. The sequence of calculations is illustrated in an example shown in 
Figure 3.5. 
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Table 3.4. Uncertain process parameters
Process parameter  Uncertainty  Notes 
Equilibration buffer pH  ± 0.05 pH  Neutralised Protein A peak pool is brought to correct pH by titration. If 
TRIS is used, note it has a pI temperature dependence. 
Equilibration buffer counterion concentration (mM)  ± 5 mM  Counterion concentration from Protein A elution buffer. 
Bed height (cm)  ± 0.5 cm  - 
Compression factor  1.15 – 1.25  - 
Load volume (ml)  ± 1 ml  Usually  ±  5%  for  a  large  scale  column.  The  uncertainty  for 
experimental studies conducted in this work was ± 1ml using a 50 ml 
super loop.  
Total load concentration (mg/ml)  ± 0.2 mg/ml  Measured using A280 reading of the neutralised Protein A peak pool, 
and includes contributions from all protein species in load. 
Load  monomer,  dimer  and  multimer  composition  
(on a mass fraction basis)  
± 0.05   Not usually measured prior to AEX WPC but general range will be 
known from process development studies. 92 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.5. The sequence of calculations used for the stochastic simulations conducted in this work. 
   
START 
Step 1. Assign stochastic values to uncertain 
variables/parameters 
i)  Assign a probability distribution function e.g. 
uniform, triangular, normal etc. 
ii)  Define probability density function 
arguments, e.g. upper and lower bounds, 
average, standard deviation etc.  
Step 2. Conduct multiple simulations  
i)  Randomly assign uncertain 
variables/parameters values from 
probability density function specified in 
step 1. 
ii) Each time the simulation is reset assign a 
new value for the uncertain 
variable/parameter. 
 
Step 4. Determine probability of meeting CQA 
of performance criteria 
i)  Plot CQA/process performance parameter 
probability density function (pdf). 
ii)  Probability is equal to the area under pdf 
where CQA/performance criteria are met. 
 
Step 3. Record critical quality attributes and 
process performance parameters 
i)  At the end of each simulation record the 
value of critical quality attributes and 
process performance parameters 
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The  stochastic  simulations  considered  uncertainty  in  multiple  process  variables  and 
parameters as shown in Table 3.4. They include: (i) equilibration buffer ionic strength, (ii) 
equilibration buffer pH, (iii) total load material concentration, (iv) load material monomer, 
dimer and multimer composition, (v) resin compression factor for the packed bed, (vi) load 
volume  and  (vi)  column  volume.  Uncertainty  in  the  load  material  concentration  and 
composition can be attributed to the biological source of load material, and the desire to 
minimise the use of analytics on process intermediates. The practical challenges of operating 
chromatographic  equipment  results  in  uncertain  bed  heights,  resin  compression,  and 
volumes of material applied to the column. The pH and counterion concentration can only be 
controlled to the precision of measurement devices. Note that the uncertainty in the load 
volume is due to practical inaccuracies when applying the desired volume to the column, i.e. 
not due to uncertainty in the total load concentration and column volume, which are both 
assumed correct when calculating the load volume in the model. Further details are provided 
alongside simulation results.  
 
3.4. Model calibration 
The  WPC  AEX  model  developed  in  this  work  is  based  upon  characterisation  of  the 
equilibrium isotherms of three critical components of the WPC separation (monomer, dimer 
and multimer), as a function of the product (monomer) partition coefficient, K . This was 
achieved using batch adsorption experiments (sections 1.2.2.1 to 1.2.2.4). In the following 
section,  the  experimental  adsorption  isotherm  data  collected  from  the  batch  adsorption 
experiments is presented and discussed. The data is then used to fit the adsorption isotherm 
model parameters described in section 1.2.3 using parameter estimation in gPROMS (section 
1.2.4). 
 
3.4.1. Experimental adsorption isotherms 
Adsorption  isotherms  are  shown  for  monomer  in  Figure  3.6,  dimer  in  Figure  3.7,  and 
multimer in Figure 3.8, at the mobile phase conditions described in Table 3.3. The initial 
slopes  of  all  monomer  isotherms  (Figure  3.6)  matched  the  target  product  partition 
coefficients, and confirming suitable mobile phase conditions were achieved in the batch 
adsorption experiments. The data scatter is due to experimental inaccuracies in the batch 
adsorption  method.  A  robot  was  used  to  ensure  high  precision  when  dispensing  resin 
solutions.  However,  all  protein  dispensing  was  completed  by  hand  which  introduced 
variability,  especially  during  series  dilution  of  the  equilibration  and  elution  supernatant, 
which was required for measurement of protein concentration by UV spectroscopy. It was 
also difficult to control the pH and counterion concentration of the mobile phase, which is 94 
 
important  as the  partition coefficient and thus the binding  strength  is  sensitive  to small 
changes in these parameters. The pH was sensitive to temperature change as TRIS is used 
for  buffering,  and  the  RSM  predictions  used  to  identify  operating  conditions  contain 
uncertainty themselves. Despite the scatter, the data was deemed adequate for early process 
development objectives where an exact process representation is unnecessary. 
 
Adsorption isotherms (monomer in Figure 3.6, dimer in Figure 3.7, and multimer in Figure 
3.8) at a constant product partition coefficient were similar regardless of the molecule or 
exact  mobile  phase  conditions,  suggesting  that  the  adsorption  isotherms  can  be 
approximated exclusively as a function of the product partition coefficient. This facilitates a 
generic  model  to  be  formulated  for  this  system  which  can  be  applied  irrespective  of 
molecule, providing the unique relationship between the product partition coefficient and 
mobile  phase  conditions  is  determined  using  the  traditional  high  throughput  screening 
methodology, presented in detail in the literature (Kelley et al., 2008a). 
 
As the product partition coefficient increases, the monomer and dimer adsorption isotherms 
become  increasingly  nonlinear,  and  the  bound  concentrations  increase  (Figure  3.6  and 
Figure 3.7). It is interesting to consider dimer removal implications for a typical batch of 
load material which contains 3% dimer and 90% monomer at a total concentration of 8 
mg/ml, corresponding to 0.24 mg/ml dimer and 7.2 mg/ml monomer. At these industrially 
relevant concentrations, the amount of dimer that binds to the resin (Figure 3.7) is typically 
an order of magnitude lower than monomer (Figure 3.6), regardless of partition coefficient. 
The example illustrates the difficulty of developing a process which can achieve adequate 
dimer removal whilst maintaining monomer recovery without fundamental knowledge of the 
adsorption isotherms. The relative shapes of the monomer and dimer isotherms (Figure 3.6 
and Figure 3.7, respectively) suggest a reduction in load concentration may reduce monomer 
binding and thus increase monomer recovery, with minimal impact on dimer removal. 
 
The  multimer  batch  adsorption  data  suggests  multimer  isotherms  remain  unchanged 
regardless of the partition coefficient (Figure 3.8). Matching isotherms were observed at 
partition coefficients of 1 and 3. A multimer capacity of 11 mg/ml ± 1 mg/ml was found, 
which is in agreement with understanding of the WPC AEX system at Pfizer. Experimental 
discrepancies found in SEC analytics indicated that insufficient multimer was present in the 
load  material  used  for  partition  coefficient  of  10  to  reach  a  bound  concentration  of  11 
mg/ml, thus an isotherm could not be generated. Because of the very nonlinear isotherms at 
partition coefficients at 1 and 3, a conservative assumption is that the multimer isotherm at a 
partition coefficient of 10 is similar.  95 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.6. Monomer adsorption isotherm data from batch adsorption experiments at product partition 
coefficients, K , of 1, 3 and 10.  
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Figure 3.7. Dimer adsorption isotherm data from batch adsorption experiments at product partition coefficients, 
K , of 1, 3 and 10. 97 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.8. Multimer adsorption isotherm data from batch adsorption experiments at product partition 
coefficients, K , of 1 and 10. 
 
 
Clearly the AEX WPC system provides extremely robust multimer removal provided the 
column  is  not  over  challenged.  The  data  shown  in  Figure  3.8  suggests  that  even  large 
changes in the pH and counterion concentration have no effect on the multimer isotherms 
within  the  WPC  operating  region  considered  (1  <  K   <10),  and  the  concentration  of 
multimer in typical load material will seldom fall to levels where the resin capacity falls 
below 11 mg/ml (±0.05 mg/ml). 
 
 
Table 3.5. Values of estimated isotherm parameters in Equation 3.3 to 3.7 
Species     StDev     StDev     StDev 
Monomer  1.67782  0.056  0.031065  0.0019  -  - 
Dimer  23.4248  1.8  4.28984  0.44  3.7612  0.53 
Multimer  2035.64  290  183.224  29  -  - 
 
 
   98 
 
3.4.2. Adsorption isotherm model fit 
The adsorption isotherm models were fit to averaged batch adsorption data as shown in 
Figure 3.9. Estimated parameter values are shown in Table 3.5. The model gave excellent 
predictions which was interesting given the simplistic nature of the empirical equations used 
to link the product partition coefficient, K , to the isotherm parameters,    and   . Values for 
classical  Langmuir  parameters  (i.e.  saturation  capacity  and  equilibrium  constant)  can  be 
determined from the estimated parameters. The data suggest the saturation capacity of the 
monomer is constant regardless of the partition coefficient at 59 mg/ml settled resin. The 
saturation capacity of the dimer increases between partition coefficients of 0 – 4 and then 
levels off. At a partition coefficient of 4, the dimer saturation capacity has already reached 
90% of the saturation capacity at a partition coefficient of 10. Although this suggests that 
increasing the partition coefficient past 4 may not be helpful for increasing impurity removal 
whilst maintaining recovery, dimer removal at partition coefficients higher than 4 will be 
more robust because the adsorption isotherm will be less sensitive to changes in pH and 
counterion concentration. The estimated parameters suggest the multimer saturation capacity 
is constant at 11 mg/ml. As discussed previously, this is in agreement with understanding of 
the WPC AEX system at Pfizer. 
  
3.5. Model applications 
A  model  of  the  weak  partitioning  anion  exchange  chromatography  process  has  been 
developed. The  model  consists  of a  basic  mass  balance and a  description  of  adsorption 
equilibrium (section 1.2.3) which was calibrated using batch adsorption experimental data. 
The application of the model at an early stage of process development is now considered. 
The  model  is  combined  with  stochastic  simulation  (section  1.2.5)  and  used  to  explore 
operating  conditions  for  two  case  studies  by  generating  probabilistic  design  spaces  for 
molecules A and B. The stochastic calculations generate probability density functions of 
process  performance  parameters  (flowthrough  recovery)  and  critical  quality  attributes 
(product purity), as a function of the variability experienced in process variables (e.g. total 
load concentration and load composition) and process parameters (e.g. buffer pH, buffer 
counterion concentration, load volume, bed height, resin compression) shown in Table 3.4. 
The  probabilistic  design  spaces  are  used  to  select  promising  operating  conditions  for 
providing  robust  impurity  clearance  whilst  maintaining  product  recovery,  which  are 
subsequently tested experimentally via column runs. An in-depth analysis of monomer – 
dimer selectivity, maximum load challenge, recovery, and the impact of uncertainty in the 
process is then conducted, supported by relevant experimental studies. 
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Figure 3.9. Adsorption isotherm model (lines) fit to batch adsorption experiments, data points showing 1 standard 
deviation. A. Monomer and B. Dimer: ■   1, ●   3, ▲   10. C. Multimer: ♦    1-10. 
B 
A 
C 100 
 
3.5.1. Case studies 
Case study 1 considers monoclonal antibody A. The load material contains 89% monomer, 
9% dimer, and 2% multimer. Traditionally this composition would represent too great of a 
purification challenge for a two column process due to the high percentage of dimer. As a 
result, a third chromatography column would be required with an associated increase in 
costs. In this study, the model is used to explore whether there are conditions available in the 
design space which would achieve sufficient impurity removal with satisfactory product 
recovery  to  facilitate  a  two  column  process.  Stochastic  simulations  were  conducted  to 
calculate the probability of meeting the desired product purity (> 0.98 monomer) across a 
knowledge space encompassing parameter ranges shown in Table 3.6. 
 
Case study 2 considers monoclonal antibody B. The load material contains 89% monomer, 
2% dimer and 9% multimer. The purification should be straightforward because the load 
material contains only small amounts of dimer. However, it is important to ensure that the 
load challenge  is  carefully  selected so that  no  breakthrough  of  multimer  occurs.  In  this 
study, the model is used to find conditions which achieve robust impurity removal whilst 
maximising  product  recovery.  Stochastic  simulations  were  conducted  to  calculate  the 
probability of meeting the desired product purity (> 0.98 monomer) across a knowledge 
space encompassing parameter ranges shown in Table 3.6. 
 
 
Table 3.6. Parameter ranges explored during model simulations. 
Parameter  Lowest value considered   Highest value considered 
MAb A  MAb B  MAb A  MAb B 
Total load concentration  2 mg/ml  2 mg/ml  11 mg/ml  11 mg/ml 
Load challenge  40 mg/ml resin  60 mg/ml resin  120 mg/ml resin  140 mg/ml resin 
Product partition coefficient, K   1  1  10  10 
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Figure 3.10 shows the knowledge space explored at a partition coefficient of 3 and 1 for 
Case studies 1 and 2, respectively. The shaded areas show the region where the predicted 
probability of assuring that flowthrough material purity  is greater than 98% is 1.0 (red), 0.9 
(purple) and 0.8 (pink). The contour lines show the predicted recovery mean. Interestingly, 
the probability of meeting the purity objective drops very sharply for case study 1 compared 
to a much more gradual drop in case study 2. This is reflecting the impact of uncertain 
process parameters on the resin’s capacity for binding dimer and  multimer. Figure 3.10 
shows that multimer removal is extremely robust in this AEX WPC system regardless of 
uncertainty in pH and counterion concentration, however, dimer removal is not. Reasons for 
this will become clear when considered in depth in section 3.5.2. 
 
The probabilistic design spaces were used to select promising operating conditions.  For case 
study 1, a total load concentration of 3.3 mg/ml and a load challenge of 50 mg/ml resin was 
selected for testing experimentally. For case study 2, a total load concentration of 7.2 mg/ml 
and  a load  challenge  of  102  mg/ml  resin  was chose  for testing  experimentally.  In  both 
studies, a two column volume wash was collected separately from the flow though material. 
The wash phase is a normal part of the AEX WPC process, and so it was interesting to 
examine what impact the wash had on the final product recovery and purity. 
 
Figure 3.11 shows the resulting chromatograms from the experimental studies conducted to 
test the operating conditions selected using the probabilistic design spaces, showing UV 
absorption at 280 nm of the material exiting the column during the experiment. Table 3.7 
shows  the  predicted  and  experimental  flowthrough  recovery  and  purity,  and  the  final 
recovery and purity when the material collected during the wash phase is included. For both 
studies, model recovery predictions were good, and the desired purity was met. The results 
for case study 1 were particularly exciting, as a recovery of 82% was achieved when the 
wash  material  was  included.  Although  lower  than  usually  achieved  in  the  AEX  WPC 
platform step, it is equivalent to recoveries of approximately 90% for the second and third 
columns in the alternative 3 step process (i.e. 90% × 90% = 81%), but without the extra time 
and cost of developing and operating the third column. The reasons for the success of the 
experimental studies will be explored and discussed in detail in the following section. 
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Figure 3.10. A. Knowledge space explored at    = 3 for case study 1. B. Knowledge space explored at    1 for 
case study 2. The shaded areas show the region where the predicted probability of assuring that flowthrough 
material purity is greater than 98% is 1.0 (red), 0.9 (purple) and 0.8 (pink). Contour lines show predicted product 
recovery.  
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Figure 3.11. Experimental chromatograms from A. case study 1, total load concentration = 3.3 mg/ml, load 
challenge = 50 mg/ml and    = 3. B. case study 2, total load concentration = 7.2 mg/ml, load challenge = 102 
mg/ml and    = 1. 
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Table 3.7. Showing model predictions and experimental results from Case study 1 (total load concentration = 3.3 
mg/ml, load challenge = 50 mg/ml and    = 3), and Case study 2, (total load concentration = 7.2 mg/ml, load 
challenge = 102 mg/ml and    = 1).  
 
Case study  Data source  Flowthrough 
purity 
Flowthrough 
recovery 
Final 
purity 
Final 
recovery 
1  Model  99.4%  64.1%  -  - 
Experimental  98.1%  68.1%  98%  82% 
2  Model  99.7%  88.0%  -  - 
Experimental  98.9%  93.3%  99%  100% 
 
 
 
Conclusion 
Operating conditions for the two case studies were chosen by manual exploration of model 
predictions.  A  systematic  method  for  identifying  optimal,  robust  operating  conditions  is 
desirable, but was beyond the scope of this work. Due to the complexity of the relationships 
between key process parameters and variables, and noting that each operating condition has 
a different robustness, it is clear that it is that exploration of the design space generated by 
the  model  by  an  inexperienced  process  developer  will  not  be  able  to  find  the  optimal 
operating space. Despite providing a more sophisticated methodology than the traditional 
experimentation only approach, an experienced process developer is required to analyse the 
data  and identify  optimal  operating  conditions  in  terms  of  any  objective  function,  be it 
maximising purity, recovery, throughput or robustness. New tools and workflows such as 
incorporating mathematical optimisation studies into the development process are required 
to  assist  experienced  process  developers,  and  should  enable  them  to  spend  more  time 
making decisions based on their knowledge and understanding, rather than spending time 
generating data. 
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3.5.2. In depth analysis of WPC 
In the following section, an in-depth analysis of monomer – dimer selectivity, maximum 
load  challenge,  recovery,  and  the  impact  of  uncertainty  in  the  AEX  WPC  system  is 
conducted, supported by relevant experimental studies. 
 
Selectivity 
Selectivity  is  the  driving  force  of  chromatographic  separations,  and  is  traditionally 
calculated by dividing the monomer partition coefficient (the product) by the dimer partition 
coefficient  (the  impurity).  The  partition  coefficient  is  defined  as  the  ratio  between  the 
concentration  of  bound  and  unbound  protein  in  equilibrium  in  the  linear  region  of  the 
adsorption  isotherm  (Kelley  et  al.  2008a).  However,  in  industrial  separations,  the  load 
concentrations  are  rarely  low  enough  for  binding  to  occur  in  the  linear  region  of  the 
adsorption  isotherm,  and  so  selectivity  in  its  traditional  definition is  misleading.  In  this 
work, we calculate a similar selectivity parameter that is useful for studying monomer and 
dimer binding in a column system. The selectivity is calculated using Eq 3.10, where q is the 
bound concentration (mg/ml) and C is the unbound concentration (mg/ml):  
 
      Selectivity	 =	
        
          
         
           
      [3.10]   
 
A high selectivity is desirable as it leads to a better separation between monomer and dimer. 
The model can be used to calculate the selectivity as a function of load material dimer 
composition and total load concentration at partition coefficients of 1, 3 and 10 (Figure 
3.12). Figure 3.12 shows that in general, a decrease in load concentration results in higher 
selectivity. The capacity of dimer decreases as the load concentration decreases (as shown in 
the dimer adsorption isotherms in Figure 3.9), thus, the increase in selectivity is a result of 
an  increase  in  monomer  recovery.  The  impact  of  decreasing  the  load  concentration  is 
specific  to  the  exact  dimer  composition  in  the  load  material.  Although  operating  at  a 
partition coefficient of 10 may give the highest selectivity, the high selectivity occurs at 
industrially irrelevant compositions and concentrations. A partition coefficient of 1 gives the 
highest  selectivity  at  industrially  relevant  load  material  compositions.  However,  it  is 
important to note that although the selectivity is high, this isn’t conveying greater dimer 
removal, only higher monomer recovery, as the increase in selectivity is due to increasing 
monomer recovery. 
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Figure 3.12. Monomer - dimer selectivity (contours and colours) at product partition coefficients, K , of 1, 3 and 
10. 
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Load challenge 
In practice, it is desirable to maximise the load challenge in order to increase throughput. 
Contour  plots  are  shown  in  Figure  3.13  which  show  the  (theoretical)  maximum  load 
challenge that enable full removal of dimer in the load material for partition coefficients of 
1, 3 and 10. The corresponding monomer recovery is shown in Figure 3.14. The nonlinear 
behaviour of the mass challenge and recovery contours is due to the nonlinear nature of the 
adsorption  isotherms  (Figure  3.9),  in  particular  the  dimer  isotherms.  As  expected,  the 
maximum allowable load challenges increase as the partition coefficient increases (Figure 
3.13).  However,  an  increasingly  lower  load  concentration  must  be  used  to  reach  an 
industrially acceptable recovery as the partition coefficient increases (Figure 3.14). The plots 
are particularly useful for showing the limitations of AEX WPC system for dimer removal. 
Notice that even at a partition coefficient of 10, once the dimer load composition increases 
above 6% the maximum load challenge becomes less than 100 mg/ml (Figure 3.13, bottom). 
 
Recovery 
Figure  3.14  shows  that  reducing  the  total  load  concentration  is  predicted  to  improve 
monomer  recovery  whilst  maintaining  impurity  removal  in  the  flowthrough  material. 
Experimental column studies were conducted at partition coefficients of 1, 3 and 10, to test 
model flowthrough purity and recovery predictions. Depth filtered load material was used, 
therefore, the material contained negligible amounts of HCP, DNA and leached Protein A. 
Process parameters that were held constant during column studies are described in Table 3.8. 
An overlay of model predictions and experimental data is shown in Figure 3.15, and values 
are  reported  in  Table  3.10.  Model  predictions  in  Table  3.10  are  shown  with  associated 
uncertainty due to uncertain process parameters and variables. The stochastic simulation 
parameters used to calculate these are shown in Table 3.9. 
 
 
Table 3.8. Process parameters held constant during column studies to test model predictions 
Process parameter  K  1  K  3  K  10 
Load challenge (mg/ml resin)  42  66  70 
Superficial velocity (cm/hr)  150  150  150 
Load monomer composition  0.9  0.895  0.9 
Load dimer composition  0.075  0.08  0.075 
Load multimer composition  0.025  0.025  0.025 
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Figure 3.13. Maximum load challenge possible whist providing full removal of dimer in the load material 
(contours and colours) at product partition coefficients, K , of 1, 3 and 10. 
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Figure 3.14. Predicted monomer recovery (contours and colours) when using the maximum load challenge 
possible whist providing full removal of dimer in the load material, at product partition coefficients, K , of 1, 3 
and 10. 
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Model recovery predictions (Table 3.10) were satisfactory at all partition coefficients. The 
experimental recovery was consistently within one standard deviation of predicted recovery. 
Purity predictions were good for a partition coefficient of 3 and 10, but partition coefficient 
1 purity predictions were inaccurate, outside of the predicted variance in model predictions. 
Monomer recovery predictions at a partition coefficient of 1 were good, which supports the 
hypothesis that experimental error was not the cause of the discrepancy. The data suggests 
the column dimer capacity is less than experimental batch adsorption isotherms at K  = 1. 
The model does not account for dynamic phenomena occurring in the column, and therefore 
the  disagreement  may  have  been  mass  transfer  related,  although  it  is  unusual  that  the 
partition coefficient 3 and 10 column studies would be unaffected by this. 
 
Despite the unsatisfactory predictions at a partition coefficient of 1, the experimental results 
were  very  encouraging  as  they  revealed  scope  for  previously  unidentified  process 
improvements. Both simulations and experiments were in agreement that reducing the total 
load concentration increases the monomer recovery in the flowthrough (Figure 3.15). The 
rate  of  increase  in  monomer  recovery  increases  as  concentration  decreases  for  partition 
coefficients. Higher partition coefficients experience a greater increase in monomer recovery 
over  the  concentration  range  considered  (4  –  12  mg/ml).  However,  higher  partition 
coefficients  have  much  lower  recoveries  at  the  high  load  concentrations  than  the  lower 
partition coefficients, which mean that product recovery in the flowthrough material is not at 
industrially relevant levels until the load concentration is low. 
 
The result that reducing the total load concentration increases the monomer recovery in the 
flowthrough is exciting because reducing the load concentration may enable higher partition 
coefficients to be utilised for improved dimer removal. In the past, the low recovery at 
higher partition coefficients using conventional load concentrations (e.g. 7-10 mg/ml) may 
well  have  rendered  a  two  column  process  infeasible.  The  data  from  studies at  partition 
coefficients of 3 and 10 show that a reduction in load concentration from 12 mg/ml to 4 
mg/ml increased the product recovery from 50% to 72% for a partition coefficient of 3, and 
a reduction in load concentration from 8 mg/ml to 4 mg/ml increased product flowthrough 
recovery from 32% to 57% (Table 3.10). For both partition coefficients, dimer removal was 
not  affected.  The  disadvantage  of  reducing  the  load  concentration  and  the  low  load 
challenges is that the throughput of the AEX WPC step is reduced. However, the savings 
achieved by not requiring a third chromatography step may offset such losses, so this is an 
option worth exploring further.    111 
 
Table 3.9. Stochastic simulation parameters (number of simulations = 1000) 
Factor  Distribution  Distribution 
type 
Average  Standard 
deviation  
Upper   Lower 
Equilibration buffer pH  Random  Uniform  Depends on partition coefficient  -  Average + 0.05  Average – 0.05 
Equilibration buffer 
counterion concentration 
(mM) 
Random  Uniform  30  -  35  25 
Column volume (ml)  Random  Uniform  2.95  -  3.04  2.85 
Compression factor  Random  Uniform  1.2  -  1.25  1.15 
Load volume (ml)  Random  Normal  Depends on load concentration  1  -  - 
Total load concentration 
(mg/ml) 
Random  Normal  Varied during column studies  0.2  -  - 
Load monomer, dimer and 
multimer composition 
Random  Uniform  Depends on partition coefficient  -  Average + 0.05  Average – 0.05 112 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.15. Overlay of model flowthrough recovery and purity predictions (lines) and experimental data from 
column studies (data points) at product partition coefficients, K , of 1, 3 and 10. 
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Table 3.10. Predicted and experimental flowthrough recovery and purity (the standard deviation of model predictions are calculated as a result of process uncertainty), model predictions within 
standard deviations are shown in italic bold 
  
Partition 
coefficient 
Total load 
concentration 
Experimental 
purity 
Purity mean and 
stdev 
Experimental 
recovery 
Recovery mean 
and stdev 
Probability purity 
> 98% 
1  12.8  95.7  98.8 ± 0.8  57  53 ± 7.3  0.93 
7.9  95.0  99.6 ± 0.8  65  68 ± 4.4  0.94 
5.8  95.8  99.4 ± 0.8  79  75 ± 3.4  0.86 
3  12.3  97.8  98.2 ± 1.2  50  46 ± 6.3  0.67 
8.1  98.2  98.2± 1.0  61  56 ± 5.4  0.71 
6.2  97.8  98.1 ± 0.9  55  63 ± 4.9  0.69 
4.2  95.8  97.9 ± 0.8  72  71± 4.1  0.57 
10  8.1  100  100 ± 0.2  32  30 ± 6.8  1.0 
6.3  100  99.9  ± 0.3  39  36 ± 6.9  1.0 
4.0  100  99.9 ± 0.3  57  46 ± 7.0  1.0 114 
 
 
Uncertainty 
The impact of uncertain process parameters and variables was considered in more detail for 
the studies conducted at a total load concentration of approximately 8 mg/ml. A total load 
concentration of 8 mg/ml is the most industrially relevant of the concentrations used in the 
column studies. Table 3.11, Table 3.12 and Table 3.13 show the mean, average and quartiles 
of the partition coefficient, monomer capacity, dimer capacity, load challenge, monomer 
loaded,  dimer  loaded,  recovery  and  purity  when  the  partition coefficient  is  1,  3  and  10 
respectively.   
 
The stochastic simulations revealed the uncertainty in the partition coefficient as a function 
of  uncertainty  in  the  pH  (±  0.05)  and  the  counterion  concentration  (±  5mM)  of  the 
equilibration buffer. The product partition coefficient means and standard deviations were 1 
±  0.15,  3.1  ±  0.58  and  10.2  ±  2.39,  respectively. As  expected,  higher  product  partition 
coefficients were more uncertain, as smaller changes in counterion concentration and pH 
have  a  larger  effect  on  the  product  partition  coefficients  (Figure  3.3).  However,  the 
associated means and standard deviations in the dimer capacity were 8.9 ± 0.74, 13.6 ± 0.85 
and  17.1  ±  0.68,  respectively.  The  standard  deviations  of  dimer  capacity  are  similar 
regardless of partition coefficient, because changes in the buffer conditions have smaller 
impact on dimer adsorption isotherms at higher partition coefficients. The implication for 
process  development  is  that  the  impact  of  increased  uncertainty  of  higher  partition 
coefficients on impurity removal can be considered negligible for the AEX WPC system. 
 
For  desired  product partition  coefficients  of  1, 3  and  10, the  highest  and lowest  values 
observed as a function of pH and counterion uncertainty were 0.74 – 1.44, 1.9 – 4.7 and 5.8 
–  17.3,  respectively,  which  are  surprisingly  large  The  highest  observed  values  were 
consistently further from the mean than the lowest observed values. This is preferable to the 
lowest observed values being further from the mean, because a lower than desired partition 
coefficient  value reduces product  purity,  which  can  potentially  mean  the  batch  must  be 
discarded, whereas a higher than desired  partition coefficient will reduce recovery, but the 
material may still be used. Uncertainty in the dimer capacity (8.9 mg ± 0.74, 13.6 mg ± 0.85 
and 17.1 ± 0.68, respectively) was similar to the uncertainty in the dimer loaded (9.3 mg ± 
0.74, 15.6 ± 0.91 and 15.3 mg ± 0.81, respectively) which is reassuring, considering that the 
dimer capacity is a function of uncertainty in the pH, counterion concentration, total load 
concentration, load composition, column volume and compression factor.  
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Uncertainty in the load challenge was due to uncertainty in the total load concentration 
(normal distribution, average = 8 mg/ml, standard deviation = 0.2 mg/ml), column volume 
(2.85 to 3.04 ml based on a bed height of 15 cm ± 0.5 cm), and load volume (normal 
distribution, average = dependent on load challenge, standard deviation 1 ml). The load 
challenge means and standard deviations were 42 ± 2.95 mg/ml resin, 66.1 ± 3.29 mg/ml 
resin and 70.2 ± 3.53 mg/ml resin for studies conducted at partition coefficients of 1, 3 and 
10,  respectively.  The  corresponding  maximum  and  minimum  load  challenges  at  each 
partition coefficient were 51.4 to 32.6 mg/ml resin, 76.0 to 56.9 mg/ml resin, and 81.5 to 
59.3  mg/ml  resin,  respectively.  The  large  ranges  and  standard  deviations  in  the  load 
challenge  show  the  importance  of  conservative  use  of  the  column  capacity,  in  case  the 
column  becomes  over  challenged,  resulting  in  impurities  eluting  into  the  flowthrough 
material. The data also illustrates how higher load challenges are more uncertain than lower 
load  challenges.  When  the  total  load  concentration  is  decreased  but  the  load  challenge 
remains constant, the uncertainty in load challenge increases further due to the larger impact 
of load concentration uncertainty.  
 
The  important  implications  of  the  stochastic  simulations  for  purification  process 
development can be illustrated by model predictions at a partition coefficient of 3. Although 
the model predicts that the purity will be 97.8%, as shown by the mean (which is close to 
acceptable  product  quality),  the  median  of  97.8%  shows  that  approximately  50%  of 
experimental  studies  will  result  in  a  purity  that  is  lower  due  to  uncertainty  in  process 
parameters.  Clearly  this  is  why  safety  margins  are  built  into  processes.  These  studies 
illustrate that models can be especially useful for uncertain processes such as bioseparations, 
because  stochastic  simulations  can  be  used  to  help  select  conditions  for  which  the 
uncertainty is allowed. In this case, the model can ensure that the lowest impurity capacity 
due to normal process uncertainty is always greater than the highest amount of impurity 
loaded due to process uncertainty. By incorporating process uncertainty into process models, 
and then designing the process around understanding of the impact of that uncertainty on 
process performance, greater assurance of product quality can be obtained, compared to the 
traditional approach where process robustness as designed by empirical rules of thumb and 
tested by repeated experiments.  
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Table 3.11. Statistics from stochastic simulation of column studies where the partition coefficient = 1, and the total load concentration = 7.86 mg/ml data 
 
       
Statistical parameters  K   Monomer 
capacity 
(mg) 
Dimer 
Capacity 
(mg) 
Load 
challenge 
(mg/ml resin) 
Monomer 
loaded 
(mg) 
Dimer 
loaded 
(mg) 
Recovery  Purity 
Mean  1.0  37  8.9  42.0  114.4  9.3  67.4  99.3 
Standard Deviation  0.15  4.50  0.74  2.95  7.70  0.74  4.39  0.78 
Quartiles 
100  Maximum  1.44  71  10.8  51.4  137.9  11.4  77.9  100.0 
99.5    1.40  69  10.6  49.6  135.8  11.1  76.2  100.0 
97.5    1.35  65  10.3  47.6  129.4  10.7  74.7  100.0 
90    1.24  62  9.9  45.8  124.3  10.2  72.9  100.0 
75  Quartile  1.14  59  9.5  44.1  119.7  9.8  70.8  100.0 
50  Median  1.01  54  8.9  42.1  114.3  9.3  67.6  99.5 
25  Quartile  0.91  50  8.3  39.9  108.8  8.7  64.4  98.7 
10    0.84  47  7.9  38.2  104.8  8.3  61.4  98.1 
2.5    0.79  44  7.6  36.8  100.2  7.9  58.3  97.6 
0.5    0.76  43  7.4  34.8  95.9  7.6  55.6  97.1 
0  Minimum  0.74  42  7.2  32.6  90.8  7.0  52.2  96.9 117 
 
Table 3.12. Statistics from stochastic simulation of column studies where the partition coefficient = 3, and the total load concentration = 8.06 mg/ml data 
 
Statistical parameters  K   Monomer 
capacity 
(mg) 
Dimer 
Capacity 
(mg) 
Load 
challenge 
(mg/ml 
resin) 
Monomer 
loaded 
(mg) 
Dimer 
loaded 
(mg) 
Recovery  Purity 
Mean  3.1  78  13.6  66.1  179.9  15.6  56.2  97.9 
Standard Deviation  0.58  9.07  0.85  3.29  8.44  0.91  5.41  0.81 
Quartiles 
100  Maximum  4.7  106  16.2  76.0  203.8  18.4  70.4  100.0 
99.5    4.6  100  15.6  74.3  198.8  17.7  67.7  100.0 
97.5    4.3  96  15.2  72.2  195.2  17.3  65.5  99.7 
90    3.9  91  14.7  70.3  189.9  16.8  63.2  98.9 
75  Quartile  3.5  85  14.3  68.4  184.7  16.2  60.5  98.4 
50  Median  3.0  78  13.6  66.1  179.0  15.6  56.4  97.8 
25  Quartile  2.6  71  13.0  63.8  173.0  14.9  52.3  97.3 
10    2.3  67  12.5  61.7  168.3  14.4  49.0  96.8 
2.5    2.1  62  12.0  59.6  161.8  13.8  45.9  96.4 
0.5    2.0  60  11.7  57.9  157.2  13.3  42.8  96.0 
0  Minimum  1.9  55  11.2  56.9  155.5  12.9  37.5  95.7 
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Table 3.13. Statistics from stochastic simulation of column studies where the partition coefficient = 10, and the total load concentration = 8.09 mg/ml data 
   
Statistical parameters  K   Monomer 
capacity 
(mg) 
Dimer 
Capacity 
(mg) 
Load 
challenge 
(mg/ml resin) 
Monomer 
loaded 
(mg) 
Dimer 
loaded 
(mg) 
Recovery  Purity 
Mean  10.2  133  17.1  70.2  190.8  15.3  30.3  100 
Standard Deviation  2.39  10.14  0.68  3.53  8.64  0.9  6.1  0.2 
Quartiles 
100  Maximum  17.3  71  19.0  81.5  216.2  18.3  48.2  100.0 
99.5    16.6  162  18.8  78.7  211.2  17.6  44.6  100.0 
97.5    15.4  157  18.4  77.0  207.5  17.2  41.2  100.0 
90    13.6  152  18.0  74.9  202.0  16.7  38.1  100.0 
75  Quartile  11.9  146  17.6  72.6  196.7  16.1  34.6  100.0 
50  Median  10.0  140  17.1  70.1  190.9  15.5  30.3  100.0 
25  Quartile  8.4  133  16.6  67.8  184.8  14.8  25.9  100.0 
10    7.3  125  16.2  65.6  179.8  14.3  22.3  100.0 
2.5    6.6  119  15.8  63.7  173.5  13.8  18.7  99.3 
0.5    6.2  113  15.5  61.4  168.7  13.3  15.9  98.7 
0  Minimum  5.8  110  15.0  59.3  166.7  12.9  8.9  98.1 119 
 
3.6. Conclusion 
A model based approach for linking experimental high throughput batch bind screens (HTS) 
and  scouting  runs,  traditionally  conducted  during  process  development  of  a  weak 
partitioning chromatography (WPC) anion exchange (AEX) polishing step (part of Pfizer’s 
two-step  platform  monoclonal  antibody  purification  process),  has  been  proposed.  The 
approach involves formulating a simplistic ‘platform’ model, which once developed, can be 
applied  to  new  candidate  molecules  based  on  the  results  of  a  standard  high  throughput 
screen.  This  is  achieved  by  characterising  the  equilibrium  isotherms  of  three  critical 
components of the WPC separation, namely the product monomer, dimer and multimer, as a 
function of the product partition coefficient (rather than the conventional approach of pH 
and counterion concentration) via ultra-scale down batch adsorption experimentation. Use of 
the model is limited to an early stage of process development. This reduces the impact of 
inaccuracies due to simplifications made when formulating the model. Important advantages 
are realised by harnessing the models predictive power when (1) there are maximum degrees 
of freedom available for bioseparation design, and (2) minimal investment has been made in 
the product.  
 
It  has  been  shown  how  the  model  based  approach  is  useful  for:  (1)  Increasing  process 
understanding,  by  providing  a  more  informative  method  for  exploring  how  process 
parameters can be controlled in order to raise product recovery to acceptable levels, whilst 
maintaining impurity clearance, and (2) assisting process development, by providing a link 
between high throughput screen and scale down column studies. The model can quickly 
identify operating parameter ranges that are of interest for the purification of feed streams 
with challenging compositions. When combined with stochastic simulation, the model can 
explore the impact of process variability on product quality and process performance. This 
approach enables the purification of previously impossible to purify feed streams using the 
two-step  platform  monoclonal  antibody  purification  process.  It  also  identifies  promising 
parameter  ranges  to  explore  experimentally,  thus  accelerating  process  development  and 
helping optimise column performance. 
 
One of the problems with existing work on modelling chromatographic processes in industry 
is a lack of understanding as to how these models fit into industrial workflows which are 
dominated by significant time and material constraints, and a high risk of candidate failure. 
The proposed approach of using models at an early stage of process development can form 
part of a wider modelling approach, where the isotherms developed at this early stage are 
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experiments required to determine mass transfer parameters are already conducted as part of 
the  existing  development  approach.  All  that  may  be  required  is  a  fractionation  of  the 
flowthrough  material  and  a  greater  analytical  burden  to  determine  the  composition  of 
samples. The number of parameters that need to be estimated depends on the complexity of 
the selected mass transfer model, so one possible approach is to increase model complexity 
as the development process proceeds. For example, a simple mathematical description (e.g. 
neglecting  resin  particles)  of  the  mass  transfer  at  standard  processing  conditions  is 
developed during phase 3, and then more detailed descriptions of particle kinetics and or 
competitive adsorption can be developed post approval.  
 
An understanding of the mass transfer occurring in the AEX WPC system is particularly 
interesting as it would enable the wash phase to be studied. If the length of the wash phase is 
not an issue, then the implications for process development around use of the wash phase are 
intriguing. The current 1 CV wash phase is very successful at increasing monomer recovery 
whilst maintaining impurity removal at low partition coefficients. As the dimer isotherms 
become more nonlinear as the partition coefficient increases, it follows that the wash phase 
will be even more successful at separating dimer from monomer as the partition coefficient 
increases. An increase in the washlength can be leveraged to offset any loss in recovery 
incurred  by  higher  partition  coefficients.  The  model  has  shown  that  a  decrease  in  load 
material concentration can increase recovery, however, this also decreases productivity. One 
possible approach is to load at high partition coefficients and a high load concentration to 
maximise the load challenge, productivity and capacity for impurities, but recover the extra 
bound monomer by washing for longer. Determining the washlength is very challenging 
experimentally, but is simple using a model. In addition, the model can predict how a non-
isocratic  weak  partitioning  process,  i.e.  changing  the  product  partition  coefficient  either 
during the load or the wash phase. An experimental effort to determine how to do this is 
extensive, but with the model developed in this work, the design space can be mapped 
quickly and efficiently. 
 
Clearly there are exciting opportunities for applying the model for elucidating a range of 
very  interesting  design  and  development  questions.  There  is  scope  for  a  number  of 
improvements to the AEX WPC platform. The problem with the model is that it assumes an 
ideal column system, which is rarely the case in industry where resin fouling and aging is 
commonplace. This will be considered in the following chapter (Chapter 4). 
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Chapter 4.  Resin Fouling 
Resin fouling over a chromatography column’s lifetime can cause significant (undesired) 
changes  in  process  performance.  A  lack  of  fundamental  knowledge  and  mechanistic 
understanding of fouling in industrial bioseparations limits the application of mechanistic 
models  in  industry.  Scanning  electron  microscopy  (SEM),  batch  uptake  experiments, 
confocal laser scanning microscopy (CLSM) and small-scale column studies are applied to 
characterize fouling observed during process development of the AEX WPC considered in 
the  first  results  chapter.  Fouled  resin  samples  analyzed  by  SEM  and  batch  uptake 
experiments indicated that after successive batch cycles, significant blockage of the pores at 
the resin surface occurred, thereby decreasing the protein uptake rate. Further studies were 
performed using CLSM to allow temporal and spatial measurements of protein adsorption 
within  the  resin,  for  clean,  partially  fouled  and  extensively  fouled  resin  samples.  These 
samples  were  packed  within  a  miniaturized  flowcell  and  challenged  with  fluorescently 
labeled  bovine  serum  albumin  (BSA)  that  enabled  in  situ  measurements.  The  results 
indicated that the foulant has a significant impact on the kinetics of adsorption, severely 
decreasing the protein uptake rate, but does not cause a decrease in saturation capacity. 
The impact of the foulant on the kinetics of adsorption was further investigated by loading 
BSA onto fouled resin over an extended range of flow rates. By decreasing the flow rate 
during  column loading,  the  capacity  of  the  resin  was  recovered.  The  data  supports  the 
hypothesis that the foulant is located on the particle surface, only penetrating the particle to 
a limited degree. The increased understanding of resin fouling can direct future efforts to 
mitigate this detrimental phenomenon and maintain process performance, whilst providing a 
basis for the development of new fouling models. 
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4.1. Introduction 
Fouling of chromatographic resin over operational lifetimes is a serious issue associated 
with industrial separations, attributed to repeated or prolonged exposure to the complex mix 
of  components  commonly  seen in feed streams.  Despite  this,  there  have  been  very  few 
(mainly experimental) studies conducted on this subject (Boushaba et al., 2011; Bracewell et 
al.,  2008;  Chau  et  al.,  2006;  Shepard  et  al.,  2000;  McCue  et  al.,  2008).  The  lack  of 
fundamental  knowledge  and  mechanistic  understanding  of  fouling  in  industrial 
bioseparations  limits  the  application  of  mechanistic  models  in  industry,  and  must  be 
addressed in order for mechanistic models to be applied to industrial separations without 
giving  increasingly  unrealistic  model  predictions  over  the lifetime  of  a  chromatographic 
separation. 
 
In this work, we consider a case study where resin fouling had been observed during process 
development;  that  of  an industrial  anion  exchange  polishing  step  following  a  protein  A 
affinity capture step in a process for the purification of a monoclonal antibody. The anion-
exchange chromatography, which operates in weak-partitioning mode (Kelley et al., 2008), 
was characterized through high throughput screening experiments (Coffman et al., 2008; 
Kelley et al., 2008), as well as in-house cycling studies performed on qualified scale-down 
models, and large-scale manufacturing runs. 
 
The anion exchange resin has been successfully used as part of a two column platform 
process for the purification of numerous monoclonal antibodies in the past (Kelley et al., 
2008), with no significant fouling phenomena observed. Hence it was surprising that for this 
protein as column lifetime increased, when protein A elution pool material was loaded onto 
the  AEX  resin,  significantly  earlier  breakthrough  of  impurities  and  premature  loss  of 
capacity was observed. Interestingly, it was found that the lifetime of the AEX resin was 
linked to the Protein A cycle number such that as Protein A cycle number increased, there 
was a consequent increase in capacity of the AEX polishing step. The data suggested a 
unique quality of the particular feed stream resulted in the fouling. Iskra et al. (2013) also 
found  that the  fouling  could  be  accelerated  by  overloading  the  AEX  resin  well  beyond 
normal operating conditions.  
 
Different  control  strategies  were  considered  for  preventing  impurity  breakthrough  and 
improving resin lifetimes. An investigation using small-scale chromatography, dynamic light 
scattering, mass spectroscopy and fourier transform infrared spectroscopy (FTIR), indicated 
that the most likely hypothesis was that resin was being fouled by a combination of product 123 
 
and host cell proteins. A detailed account has been presented in the literature (Iskra et al., 
2013). In this work, the objective is to elucidate on this resin fouling case study, by revealing 
the location of the foulant, and determining the mechanistic effects fouling has on protein 
uptake kinetics and resin capacity.  
 
Scanning Electron Microscopy (SEM), batch uptake experiments, Confocal Laser Scanning 
Microscopy (CLSM) on a miniaturised packed bed, and small scale column experiments are 
conducted on samples of fouled resin derived from the industrial process using the worst 
case feed stream and overloading conditions. SEM and batch uptake experiments are used to 
give  initial  indications  of  foulant  location  and  resin  performance  as  fouling  progresses, 
before CLSM is used to conduct a more detailed investigation. TexasRed labelled BSA is 
used as a reporter molecule for protein uptake kinetics. The technique uses a flowcell to 
measure changes at various stages of fouling in resin capacity and uptake kinetics, at a 
particle level. The time and space distribution of the labelled BSA within the resin particles 
is recorded in situ in order to facilitate a comparison between clean, partially fouled and 
extensively fouled resin. Finally, column studies are conducted to investigate the effect of 
the foulant on protein uptake and breakthrough performance of a column system. Together 
these techniques (summarised in Table 4.1) enable us to determine the spatial location of the 
foulant and its effect on the process during protein uptake. 
 
4.2. Experimental materials and methods 
4.2.1. Chemicals 
All chemicals were purchased from Sigma-Aldrich (Dorset, UK) and were of analytical 
grade unless stated otherwise.  
 
4.2.2. Chromatography resin and equipment 
MabSelect  Protein  A  affinity  chromatography  resin  was  obtained  from  GE  Healthcare 
(Uppsala,  Sweden).   Fractogel®  EMD  TMAE  HiCap  (M)  anion  exchange  resin  was 
obtained from EMD Merck (Darmstadt, Germany).  All laboratory experiments were carried 
out using an ÄKTA FPLC chromatography system from GE Healthcare (Uppsala, Sweden). 
 
   124 
 
 
 
Table 4.1. Experimental methodology for investigating clean, partially found and extensively fouled resin samples. 
Experiment  Results  Purpose 
 
Batch experiments 
 
Uptake curves 
 
Initial indication of impact of fouling on uptake 
rate and saturation capacity 
Scanning electron microscopy  Images of particle surfaces  Morphology of resin surface 
Confocal  laser  scanning  microscopy 
(CLSM) during live uptake experiments 
Radial light intensity profiles of a BSA reporter molecule 
during uptake in a miniature column 
Fouling effect on intraparticle profiles of bound 
BSA reporter molecule during uptake 
Column lifetime studies investigating load 
flowrate 
BSA reporter molecule breakthrough curves and dynamic 
binding capacities 
Fouling  effect  on  BSA  reporter  molecule 
breakthrough  and  dynamic  binding  capacity  at 
different loading flowrates  
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4.2.3. Proteins 
The monoclonal antibody (mAb) used in these studies was humanized IgG1 produced in 
recombinant Chinese hamster ovary (CHO) cells grown in serum free medium. Downstream 
processing  prior  to  the  anion  exchange  step  considered  in  this  work  consisted  of 
centrifugation and depth filtration, followed by Protein A chromatography. Bovine serum 
albumin (BSA) - Texas Red(R) conjugate was purchased from Invitrogen, Paisley, UK. 
 
4.2.4. Protein A Chromatography 
The  column  used  in  protein  A  chromatography  was  1.6 cm  in  diameter  and  30  cm  in 
height.   The  column  was  equilibrated  with  0.15  M  sodium  chloride  at  pH  7.5  prior  to 
loading.  Clarified condition media was then applied followed by a two column volumes 
(CV) wash of the equilibration buffer.  This was followed by 5 CV’s of 1.8 M calcium 
chloride at pH 7.5.  The elution pool consisted of material collected from start in UV rise, to 
a  total  of  2.5  CV’s,  collected  as  the  process  pool.   The  remaining  bound  protein  was 
removed using an additional 5 CV’s of low pH followed by sanitisation with 50 mM NaOH, 
0.5 M Sodium Sulfate, and stored in 16% ethanol, 150 mM NaCl, 50 mM TRIS, pH 7.5.   
 
4.2.5. Anion exchange chromatography 
The anion exchange columns used in this study were 0.5 cm in diameter and either 5 or 15 
cm in height, and were operated in weak partitioning mode (Kelley et al., 2008, Iskra et al., 
2013).  The columns were equilibrated with 50 mM TRIS, 10 mM NaCl at pH 8.1. Protein A 
peak  pools  were applied  to  the column  at  150  cm/hr  followed  by  a  3  CV wash  of the 
equilibration buffer. Protein A peak pools contained the product of interest, host cell protein, 
DNA  and  residual  Protein  A  which  had  leached  from  the  affinity  capture  resin,  and 
approximately 3.5% high molecular mass species (HMMS). The turbidity of the Protein A 
pool was 28.1 NTU (Iskra et al., 2013). The load eluate and wash volumes were collected 
together as the process pool, and any remaining bound protein was removed using a 2 M 
NaCl strip buffer.  The columns were sanitized with 2 M NaCl, 0.5 M NaOH and stored in 
16% ethanol, 150 mM NaCl, 50 mM TRIS, pH 7.5. The loading conditions used during 
column  runs  (50  mM  TRIS,  10  mM  NaCl  at  pH  8.1)  had  been  determined  by  high-
throughput screening (HTS) under batch binding conditions, and were confirmed using scale 
– down column chromatography experiments to provide sufficient clearance of impurities 
(residual HMMS < 1.5%, HCP clearance > 3.0 LRV, and leached Protein A clearance > 3.0 
LRV), while maintaining yield > 90%, prior to resin fouling. These conditions would be 
expected to produce the desired product quality in large scale manufacturing (Iskra et al., 
2013).  
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4.2.6. Generation of fouled resin samples 
Three  resin  samples  were  used  in  subsequent  experimental  studies  to  characterise  the 
fouling.  These  were  generated  by  conducting  multiple  cycles  of  the  anion  exchange 
chromatography on a column 0.5 cm in diameter and 15 cm in height, using the worst case 
feed  stream  and  overloading  conditions  (Iskra  et  al.,  2013),  according  to  the  standard 
operating procedure set out previously. The three resin samples are classified as follows: 
unused clean resin, fully fouled resin representative of resin at the end of the column’s 
lifetime  (hereon  referred  to  as  extensively  fouled  resin),  and  partially  fouled  resin, 
representative of an intermediate state of fouling. 
 
4.2.7. Batch uptake experiments  
A set amount of TMAE HiCAP (M) resin was allowed to settle by gravity. After measuring 
the settled volume, the resin was washed with ultra-pure Millipore water to remove the 
storage ethanol solution and then equilibrated with 0.05 M TRIS Base pH 9.0 HCl adjusted 
buffer, giving a final concentration of 50% (v/v). 50 µl of this slurry was then aliquoted to a 
2 mL eppindorf tube. Adsorption was started by adding 2 mL of Texas Red labelled BSA to 
the resin sample (Overall BSA concentration: 5 mg/mL, dye to protein (D/P) ratio: 0.01). 
The eppindorf was kept under constant agitation, except at fixed times when the eppindorf 
tube was quickly centrifuged for 10 s at 1200 g, before a 50 µl sample was taken from the 
supernatant and collected for subsequent UV analysis at 280 nm and 593 nm by a Nanodrop. 
The sedimented resin particles were quickly resuspended by resuming agitation. For the 
duration of the experiment resuspension was ensured by placing the eppendorf tube onto an 
orbital shaker rotating at 2000rpm, and confirmed by visual inspection. 
 
4.2.8. Scanning Electron Microscopy (SEM) 
Sample preparation for SEM consisted of sample drying followed by gold coating. A thin 
layer of resin slurry was pipetted onto a glass slide which had been pre-coated in gold and 
mounted onto a copper block. Excess liquid was carefully adsorbed on filter paper without 
contacting  the  resin  particles,  before  the  sample  was  left  for  30  minutes  to  allow  any 
remaining  ethanol  to  evaporate.  The  dried  sample  was  thereafter  transferred  to  a  high 
resolution ion beam coater (Gatan Model 681, Oxford, UK), and ion sputtered with gold at 
an angle of 45
o in order to form a 2-3 nm gold layer on the surface of the resin particles. The 
ion beam coater was operated at 6mA at an acceleration voltage of 10 keV. Coated surfaces 
were subsequently imaged with a JEOL JSM-7401F scanning electron microscope (JEOL 
Ltd., Tokyo, Japan) at 1 keV accelerating voltage.  
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4.2.9. Live uptake imaging by Confocal Laser Scanning Microscopy  
Image acquisition was performed on an inverted confocal laser scanning microscope (Leica 
TCS  SPEinv,  Leica  Microsystems  GmbH,  Mannheim,  Germany)  equipped  with 
krypton/argon (λ = 488 nm and  λ = 568 nm) and helium/neon (λ = 633 nm) lasers. Using a 
40x  oil immersion  objective,  images  (512×512)  were  captured (3  averages) through  the 
Leica  Application  Suite  (LAS)  software  (Version  2.0)  (Leica  Microsystems  GmbH, 
Mannheim, Germany). Optimal laser settings, including laser intensity, signal gain, offset 
and emission detection range were determined to ensure that there were no auto fluorescence 
effects, and that even at full particle saturation the detected emitted light intensity stayed 
within the confocal laser scanning microscope’s detection range. The settings were then kept 
constant for the duration of the study.  
 
In order for BSA to be detected by the confocal laser scanning  microscope, it must be 
labelled by a suitable fluorescent dye molecule (Ljunglöf and Thömmes, 1998). There are 
many different dye molecules currently available for this purpose. However, it has been 
reported  that  the  attachment  of  dye  molecules  can  significantly  change  the  adsorption 
behaviour of the BSA and therefore must be carefully selected (Hubbuch and Kula, 2008; 
Teske et al., 2006).  BSA conjugated to TexasRed, AlexaFluoro488, Cy3 and Cy5 on a 
strong anion exchanger chromatographic system, similar to that considered in this work, has 
previously been screened to determine which was most suitable for CLSM (Susanto et al., 
2006). The elution profiles of the conjugates were compared with native BSA in relation to 
retention time and peak shape. BSA TexasRed conjugate showed the least deviation from 
the  native  BSA,  and  was therefore  selected  in this work.  The  ratio  between native  and 
TexasRed conjugated BSA was tested by measuring UV adsorption at 280 nm and 593 nm 
throughout the batch uptake experiments.  The constant ratio during protein uptake over 1 
hour confirmed that there were minimal competitive effects in our system.  
 
In order to minimise the readsorption of emitted fluorescence by other dye molecules, a dye 
to  protein  ratio  (D/P)  of  0.01  was  used  for  the  feed  solution  following  recommended 
literature D/P ratios (Hubbuch and Kula, 2008). At this D/P ratio we were able to assume 
that  the  contribution  of  emitted  fluorescence  readsorption  to  light  attenuation  could  be 
neglected.  
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Figure 4.1. A. Side elevation of the miniaturized flowcells setting within the confocal laser scanning microscope. 
XY image acquisition plane shown on diagram. B. Three dimensional representation of the miniaturized flowcell 
used for live imaging of the intra-particle uptake within a packed bed. 
 
Control experiments investigating fluorophore bleaching upon repeated use were completed, 
and confirmed that bleaching could be neglected for the purposes of this work. A range of 
precautions  were  taken  to  minimise  fluorophore  bleaching  throughout  the  experimental 
work: the use of low laser powers, minimised exposure times and wrapping all samples in 
aluminium foil in order to minimise exposure to light during transition and storage. 
 
A miniaturized flowcell was fabricated similar in design to that used by Hubbuch and Kula 
(2008). Four horizontal channels (10mm length, 1mm diameter) were drilled into a Pyrex 
block with 45
O inlets on both sides. A viewing window was then created by fixing a cover 
slip  onto  the  open  face  of  the  block  with  epoxy  glue  Araldite®  (Huntsman  Advanced 
Materials, Cambridge, UK) in order to seal each channel. The resulting effective column 
volume was 0.02 mL. A schematic of the flowcell is shown in Figure 4.1. 
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CLSM LASER 
XY PLANE 
A  B 
Z 
X  Y
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Flowcell channels were packed by manually administering resin slurry (50% (v/v)) from a 
syringe. Great care was taken to ensure that the resin was not over or under packed. Frits 
were placed at either end of the channel, which was then connected to a syringe pump. The 
resin was washed with ultra-pure Millipore water to remove the storage ethanol solution (2 
mL,  150  cm/hr),  before  equilibration  with  0.05  M  TRIS  Base  pH  9.0  HCl  adjusted 
equilibration buffer (2 mL, 150 cm/hr).  
 
Texas Red labelled BSA feed was adjusted to the required pH and salt concentration in the 
running buffer, and loaded onto the resin bed within the flowcell channel at 150 cm/hr for 90 
minutes. Images were recorded using a Confocal Laser Scanning Microscope at set time 
intervals with excitation at 568 nm and emission detection in the range 550 nm – 701 nm. 
The setting of the flowcell within the laser scanning confocal microscope is shown in Figure 
4.1 . 
 
4.2.10. Live uptake data processing 
The large  number  of  confocal  images  from  the  flowcell  experiments  were  processed  to 
generate a reliable set of radial light intensity profiles. This was done in order to allow a 
direct comparison of the spatial location of BSA within resin particles during protein uptake 
between  the  clean,  partially  fouled  and  extensively  fouled  samples  over  the  90  minute 
experiments. For each experimental data set 5 particles were selected for data processing 
from  the  area  of  the  flowcell  imaged.  We  found  that  using  more  than  5  particles  gave 
negligible benefits in terms of the reliability of our data. The appropriate XY image where 
the focal plane intersected with the centre of each particle was then selected at each time 
interval,  as  illustrated  in  Figure  4.2A.  This  was  possible  because  at  each  time  interval 
throughout the 90 minute flowcell experiments, images of XY planes of the flowcell bed 
area under scrutiny were taken over a range of z values at 5 µm intervals. The selection of 5 
particles from those available (up to 14) also helped us to ensure this centre cross-section 
positioning, as we were able to only select particles where the focal plane exactly intersected 
with the centre of each particle. 
 
The next step was to generate radial profiles of the emitted light intensity. This is typically 
done by a simple linear profile evaluation through the central cross section of a scanned 
particle  (Hubbuch  and  Kula,  2008).  However,  this  method  neglects  the  inhomogeneous 
nature of protein uptake due to effects such as particle contact points and fouling. In this 
work, the emitted fluorescence intensity was measured as a function of the radial coordinate 
and  subsequently  averaged  over  particle  circumference  in  order  to  account  for  this 
inhomogeneous uptake (Figure 4.2C). We utilized ImageJ v1.31 for this purpose, which is  
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an imaging software developed by the Research Services Branch of the National Institute of 
Mental  Health  in  Bethesda,  Md,  USA  and  is  freely  available  in  the  public  domain 
(Abramoff, 2004; Rasband, 2011).  
 
The radial profiles of each particle were then normalised by dividing the radial dimension by 
the  appropriate  particle  diameter.  In  this  work  the  particle  -  fluid  phase  boundary  was 
identified by the highest emitted light intensity across the radial profile, and subsequently 
used to calculate the particle diameter. It was found that the emitted light intensity values 
outside  the  determined  particle  -  fluid  phase  boundary  consistently  dropped  to  an 
insignificant value within 4 µm of the particle diameter over the range of particle diameters 
analysed (50 - 90 µm), for all resin samples. This is in agreement with the literature, where 
lengths of this region typically fall between 2 - 10µm (Dziennik et al., 2005; Susanto et al., 
2006). All emitted light intensity data was corrected for light attenuation effects following 
the methodology set out by Susanto at al. (2006). Lastly, the corrected emitted light intensity 
radial profiles (normalised by particle diameter and averaged over particle circumference) 
were averaged over the 5 particles per resin sample. The resulting set of data thus describes 
the average time and space distribution of the BSA in the resin samples throughout the 90 
minute flowcell experiment. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.2. A. The XY plane intersecting with centre of the particle of interest (POI) is selected. B. The POI’s 
centre XY plane image from CLSM, also showing all available particles in the flowcell area imaged. C. 
Illustrating how the emitted fluorescence intensity is measured as a function of radial coordinates (dotted line), 
and is averaged over particle circumference (dashed line).  
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4.2.11. Column studies  
An iterative procedure where a column 0.5 cm in diameter and 5 cm in height was subjected 
to multiple anion exchange chromatography cycles using representative load material and a 
scheme  of  over  challenge  was  performed,  until  the  cumulative  amount  of  protein  from 
protein A peak pools that had been challenged onto the resin reached predefined amounts (1, 
2, 3, 4, and 5 g/ml). Each time the cumulative load challenge reached one of the predefined 
amounts, the cycle in progress was allowed to run to completion, i.e. the column washed, 
eluted,  sanitized  and  placed  into  storage  buffer  according  to  the  methodology  set  out 
previously  (Section  4.2.5),  and  the  anion  exchange  cycling  paused.  The  effect  of  resin 
fouling that had occurred during the anion exchange cycling was then measured via full 
breakthrough  of  BSA  at  different  flowrates  (0.49,  0.33,  0.16,  0.08  ml/min).  BSA 
breakthrough was conducted as follows: The column was equilibrated with 50 mM TRIS, 10 
mM NaCl at pH 9.0. BSA was then applied to the column at the specified flowrate (load 
concentration 10 mg/ml, load challenge 300 mg/ml). Any bound BSA was then removed 
using a 50 mM TRIS, 2 M NaCl, pH 7.5 elution buffer.  The column was further cleaned 
with 2 M NaCl, 0.5 M NaOH, and then placed in storage buffer (16% ethanol, 150 mM 
NaCl, 50 mM TRIS, pH 7.5). Once the breakthrough of BSA had been recorded at each 
flowrate, the column was returned to anion exchange chromatography cycling. 
 
4.3. Results and Discussion 
The overall objective of this work was to determine the location of fouling on resin particles 
and the effect of this fouling on protein kinetics and resin capacity in an anion exchange 
polishing step from an industrial purification process. In the following, the results from SEM 
imaging and batch uptake experiments are presented which give initial indication of the 
foulant location and the progressive nature of the effect with cycle number. Following this, 
the results from a detailed CLSM investigation are presented. This includes the intra-particle 
radial  adsorption  profiles  during  protein  uptake  within  the  miniaturized  flowcell  bed, 
accompanied  by  corresponding  uptake  curves.  Finally,  the  results  from  column  studies 
which include BSA breakthrough profiles and dynamic binding capacities over a range of 
flowrates with increasing cycle number and hence also increasing fouling.  
 
4.3.1. Batch Experiments 
The batch experiments were designed to give an initial indication of the effect that the 
foulant had on protein uptake, and to confirm that there were no competitive effects in the 
system  due  to  modification  of  BSA  binding  characteristics  when  conjugated  with  the 
TexasRed flurophore, in preparation for the CLSM study. Figure 4.3 shows the batch uptake  
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curves of BSA with clean, partially fouled and extensively fouled resin samples.  For all 
samples the batch adsorption kinetics were consistant with previous literature results on 
tentacle  exchangers  (Almodóvar  et  al.,  2011;  Urmann  et  al.,  2010).    However,  a  clear 
difference in the initial uptake rates was observed with clean resin having the fastest uptake, 
followed by partially fouled resin, then extensively fouled resin. More detailed analysis of 
the data indicated that the initial uptake of BSA by clean resin was roughly twice as fast as 
uptake by extensively fouled resin, indicating fouling significantly impacts mass transfer. 
  
Figure 4.3 shows that by the end of the experiment equilibrium had not been reached by any 
of the resin samples. Although the amount of BSA bound to the extensively fouled resin was 
lower than the amount bound to the clean resin (partially fouled resin ~87% amount bound 
to clean resin, extensively fouled resin ~ 82% amount bound to clean resin), uptake was still 
ongoing.  Firm  conclusions  regarding  the  effect  that  the  foulant  had  on  the  saturation 
capacity of the resin could therefore not be made. As there was a constant ratio between 
conjugated and non-conjugated BSA in the supernatant throughout uptake, confirmation that 
there were no competitive adsorption effects in the system was achieved (not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Batch uptake curves of 5mg/ml BSA at 0.05M TRIS Base pH 9.0, by clean ■, partially fouled ●, and 
extensively fouled ▲ Fractogel® EMD TMAE HiCap (M) resin particles during batch experiments. (Feed to 
resin volume ratio 80:1 (80×)). A. Bound BSA concentration as a function of time. B. Bulk mobile phase BSA 
concentration as a function of time. 
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4.3.2. Scanning Electron Microscope Imaging 
Figure 4.4 shows high resolution SEM images of clean, partially fouled and extensively 
fouled resin particles at progressively higher magnifications. The area of the particle under 
analysis was kept constant for each sample. The images show distinct differences in the 
particle surface morphology between the three samples. In the clean resin (Figure 4.4A), the 
surface is well-defined, homogenous, and the pores are clearly accessible. By comparison, 
the  extensively  fouled resin  (Figure  4.4C)  shows  a high  amount  of  pore  blockage  by  a 
material covering much of the surface. This is particularly clear on the highest magnification 
image (10000x for A3/B3/C3). In Figure 4.4, images CX and CY illustrate the magnitude of 
the  fouling,  with  many  particles  showing  completely  clogged  pore  entrances  over  a 
significant percentage of particle surface area. Fouling on partially fouled resin surface is not 
as obvious, but does show an intermediate level of pore blockage (Figure 4.4B). 
 
Interestingly,  circular  patches  were  found  on  the  extensively  fouled  resin  which  were 
comparable in surface morphology to that seen in the clean resin images in Figure 4.4C. 
These are regions where particle – particle contact occurs within the packed bed, and show 
little or no fouling. Previous studies have also shown such areas, clearly distinguishable 
from  the  rest  of  the  particle  surface, and  have  reported  localised  external  mass  transfer 
resistance through these regions (Hubbuch et al., 2002; Jin, 2010; Siu et al., 2007).  In 
addition to the pore blocking, images CX and CY show larger pieces of clumped material on 
the particle surface that were common throughout fouled and partially fouled particles. The 
SEM imaging suggests a mechanism where the foulant blocks pore entrances but does not 
penetrate a significant distance into the particle, instead continuously growing outwards over 
successive cycles. This is in agreement with results by Jin et al. (2010) who reported the 
progressive build-up of lipid based foulant on the surface of Sepharose® Butyl-S 6 Fast 
Flow resin over successive cycles.  
 
4.3.3. Live uptake experiments 
The purpose of the live uptake experiments was to conduct a direct comparison between the 
clean, partially fouled, and extensively fouled resin based on their intra-particle radial light 
intensity profiles, during uptake of a BSA reporter molecule in a packed bed using confocal 
laser scanning microscopy (CLSM). The light intensity is proportional to the concentration 
of bound protein, and therefore can be used to estimate differences in the intra-particular 
mass transfer and adsorption (Figure 4.5). Integrating the area underneath the radial light 
intensity profiles, and correcting for the spherical nature of resin particles, indicates the 
relative amount of BSA bound to the different resin samples throughout uptake (Figure 4.6).  
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Figure 4.4. Scanning electron microscopy images of A. Clean B. Partially fouled. C. Extensively fouled 
Fractogel® EMD TMAE HiCap (M) resin particles. A1. x1000 B1. x450 C1. x750 A2/C2. x3000 B2. x2000 
A3/B3/C3. x10000. CY. x2,000. CY. x7,000. 
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Figure 4.5 and Figure 4.6 show a dramatic difference was found in the protein uptake rate of 
the different samples. Clean resin had the fastest uptake, followed by partially fouled, then 
extensively fouled resin. Partially fouled resin took approximately twice as long as the clean 
resin to reach the highest light intensity seen in the experiments, and fouled resin still had 
not reached this value after 85 minutes of loading. However, the amount of BSA bound to 
the partially and extensively fouled resin samples was approaching that of the clean resin at 
the end of the experiment. Partially fouled resin was at 98%, and extensively fouled resin at 
83%, of the clean resin’s capacity, and adsorption was still ongoing. This suggests that if the 
partially fouled or extensively fouled resin is challenged for long enough, it will eventually 
reach the capacity of the clean resin, or somewhere near this.  
 
For all three resin samples there was minimal difference between the shape of the intra-
particle  binding  profiles.  Some  differences  would  have  expected,  either  localized  or  in 
general, between the different resin samples had foulant been irreversibly binding to intra-
particular binding sites, but this was not the case. In Figure 4.5, the peak close to the exterior 
boundary of the particle does become marginally wider and less defined with fouling, but 
this effect is minimal. This flattened region of the profiles in the fouled resin samples is 
approximately 3 µm in length, and may indicate that slightly less protein may be binding to 
this region as fouling worsens. These results are all in agreement with the hypothesis that the 
foulant forms a layer on the surface of the resin and does not significantly penetrate into the 
particles. It appears that as the foulant blocks access to the pore entrances, the available 
surface area where protein can diffuse freely into the particle therefore decreases, which 
introduces increased resistance to mass transfer. This causes the dramatic differences in 
uptake, but minimal differences in capacity which we saw between the resin samples. Intra-
particle mass transfer thus does not appear to be a limiting step. 
 
4.3.4. Column studies 
Column breakthrough experiments were used for studying the effect of the foulant on resin 
performance.  Scale  down  cycling  studies  provided  fouled  samples  to  measure  BSA 
breakthrough over an extended range of flow rates. The use of BSA for breakthrough studies 
was not intended to replicate industrial process behaviour. Instead, the BSA was used as an 
analytical tool to test the pore blockage hypothesis where resin fouling would hinder mass 
transfer into the resin, only allowing capacity of the resin to be recovered at high residence 
times. 
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Figure 4.5. Average radial emitted light intensity of BSA (stationary phase: A. Clean. B. Partially fouled. C. 
Extensively fouled Fractogel® EMD TMAE HiCap (M) resin particles) over time (0, 5, 10, 30, 60mins), during 
the uptake of Texas Red labelled BSA from the process feed (5mg/ml BSA, D/P ratio = 0.01, 0.05M TRIS Base 
pH 9.0 HCl adjusted, 150cm/hr), during flowcell experiments.   
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Figure 4.7 shows that over the course of the column studies, both the shape and the position 
of BSA breakthrough changed drastically as cycle number increased. Figure 4.8 illustrates 
the  corresponding  decrease  in  dynamic  binding  capacity  (DBC),  which  for  the  normal 
operating flowrate of 0.49 ml/min (~150 cm/hr), dropped by 71% over the course of the 
study. At this flowrate, Figure 4.7 shows that for clean resin, breakthrough begun after 
approximately 10 CV of material had been applied to the column. In contrast, when the resin 
was extensively fouled, onset of breakthrough was rapid, beginning after less than 1 CV, 
similar to what would be expected during operation in flow through mode with minimal 
protein binding.  
 
The shape of the breakthrough went from sharp to diffuse as fouling progressed (Figure 4.7), 
and indicated that the loss in capacity and rapid breakthrough observed at the end of the 
study was due to severe mass transfer resistance, rather than a decrease in capacity due to 
foulant binding in place of the protein molecule of interest. Breakthrough would have been 
expected to remain sharp if the mass transfer was not affected by fouling, which was not the 
case.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Relative uptake curves of clean ■, partially fouled ●, and extensively fouled ▲ Fractogel® EMD 
TMAE HiCap (M) resin calculated from integrating under intra-particle labelled BSA profiles during uptake in a 
packed bed in Figure 5, and correcting for the spherical nature of resin particles. 
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Figure 4.7. Breakthrough curves of 10 (mg/ml) BSA load in 0.05M TRIS Base pH 9.0 at different flow rates on a 
0.98ml TMAE HiCap (M) column, 5cm in length. Load phase begins at 10ml. The column had been previously 
challenged with Protein A peak containing 1g (A), 3g (B) and 5g (C) of mAb. The control experiment using 
clean resin at 0.49 ml/min (~150 cm/hr) is shown for reference on each graph. 
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Figure 4.8. Fractogel® EMD TMAE HiCap (M) resin BSA dynamic binding capacity (at 90% breakthrough) as a 
function of load flow rate on a 0.98ml TMAE HiCap (M) column, 5cm in length. The column had been 
previously challenged with Protein A peak containing 0g ■, 1g ●, 3g ▲, 5g ▼of mAb. The load concentration of 
BSA was 10mg/ml in 0.05M TRIS Base pH 9.0. Data arrived at from Figure 7. 
 
 
The data shows that by decreasing the flow rate, the dynamic binding capacity (DBC) lost 
due to fouling can be recovered (Figure 4.8). Reducing the flow rate from 0.49 ml/min (~150 
cm/hr) to 0.08 ml/min (~25 cm/hr) at the highest level of fouling (after 5g of feed material 
had been challenged), resulted in the DBC increasing from 47 mg/ml to 146 mg/ml resin, a 3 
fold increase. A linear equation with an r
2 value of 0.997 was fit to the data from Figure 4.8. 
The y intercept of this equation showed that with the fouling levels experienced at the end of 
the study, the theoretical maximum DBC was 167 mg/ml resin, the same DBC as the control 
run conducted at the start of the study using clean resin. This further supports the hypothesis 
that the foulant is located on the particle surface, only penetrating the particle to a limited 
degree. The increase in time that particles are exposed to BSA at lower flow rates, enables 
the BSA to overcome the mass transfer limitations as a result of the fouling, thus restoring 
DBC to pre fouled levels.  
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4.4. Conclusion 
Batch  experiments,  Scanning  Electron  Microscopy  (SEM)  and  Confocal  Laser  Scanning 
Microscopy (CLSM) and small scale column experiments are useful tools for characterizing 
fouling in chromatographic resin. In this study the foulant was shown to progressively build 
up on the particle surface using SEM. The batch and CLSM live uptake experiments were in 
agreement that the foulant reduced the uptake rate of the BSA reporter molecule, with little 
or no change in saturation capacity. The column study confirmed that binding capacity lost 
due to the foulant could be restored by decreasing the flow rate, providing further evidence 
to support the conclusion that the foulant is located on the particle surface, only penetrating 
the particle to a limited degree. The results suggest that progressive fouling of resin can 
severely  impact  the  performance  of  chromatography  columns.  The  knowledge  and 
understanding of resin fouling gained can direct future efforts to mitigate this detrimental 
phenomenon  and  maintain  process  performance,  whilst  providing  a  basis  for  the 
development of new fouling models. 
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Chapter 5. Resin Lot Variability 
 
A model based approach is used to identify robust operating conditions for an industrial 
hydrophobic interaction chromatography at a late stage of process development. Resin lot 
and  load  material  variability  was  resulting  in  serious  performance  issues  during  the 
purification of a multi component therapeutic protein from crude material. An equilibrium 
dispersive model is developed of the HIC. Stochastic simulations are conducted to generate 
probabilistic design spaces for resins that gave the highest and lowest protein recoveries 
during  testing.  The  design  spaces  show  the  probability  of  meeting  product  quality 
specifications  for  a  key  critical  quality  attribute,  over  a  range  of  possible  operating 
conditions.  The  simulations  account  for  historical  variability  experienced  in  the  load 
material  composition  and  concentration.  The  results  are  used  to  determine  operating 
conditions that assure product quality despite the process variability. With normal process 
variability,  no  operating  condition  was  found  where  the  probability  of  meeting  product 
quality  specifications  remained  >  0.95 for  all  resin  lots.  The  stochastic  methodology  is 
extended to identify the  level  of  control required  on  the load  material  composition and 
concentration to bring process robustness to an acceptable level. This is not possible using 
an experimental method due to the impractical amount of resources that would be required. 
The results indicated that adopting an adaptive design space, where operating conditions 
are changed according to which resin lot is in use, was the favourable option for ensuring 
process robustness, which is a step change concept for bioprocessing. 
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5.1. Introduction 
Chapter  3  and  4  considered  the  use  of  mechanistic  chromatography  models  to  derive 
fundamental  process  understanding  of  specific  industrial  chromatographic  separations 
currently in development or operation at Pfizer, at an early stage of development. The goal 
was  to  accelerate  the  development  and  increase  the  robustness  of  industrial  protein 
purification processes, whilst following guidance regarding the implementation of Quality 
by  Design.  In  this  chapter,  the  same  objectives  are  considered  for  a  chromatographic 
separation at a late stage of development. 
 
Chapter 5 focuses on an industrial chromatographic separation where resin lot variability, 
combined with a variable feed stream, had resulted in serious performance issues during the 
purification  of  a  therapeutic  protein  from  crude  feed  material.  The  resin  lot  variability 
occurred on a hydrophobic interaction chromatography (HIC) that produces a complex final 
product composed of six closely related variants of a dimer protein therapeutic (~30 kDa), 
with their monomer subunits in a specific ratio. The desired ratio of monomer subunits must 
be met by this unit operation, and is a defined CQA of the final product. An extended range 
of resin lots were obtained from the supplier for testing within normal process operating 
ranges. All resin lots were within the manufacturers’ specifications for ligand density and 
chloride capacity. Despite this, many failed to meet product quality specifications during 
testing and would have incurred significant losses if used for the large scale manufacture of 
the  product.  No  link  between  resin  lot  specifications  and  successfully  meeting  process 
objectives was found. 
 
The  traditional  approach  to  identifying  an  operating  region  where  the  product  quality 
remains within the defined product specification is to conduct an extensive experimental 
effort directed by factorial design of experiments. The data would be used to generate a 
response surface model which functions as a deterministic design space. The approach is 
extremely  time  consuming  and  costly.  The  outcome  the  DOE  is  a  fixed,  inflexible 
manufacturing  process,  with  a  control  strategy  based  on  reproducibility  rather  than 
robustness. The experimental results are unlikely to bring any fundamental understanding of 
the  source  of  performance  issue,  which  means  analysing  and  understanding  reasons  for 
further batch failures would be extremely difficult.  In addition, the experimental approach 
provides  no contingency  in  case  suitable  operating  conditions  cannot  be  found,  and  the 
response surface model is limited to the data used to generate it.  
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In this chapter, a model based approach is used to identify robust operating conditions that 
ensure  the  desired  product  quality  is  met,  despite  the  resin  lot  and  inherent  bioprocess 
variability. The HIC was at a late stage of process development and had predefined mobile 
phase conditions, flow rate and column dimensions that had been fixed prior to this work.  
The  mass  challenge  and  wash  length  were  the  only  manipulated  variables  available  for 
adjustment.  An  equilibrium  dispersive  model  with  competitive  Langmuir  adsorption  is 
developed for the two most extreme resin lots which gave the highest (designated high 
binding  resin)  and  lowest  (designated  low  binding  resin)  protein  recoveries  at  normal 
operating conditions (not shown for confidentiality purposes). Micro well batch adsorption 
and  scale  down  column  experiments  are  used  for  model  calibration,  and  the  model  is 
validated against multiple scale down column experiments over an extended range of inlet 
variables and process parameters.  
 
Stochastic simulations are conducted using the validated models to generate probabilistic 
process design spaces for each resin lot. These show the probability of meeting product 
quality specifications (i.e. the product CQA), over a range of possible operating conditions, 
whilst accounting for historical variability experienced in the load material composition and 
concentration. The data is used to determine if operating conditions exist that are eligible for 
all resin lots, by assuming that the operating conditions that assure product quality for the 
polar extreme high and low resin lots are suitable for all other resin lots. The stochastic 
methodology used to generate probabilistic design spaces is then extended, demonstrating 
how stochastic simulation can be used to identify the level of control required on uncertain 
variables to bring process robustness to an acceptable level, when current uncertainty results 
in an unsatisfactory design space. In this work, the control required on the load material 
composition and concentration is determined. The presented approach can be used with any 
validated mechanistic model with parameters that are variable or uncertain, and enables the 
rapid exploration of the trade-off between control of process parameters and the robustness 
of the design space, which is not possible using DOE experimental methods due to the 
impractical amount of resources that would be required. 
 
FDA  guidance  encourages  the  application  of  mechanistic  models  to  improve  process 
understanding, based on fundamental knowledge of the underlying causes linking process 
parameters  to  product  CQA’s.  The  methodology  demonstrates  how  useful  mechanistic 
models can be for this task, for as well as determining the functional relationship between 
process parameter values and the resulting value of the CQA, the use of models can quickly 
and efficiently determine the relationship between process parameter and CQA variances, a 
key aspect of providing assurance of product quality.  
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5.2. Experimental materials and methods 
 
5.2.1. Materials 
5.2.1.1. Therapeutic protein and feed material 
The product of interest is a disulphide linked dimer protein molecule (MW = 30 kDa), 
comprised of two monomer subunits. Three variations of the monomer subunit exist due to 
slight variations in the amino acid sequence, here denoted  ,  ̅ and  . This results in six 
possible isoforms of the dimer (  , ̅ ̅,  ̅, ̅ ,  	and	    as illustrated in Figure 5.1. 
The corresponding analytical chromatogram is shown in Figure 5.2 (Top). Each form is an 
active component of the final product which must contain a specific ratio of the monomer 
subunits,    +  ̅ : , i.e. not just one product form at a given total amount is required, but 
six  closely  related  dimer  variants,  with  a  specific  ratio  of  their  monomer  subunits. 
Specifically, subunit   must account for between 25 – 45 % of all monomer subunits in the 
product, i.e. 0.25 <   < 0.45. In addition to the product, the HIC feed material contains 
several product related impurities accounting for up to 25% by mass of the feed material, 
including the individual monomer subunits ( ,  ̅ and  ), incorrectly formed product species 
(MW = 42, 60, 80 and 100 kDa), and host cell related contaminants consisting of mainly 
host cell protein (HCP) and DNA. The analytical chromatogram used to distinguish between 
the different product and impurity species is shown in Figure 5.2 (Bottom). 
 
5.2.1.2. Chromatography resin 
Multiple  (>20)  Butyl  Sepharose  4B  fast  flow  hydrophobic  interaction  resin  lots  were 
obtained from GE Healthcare (Uppsala, Sweden). The two most extreme resin lots were 
selected for use in this work based on protein recovery in process development experiments 
conducted at standard operating conditions (not shown). The resins are designated high and 
low binding resin, e.g. the high binding resin gave high protein recoveries and the low 
binding resin gave low protein recoveries. 
 
5.2.1.3. Equipment 
All  preparative  scale  laboratory  experiments  were  carried  out  using  an  ÄKTA  FPLC 
chromatography system from GE Healthcare (Uppsala, Sweden). Laboratory columns were 
1.1 – 3.2 cm in diameter and 7.4 cm in bed height. A GE Healthcare Mono S column 
(5.0mm x 50mm) high performance liquid chromatography (HPLC) column was used for 
analytics, and a a TSK-Phenyl reversed phase column was used for the phenyl reverse phase 
assay.   
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Figure 5.1. The product is a disulphide linked dimer protein therapeutic (MW ≈ 30 kDa), comprised of two 
monomer subunits. Three variations of the monomer subunit exist due to slight variations in the amino acid 
sequence, here denoted  ,  ̅ and  . This results in six possible forms of the dimer, all of which are active 
components of the final product and that must be present in the elution peak in a specific distribution. 
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 ̅ ̅ 
  ̅ 
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Figure 5.2. Analytical chromatogram of A. the product and B. the feed material. (Axis values deliberately 
removed for confidentiality purposes) 
 
. 
5.2.2. Methods 
 
5.2.2.1. Hydrophobic Interaction Chromatography 
During all runs, the columns were first equilibrated with 50 mM Tris, 1.0 M NaC1, 0.50 M 
Arg-HC1, pH 7 equilibration buffer. The elution peak from a preceding pseudo affinity 
capture chromatography was brought to the correct NaCl concentration and applied to the 
column at 4.2 CV/hr, followed by a wash step using the equilibration buffer. Elution buffer 
consisting of 20% Propylene Glycol, 50 mM Tris, 0.50 M Arg-HCl, pH 7 was then applied 
and the product peak collected. The pooling policy was fixed for all runs. Any remaining 
bound protein was removed in a strip step using 0.1 M Sodium Acetate, pH 4 sanitization 
buffer, and the column was stored in storage buffer when not in use. The efficacy of the 
elution  stage  is  well  understood,  and  was  experimentally  validated  during  process 
development. Negligible amounts of protein remain in the column after the elution stage and 
all  mass  balances  were  satisfactory  during  experimental  runs.  All  experiments  were 
conducted between 4 and 8 
oC. 
 
A 
B  
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5.2.2.2. Cation Exchange HPLC Assay 
The  Cation  Exchange  (CEX)  HPLC  assay  utilises  a  Mono  S  column  and  a  gradient  of 
sodium acetate, acetonitrile and sodium chloride at pH 5.0 in order to determine the relative 
percentages of the six dimer isoforms of the product in the sample. After equilibrating the 
column for 30 minutes, 100 µl samples at 0.5 mg/ml are injected onto a column at a flowrate 
of 1 ml/min. Over the course of the gradient, separation of the isoforms is accomplished 
based upon competitive ionic exchange of the sample ions with a counter ion in the mobile 
phase, for fixed cationic functional groups on the column resin. Absorbance at 280 nm is 
measured at the column exit. Integration of the resulting chromatogram and analysis of the 
relative percentage area of each peak indicates the percentage of each isoform in the sample. 
The total time to run each sample is 30 minutes (Figure 5.2. Top). 
 
5.2.2.3. Phenyl Reverse Phase HPLC Assay 
The Phenyl Reversed Phase (RP) HPLC assay utilises a TSK-Phenyl reversed phase column 
and a water/acetonitrile/trifluoroacetic acid gradient system to determine the relative amount 
of product and product related impurities in samples. After equilibrating the column for 30 
minutes, 100 µl samples at 1 mg/ml are injected onto a column equilibrated with a low 
percentage of acetonitrile mobile phase at a flowrate of 1 ml/min. As the organic modifier 
(acetonitrile) is increased over the course of the gradient, separation of the product related 
species and impurities is accomplished. Absorbance at 214 nm is measured at the column 
exit. Integration of the resulting chromatogram and analysis of the relative percentage area 
of each peak indicates the percentage of each species in the sample. The total time to run 
each sample is 80 minutes (Figure 5.2. Bottom). 
 
5.2.2.4. Generating purified product 
Protein  solutions  for  model  development  experiments  were  generated  from  crude  feed 
material,  i.e.  for  batch  adsorption  experiments  and  impurity/no-impurity  column 
experiments. Following initial purification by pseudo affinity capture, the material contained 
the 6 product forms of interest, as well as a range of product related impurities and host cell 
proteins (HCP’s). The product forms were further purified and isolated from impurities over 
multiple runs on the HIC considered in this work. Multiple runs were required as it was 
particularly challenging to separate the product isoform BB from similar product related 
impurities. Fractions were taken every column volume (CV) and analysed by CEX HPLC in 
order to determine the isoform distribution of the sample. Multiple samples with a range of 
isoform  distributions  were  generated  in  this  way,  and  later  pooled  in  order  to  generate 
material  with  desired  isoform  distributions  for  development  experiments.  Removal  of 
product related impurities and HCP’s was confirmed by phenyl RP HPLC.  
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5.2.2.5. Impurity/no-impurity column experiments 
To  confirm  that  the  product  related  impurities  and  HCP’s  in  the  load  material  had  a 
negligible impact on the separation of the product of interest, HIC column experiments were 
conducted with and without impurities in the load material. Experiments were identical in all 
other  aspects  i.e.  load  challenge,  product  concentration,  product  composition  and 
washlength.  In  order  to  ensure  that  the  product  in  the  load  material  was  the  same  for 
impurity and no-impurity experiments, material only containing impurities was combined 
with pure product. 
 
5.2.2.6. Batch adsorption experiments 
Batch adsorption experiments were required to generate data for calibrating the equilibrium 
adsorption isotherm parameters. Batch binding studies based on the work of Coffman et al. 
were conducted in a 96-well filter plate and were repeated in triplicate (Coffman et al., 
2008). The filter plates used throughout the experiments were round-well 800 µl plates with 
0.45 µm pore-size polypropylene membrane. 25 µl of resin was taken from a bulk reservoir 
and dispensed by the robotic liquid handler into the individual wells as 25% (v/v) slurry in 
the appropriate equilibration buffer. The plate was then centrifuged to evacuate excess liquid 
and leave damp resin. Subsequently, solutions composed of pure product, having various 
total protein concentrations (0.5 – 1 mg/ml) and isoform distributions (each component was 
varied between 20 – 60%) were added into wells containing the resin. The desired initial 
concentration and component distribution for each filter plate well was achieved by mixing 
together protein from bulk solutions of known component distributions and concentrations, 
with the appropriate amount of equilibration buffer from a bulk solution in order that the 
total volume of liquid dispensed into each well was 275µL (    ). The resin and solutions 
were then agitated on a platform shaker for 120 minutes. Separate batch uptake studies 
indicated that equilibrium was reached in less than 30 minutes (not shown), and therefore 
that this incubation time was suitable. Foil adhesive tape was used on the underside of the 
filter- plate to prevent liquid loss during shaking. After incubation, a centrifuge evacuated 
the supernatant into a UV-transparent 96 well micro plate which was stacked beneath the 
filter  plate  for  analysis.  The  supernatant  was  then  analyzed  by  a  96-well  UV 
spectrophotometer (SpectraMax 250, Molecular Devices, Sunnyvale, CA) to determine the 
concentration of protein in the supernatant,   
 . CEX HPLC was used to determine the 
percentage of each component in the supernatant,   
 . The concentration of the protein in 
the mobile phase is then calculated from Eq 1:  
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      ∙  
 
            [5.1] 
 
where        is the measured concentration in the supernatant of the micro well (mg/ml), 
determined by UV spectroscopy. An elution cycle was then conducted following the same 
methodology as the load cycle, where 275 µL of elution buffer was added to each well, the 
plate  agitated  on  a  platform  shaker  for  120  minutes  and  the  supernatant  subsequently 
collected  as  described  previously  and  analysed  using  the  spectrophotometer  and  CEX 
HPLC. The total amount of protein added to each micro well was then determined by Eq 2:  
 
   =	
        
        
+	
      
      
        [5.2] 
 
where      is  the  total  amount  of  protein  added  to  the  micro  well  (mg),            is  the 
concentration  of  the  elution  supernatant  (mg/ml),          is  the  volume  of  the  elution 
supernatant (ml),        is the concentration of the equil supernatant (mg/ml), and        is 
the volume of the equil supernatant. The amount of protein adsorbed per unit volume settled 
resin,   , is calculated using Eq 3:  
 
   =
 
  ∙  
    
       
 ∙       
             [5.3] 
 
where   
    is the percentage of component   in the load material and       is the settled 
volume of resin in the microwell (25 µl in this work). 
 
 
5.2.2.7. Pulse injection experiments 
Pulse injection experiments were required to determine the total column porosity,   . Pulses 
of NaCl were injected onto the column system and the retention time measured, accounting 
for dead time in the system. All experiments were performed in triplicate. The total column 
porosity,   , was calculated by the following equation: 
   =
   
   
        [5.4] 
 
where    is the retention time of the unretained molecule,   is the mobile phase flowrate and 
   is the column volume. 
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5.3. Mathematical methods 
 
5.3.1. Process assumptions 
The similar amino acid sequence of two of the monomer subunits (  and  ̅) results in 
similar separation properties of the product isoforms   , ̅ ̅,  ̅ and of the product isoforms 
 ̅ ,  	. In order to simplify the modeling problem, the six product isotherms were reduced 
in the model to three species:   ,  ,and	  . Because all product isoforms that remain 
bound to the column after the load and wash steps are subsequently collected in the elution 
step, only the load and wash stages of the separation are simulated and the elution peak 
composition calculated by mass balance. 
 
5.3.2. Model 
An equilibrium dispersive model was chosen to simulate the HIC (Guiochon et al., 1994, 
Kaczmarski et al., 2001) as it is faster to solve than the general rate model, which was 
important for reducing simulation time, and because fewer model parameters need to be 
determined, whilst still predicting the product CQA sufficiently well (as will be shown in 
section 4). The model is discussed in detail in the literature review section of this work and 
so is not repeated here. Model equations are summarised in Table 5.1 and described in detail 
in Appendix B.  It is important to note that when the adsorption isotherm is linked with the 
mass conservation equation, the amount of protein adsorbed per unit volume of settled resin, 
  , is converted to the amount of protein adsorbed per unit volume of stationary phase in the 
packed bed,    
  . Dividing    by  1 −     accounts for the phase ratio (Mollerup, 2008), 
and multiplying   	by a compression factor,   , defined as the ratio between settled bed 
volume and packed bed volume, accounts for bed compression (Gerontas et al., 2010). The 
necessary compression had been determined experimentally during process development in 
order  to  prevent  the  formation  of  column  headspace  under  flow  conditions.  All  model 
equations  were  implemented  and  solved  using  the  dynamic  simulation  tool  gPROMS
TM 
(Process Systems Enterprise, 2013). Discretisation of the column in the axial coordinate is 
done using the built-in orthogonal collocation on finite element method. 
 
5.3.3. Parameter estimation 
The  ‘parameter  estimation’  entity  in  gPROMS
TM  is  based  on  the  SRQPD  sequential 
quadratic programming code and was used to fit adsorption isotherm parameters (  ,  , ) 
and the apparent axial dispersion coefficient (  ). Parameter estimation was based on the 
maximum likelihood formulation, which determines values for the uncertain physical and 
variance  model  parameters  that  maximise  the  probability  that  the  model  will  predict  
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measured values from development experiments (Process Systems Enterprise, 2013). First 
the  adsorption  isotherm  parameters  are  estimated  by  fitting  the  competitive  Langmuir 
isotherm model to the three component competitive adsorption data from the micro well 
batch  adsorption  experiments  (section  5.2.2.6).  For  estimation  of  the  apparent  axial 
dispersion  coefficient,  the  full  equilibrium  dispersive  model  with  competitive  Langmuir 
adsorption is fitted to experimental product form distributions in samples taken every CV 
during the wash of a scale down column run (section 5.2.2.1). 
 
 
Table 5.1. Summary of equiliubrium dispersive model used in this chapter. For a detailed description of the 
model and variables please refer to Appendix B 
 
Equilibrium dispersive model with competitive Langmuir adsorption 
 
Mass conservation 
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where 
 
            Extra particular mobile phase concentration [mg/ml] 
             Stationary phase concentration [mg/ml]   
						     Compression factor [-] 
           Apparent axial dispersion coefficient [cm
2/s] 
             Component identifier [-] 
            Equilibrium constant [-] 
            Column length [cm] 
           Number of components [-] 
            Saturation capacity [mg/ml] 
            Concentration per unit volume settled resin [mg/ml] 
             Time [s] 
            Interstitial velocity [cm/s]  
         Axial coordinate [cm] 
           Total column porosity [-] 
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Table 5.2. Historical average and standard deviations of product form inlet concentrations. 
Variable name  Variable notation  Average (mg/ml)  Standard deviation 
   inlet concentration    , 
    0.108  0.024 
   inlet concentration    , 
    0.127  0.023 
   inlet concentration    , 
    0.104  0.023 
 
 
5.3.4. Stochastic simulation 
Stochastic  simulations  were  conducted  following  the  same  procedure  as  described  in 
Chapter  3,  Section  3.3.3.  In  this  chapter,  the  impact  of  variability  in  the  load  material 
concentration and  composition  on the ratio  of the monomer  subunits,    +  ̅ :   in the 
elution pool (a defined CQA for the HIC process) was considered. The impact of errors in 
model predictions, as well as uncertainty in controlled variables such as ionic strength, bed 
height etc. was not considered. The rational for this is discussed later. The exact parameter 
varied  in  the  mechanistic  model  was  the  inlet  concentrations  of  the  load  material,    , 
 . 
Historical averages and standard deviations from manufacturing data were used to generate 
probabilistic design spaces for current process variability (Table 5.2).  
 
In  this  chapter, the  stochastic  simulation approach  is  extended to  explore the  impact  of 
reducing variability in the load material on the design space. The aim is to identify the level 
of control required on uncertain variables to bring process robustness to an acceptable level 
when current uncertainty results in an unsatisfactory design space. Standard deviations in 
model simulations are manually assigned assuming that better control would result in less 
variability,  and  therefore  a  reduced  standard  deviation.  Manually  changing  the  load 
concentration average is also possible, and may be of interest as feed dilution is trivial, but 
this was not considered in this work. 
 
5.4. Results and discussion 
5.4.1. Impurities 
The FDA requires that the removal of various contaminants in the final drug product is 
validated  (Lightfoot  and  Moscariello,  2004).  The  complexity  and  variety  of  these 
contaminants result in a range of issues when developing a  mechanistic model that can 
accurately simulate their separation and thus fulfil this requirement. Impurities are often at 
levels on the lower detection limit of available assays, which require a large amount of 
material, time and resources in order to analyse.  
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Figure 5.3. A. Experimental comparison between column runs using feed material with and without impurities (7 
ml CV, 7.3 cm bed height, 5.7 CV/hr, inlet concentration = 0.34 mg/ml, load challenge = 2 mg/ml). Similar 
product form percentages and overlapping A280nm trace during wash and elution indicates that impurities have 
minimal impact on separation of product forms and can be neglected in the model. B. Chromatogram showing 
the A280nm trace and the percentage of product related impurities and product in samples taken every CV during 
a standard HIC run, determined by phenyl RP HPLC. The figure shows that the majority of impurities in the feed 
material elute from the column during the load phase, product forms begin to elute from the column at the end of 
the load phase and continue throughout the wash. 
   
AA 
BB 
AB 
AA 
BB 
AB  
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In  this  work,  it  was impractical in terms  of  time  and  material  requirements  to  generate 
samples in high enough volumes and concentrations of impurities in order to develop a 
mechanistic  model  for  simulating  these components.  From  an industrial  perspective,  the 
experimental  design  of  experiment  (DOE)  approach  to  developing  and  validating  the 
removal of impurities during the chromatography is preferable to a mechanistic modelling 
approach. Therefore, the effect of impurities was not included in the model. Instead, it was 
assumed that the product related impurities and HCP’s in the feed stream had a negligible 
impact on the separation of the product of interest, as the impurities are observed to flow 
through during the load phase of the chromatographic cycle (Figure 5.3B). This assumption 
was confirmed by comparing the product form distributions in fractions collected every CV 
during HIC runs with and without impurities in the feed material. Runs were identical in all 
other aspects e.g. load challenge, product form concentrations and washlength. The results 
indicated that the impurities had no effect on the product distributions (Figure 5.3A). In 
addition,  by  comparing  the  UV  traces  in  Figure  5.3A,  one  can  clearly  see  where  the 
impurities are flowing through during the load step, before the two UV traces merge and are 
in exact agreement. 
 
5.4.2. Model development 
Micro well batch adsorption experiments (3.2.2) were utilized to generate data for estimating 
the  adsorption  isotherm  parameters,    ,    , .  Figure  5.4  shows  the  multi-component 
competitive adsorption data from the micro well experiments for the high and low binding 
resin lots, at four different load material product distributions shown on the graphs in the 
ratio     % :    % :    %. The product form distribution in the load material was varied to 
ensure that the competition between the closely related product forms was captured in the 
isotherm model. Note that although the graphs show the bound concentration of the product 
form as a function of its mobile phase concentration, the mobile phase concentration of the 
other two product forms are also affecting the bound concentration. 
 
The estimated isotherm parameter values are shown in Table 5.3. The standard deviations of 
the  estimated  parameters  are  approximately  ten  percent,  indicating  there  is  still  some 
uncertainty in the parameter values. The coefficient of determination, r
2, for the model fit to 
experimental data was 0.93 for the high resin and 0.96 for the low resin. This was found to 
be sufficient for satisfactory agreement between model predictions and experimental data 
given  the  inherent  uncertainties  of  the  batch  adsorption  experiments.  Interestingly,  the 
estimated saturation capacity of the Langmuir isotherm,   , were similar for both resins, 
however, the equilibrium constants differed for all three components. This indicated that the 
source of the resin lot variability was associated with protein adsorption-desorption kinetics  
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and not the maximum saturation capacity. A detailed investigation into the exact mechanism 
behind this variability was beyond the scope of this work. 
 
Both resin lots showed significant competition between product forms, with component    
particularly vulnerable to displacement by the more strongly binding    and    forms. In 
Figure 5.4C, the    stationary phase concentrations are significantly higher compared to 
Figure 5.4B. This is due to the favourable product distribution in the load material resulting 
in fewer competing components, allowing more    to bind (Figure 5.4C load material 25% 
   : 20%    : 55%   , Figure 5.4B load material 28%    : 59%    : 13%   ). It was 
found that the low binding resin had lower binding capacities than the high binding resin. 
This was especially clear for the    component as shown in Figure 5.4C where the low 
binding  resin      stationary  phase  concentration  is  approximately  half  that  of  the  high 
binding resin. 
 
Pulse injections onto scale down columns (section 5.2.2.7) using an unretained molecule 
(NaCl) found that both resin lots had the same total column porosity, 0.9 +/- 0.02, which was 
in agreement with previous literature estimations for this resin (McCue et al., 2007).  The 
apparent axial dispersion coefficient,   , was first estimated from the number of theoretical 
plates of the column,   , according to the following correlation (Guiochon et al., 1994): 
 
             =
  
   
         [5.5]   
   
 
Table 5.3. Model parameter values obtained for low and high binding resins based on batch adsorption and scale 
down column experiments, fitted using parameter estimation in gPROMS. Figure 5.5 gives an illustration of the 
fit between experimental data and simulations achieved by estimated parameters. 
Parameter name  Parameter notation  Low  High 
   equilibrium constant    ,   4.33  6.33 
   equilibrium constant      ,   1.49  2.30 
   equilibrium constant     ,   0.52  1.01 
Saturation capacity      6.45  6.39 
Total column porosity      0.9  0.89 
Apparent axial dispersion coefficient      0.0029  0.003 
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Figure 5.4. High and low resin multicomponent competitive adsorption isotherms at a range of load material 
product distributions, as shown on the graphs in the order AA% : AB% : BB%. The experimental data is from 
micro well plate batch adsorption followed by CEX HPLC analysis. All experimental points were repeated in 
triplicate and standard error is shown on graphs.  
   
A. 53:26:21  B. 28:59:13 
C. 25:20:55  D. 31:37:32  
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Figure 5.5. Experimental and simulated multicomponent competitive adsorption isotherms for the high binding 
resin at a range of load material product distributions, as shown on the graphs in the order AA% : AB% : BB%. 
The experimental data is from micro well plate batch adsorption followed by CEX HPLC analysis. All 
experimental points were repeated in triplicate and standard error is shown on graphs. The competitive Langmuir 
isotherm model (Equation 9) was fitted to the experimental data, and simulations showed good agreement with 
experiments. 
 
 
   
AA 
AB 
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However,  the  model  was unable  to  give  satisfactory  predictions  of  the  chromatographic 
process using the value estimated from this correlation Figure 5.6. This was not unexpected, 
as the lumped mass transfer coefficient value was determined using the residence time of an 
unretained molecule (NaCl) that was significantly smaller than the protein, and thus would 
be expected to experience faster mass transfer. The apparent axial dispersion coefficient was 
therefore estimated by fitting the full equilibrium dispersive model to experimental product 
form distributions in samples taken every CV during the wash of a scale down column run. 
The value calculated by the correlation was used as the initial guess. We found that the 
estimated apparent axial dispersion coefficients for high and low binding resin lots were 
very similar (high resin = 0.029 and low resin = 0.03), indicating that mass transfer was not 
responsible for differences between the resin lots. 
 
5.4.3. Model validation 
Multiple scale down column runs were conducted for each resin lot in order to provide a 
rigorous  test  of  model  predictive  capacity,  where  the  product  form  distribution  was 
measured  across  the  wash  phase  and  in  the  elution  peak.  An  extensive  experimental 
validation of model predictive capability across the complete design space to be explored 
was  unfeasible  due  to  industrial  time  and  material  constraints.  However,  the  isoform 
distribution in the load material, total load concentration and load challenge were carefully 
selected (Table 5.3) to provide wide ranging coverage of the envisaged design space, and 
model predictions were also compared with existing elution peak product data from scale 
down  experiments  which  had  been  conducted  previously  by  Pfizer  purification  process 
development  (Table  5.4),  at  load  concentrations,  load  challenges  and  wash  lengths 
considerably different from those conducted by the authors of this work. The flowrate,  , 
wash  length,  and  bed  height,   ,  were  kept  constant  throughout  all  runs  and  a  range  of 
column volumes were used (7, 15 and 60 ml).  For both resins, the model was able to 
successfully predict the product form distribution across the wash and in elution peaks in all 
scale  down  model  validation  column  runs,  both  from  this  work,  and  those  conducted 
separately by Pfizer. Figure 5.7 shows examples where model predictions are compared with 
experiments.  Model  elution  peak  composition  was  consistently  within  +/-  5%  of 
experimentally  measured values  (Table  5.5),  which  was  similar  to  the  accuracy  seen  in 
design of experiment driven statistical response surface models of this process at Pfizer. This 
is significant, as it demonstrates that despite the complex feed stream and wide range of 
conditions tested, a relatively simplistic equilibrium dispersive model can provide similar 
accuracy predictions to a DOE type approach to design space generation, often used in 
industry. 
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Table 5.4. Model validation runs: Product percentage in load, load concentration, and load challenge. 
Run identifier  Load Challenge (mg/ml resin)  Load Concentration (mg/ml)  %     %     %    
A  1.5  0.26  35  35  30 
B  2.2  0.35  40  44  16 
C  2.4  0.44  14  38  48 
 
 
Table 5.5. Model validation runs: Experimental vs simulated percentage   and   in elution peaks  
Resin identifier  Run identifier  Exp %    Sim %    Difference  Exp %    Sim %    Difference 
High 
A  81  79  -3  19  21  +3 
B  85  82  -3  15  18  +3 
C  71  68  -3  29  32  +3 
Low 
A  90  90  0  10  10  0 
B  93  93  0  7  7  0 
C  86  81  -5  14  19  +5 
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Figure 5.6. Experimental and simulated product form distributions for the low binding resin lot during load, wash 
and in final elution peak. A. Before model refinement. B. After model refinement. The apparent axial dispersion 
coefficient and the    adsorption constant were modified from 0.0001 cm
2/s to 0.003 cm
2/s, and 5.31 to 3.5 
respectively. 
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Figure 5.7. Experimental and simulated product form distributions for the high (top) and low (bottom)  resin lots during load, wash and in final elution peak in model validation runs A (right) 
and B (left). (7 ml CV, 7.4 cm bed height, 4.2 CV/hr, load details shown in Table 5.4). Experiments and simulations were in good agreement. 
162 
 
 
5.4.4. Stochastic simulations 
The  mechanistic  models  developed  for  the  high  and  low  resin  lots  can  determine  the 
operating  conditions  where  product  quality  specifications  will  be  met for  a known  inlet 
concentration  and  composition.  However,  in  practice,  for  industrial  chromatographic 
separations the feed material is often uncharacterised prior to column loading, and will vary 
from  batch  to  batch  depending  on  upstream  operations.  In  this  work,  a  model  based 
approach combining the validated mechanistic model with stochastic simulation is used to 
account for the inherent variability of inlet concentration and composition when determining 
the ability of a resin lot to meet the process objectives (or conversely the risk of batch 
failure).  
 
The  methodology  is  illustrated  in  an  example  which  shows  the  data  generated  at  one 
potential mass challenge – wash length combination. The component inlet concentration 
distributions were generated from historical data, and are shown in Figure 5.8A. Averages 
and standard deviations are shown in Table 5.2. For illustrative purposes the first 1000 
randomly generated inlet concentrations of product form AA is shown in Figure 5.8B, and 
the corresponding value of the product CQA (i.e. subunit B must account for between 25 – 
45 % of all monomer subunits in the product, i.e. 0.25 < B < 0.45) is shown in Figure 5.8C.  
 
It is a straightforward procedure to generate useful statistical information with this data 
regarding CQA variance at each operating point, such as moments and quartiles, as shown in 
Figure 5.9 for the low binding resin. The statistical data can be conveniently displayed using 
a box and whisker plot. The bottom and top of the box are the first and third quartiles, and 
the band inside the box is the median. The end of the lower whisker represents the datum 
still within 1.5 interquartile range (IQR) of the lower quartile, and the end of the upper 
whisker represents the datum still within 1.5 IQR of the upper quartile. The minimum and 
maximum of the data is indicated in the whiskers by a straight line, and the 1% and 99% 
quartiles  are  represented  by  crosses.  Outliers  are  plotted  as  dots.  More  sophisticated 
statistical  techniques  can  be  employed  to  analyse  multivariate  interactions  and  CQA 
dependencies.  The  derived  data  can  play  a  key  role  in  the  quality  risk  assessments 
recommended by FDA guidance when developing quality products (ICH, 2005). The data 
was  transformed  into  probability  density  functions  which  were  used  to  calculate  the 
probability of meeting the product CQA as a function of inlet uncertainty, as also shown in 
Figure 5.9. Probabilistic design spaces were then generated by plotting the probability of 
meeting the product CQA (%B) as a function of available manipulated variables, e.g. mass 
challenge and wash length.  
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Figure 5.8. Example of the stochastic modeling technique used in this work. A Normal distribution of inlet 
concentration of example product form from historical operating data. B. Example of randomly selected inlet 
concentrations of product form    during the first 1000 stochastic simulations. C. Percentage   in elution peak 
over the first 1000 simulations. (Mass challenge 2 mg/ml, 5 CV wash length). D. Probability density function of 
product CQA. 
    
164 
 
Accounting for uncertainty in controlled variables such as ionic strength was beyond the 
scope of this work, but can be integrated into simulations if desired. In this case, a suitable 
isotherm with a parameter that can be assigned uncertainty concerning ionic strength, such 
as the steric mass action (SMA) isotherm, would be required (Brooks and Cramer, 1992). In 
addition, the impact of model uncertainty on stochastic predictions can be included, although 
this was neglected in this work as the CQA variance (e.g. 10% - 42% in the example shown 
in Figure 5.9) was typically much larger than the largest model error found during model 
validation studies (+/- 5%). Despite this, the uncertainty in model predictions cannot be 
easily neglected and care must be taken to ensure that robust operating areas identified by 
model predictions are tested experimentally. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.9. CQA data from stochastic simulation at mass challenge =  2 mg/ml, washlength = 5 CV in box plot 
and probability distribution form with associated moments and quartiles.low resin 
   
50% (Median) 
25% (Quartile) 
75% (Quartile) 
100% (Maximum) 
0% (Minimum) 
99% 
1% 
Outliers 
Outliers 
MOMENTS 
Standard deviation  3.74 
Mean  23 
 
QUARTILES 
100  Maximum  42 
99.5    34 
97.5    31 
90    28 
75  Quartile  26 
50  Median  23 
25  Quartile  21 
10    19 
2.5    16 
0.5    14 
0  Minimum  10 
  
165 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.10. Probabilistic design spaces for low binding (left) and high binding (right) resin lots, showing the 
probability that the resin will achieve the correct product form distribution in the elution peak over a ranges of 
possible mass challenges and wash lengths. 
 
 
Probabilistic design spaces for the low and high resin lots are shown in Figure 5.10. The 
design  space  is  defined  as  the  multidimensional  combination  and  interaction  of  input 
variables  and  process  parameters  that  have  been  demonstrated  to  provide  assurance  of 
product quality,  i.e.  that  product  CQA’s  are  met. The  key  characteristic  of  probabilistic 
design  spaces  is  that  they  provide  quantitative  information  on  the  assurance  of  quality, 
accounting for both the mean and the variance of uncertain process parameters and variables. 
No combination of mass challenge and wash length was found for either resin lot which had 
a probability of 1.0 for the historical variability experienced in the load material, i.e. that 
would guarantee the CQA is always met. However, the large size of regions where the 
probability < 0.95 meant that rarely would the process fail to meet its objectives if the 
operating  condition  was  specific  to  the  resin  lot  in  use.  The  large  difference  between 
operating conditions that give p > 0.95 for each resin are somewhat surprising given the 
small  difference  between  the  adsorption  isotherm  parameters,  but  are  due  to  the  very 
challenging CQA constraint, combined with the mean and variance of the inlet composition 
and concentration. 
 
When the design space must be eligible for all resin lots, then the probability of achieving 
the correct product form distribution in the elution peak should be high for both resin lots. 
Figure 5.11 shows an overlay of the two resins’ probabilistic design spaces. Critically, there 
was no operating region where the probability of both the low and high resin lots remained > 
0.95, i.e. risk of batch failure < 5%. Even at the optimum operating condition where the two 
LOW  HIGH 
0.75  
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curves intersect (e.g. mass challenge 2  mg/ml, wash length 4 CV), the probability only 
reaches 0.84. As a result, the operating parameter ranges available for manufacturing are 
small, and at best, 16 % of batches are still predicted to fail product quality specifications. In 
addition, the product form distribution will vary within the full allowable range (0.25 < B < 
0.45), which is undesirable when the objective is to produce a consistent product. 
 
 
 
 
 
 
 
Figure 5.11. Overlay of high and low resin probabilistic design spaces showing the operating parameter ranges 
where product quality is assured with p > 0.75 for all resins. 
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Selecting operating conditions that are eligible for all resin lots also means that high risk 
regions are selected, where deviations from usual inlet stream composition can result in 
further performance issues. For this case study, significant increases in process robustness 
can be made by adapting the design space based on the resin lot in use, rather than fixing the 
design space for all resin lots. In practice, this would involve varying the length of the wash 
length based on the resin lot in use. This adaptive approach significantly increases the size of 
potential operating regions, improves flexibility to variations in process inputs, provides a 
more consistent product composition, and enables operation further away from high risk 
regions.  This  conclusion,  that  adaptive  operation  can  bring  significant  benefits  is  in 
agreement with literature (Gétaz et al., 2013), and is a viable mode of operation under FDA 
Quality by Design guidance (ICH, 2008a). 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.12. Box plots showing variability of percentage   in elution peak as a function of variability in 
component inlet concentration, with probability of meeting quality specifications indicated next to each box plot, 
for a mass challenge of 2 mg/ml and wash length 4 CV. 
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The  probabilistic  design  spaces  presented  are  particularly  useful  as  they  provide  a 
quantitative  measure  of  the  assurance  of  product  quality,  which  either  validates  the 
robustness of potential operating regions, or indicates a need for process improvement. The 
stochastic methodology can be easily extended to identify the level of control required on 
uncertain parameters/variables to achieve adequate assurance of quality, by systematically 
reducing  the  variance  of  uncertain  parameters,  and  measuring  the  quality  response. 
Alternatively, when parameter variability is reduced due to improvements and optimisation 
by process operators as experience is built over a process lifetime, the method can identify 
how operating ranges can be expanded to give greater flexibility to process operators during 
manufacturing.  
 
For this case study, the data indicates that if the operating parameter ranges must be fixed for 
all  resin  lots,  then  process  improvements  are  needed.  Without  process  improvements, 
operating regions that provide assurance of product quality are small and are not robust. We 
now  consider  how  decreasing  variability  in  the  product  form  inlet  concentrations  via 
increased control of upstream unit operations can improve the assurance of quality when 
using an operating region fixed for all resins. Better control was assumed to result in less 
variability, and therefore a reduced standard deviation. A detailed description of how this 
can be achieved in practice is beyond the scope of this work, but could include modifications 
to  upstream  processes  such  as  optimising  the  elution  stage  of  preceding  affinity 
chromatographic separations. In any case, the study is a useful exercise for illustrating how 
stochastic  simulation  and mechanistic  models can  be  used not  only  for quantifying  risk 
associated with uncertainty, but for exploring the relationship between parameter and  CQA 
variance, a key consideration when validating quality assurance. 
 
Figure 5.12 shows box plots indicating predicted variability of the product CQA (percentage 
B  in  the  elution  peak)  as  a  function  of  the  variability  in  the  product  form  inlet 
concentrations.  The  mass  challenge  was  2  mg/ml  and  wash  length  4  CV,  previously 
identified as one of the optimal operating points for a fixed design space. The standard 
deviations considered include: 0.01, 0.015, 0.02 and 0.024. The probability of meeting the 
CQA specification is indicated next to each box plot (e.g. p = 0.998). As expected, reducing 
feed stream uncertainty (i.e. going from 0.024 towards 0.01) results in a reduction in product 
CQA  variability,  which  translates  into  increases  in  the  probability  of  meeting  quality 
specifications (i.e. for low resin, p = 0.0895 to p = 0.998).  
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Figure 5.13. Fixed design space with highest level of feed stream control considered in this work, SD = 0.01, 
(left), and ideal design space assuming no feed stream variability (right). 
 
When this is completed for all operating conditions, the size of regions with p > 0.95 (i.e. 
<5% failure) increases. Figure 5.13A shows the region where p > 0.95 for both resins at the 
lowest inlet variability considered (SD = 0.01). Even with this high level of control over the 
feed  material,  operating  regions  where  p  >  0.95  were  significantly  smaller  than  those 
available if the operating conditions were adapted according to the resin lot in use under 
normal inlet variability (Figure 5.10). Figure 5.13B shows the design space which assures 
product quality for all resins in an ideal (but unrealistic) system with no inlet variability. The 
large difference in size between Figure 5.13A (ideal system with no inlet variability) and 
Figure 5.13B (lowest inlet variability considered, SD = 0.01), provides a stark demonstration 
of  the  importance  of  considering  parameter  variances  when  designing  chromatography 
processes.  If  this  is  not  accounted  for,  then  the  result  may  be  unrealistically  good 
expectations and in turn high failure rates. 
 
5.5. Conclusion 
A model based approach was used to identify robust operating conditions for an industrial 
hydrophobic  interaction  chromatography  where  resin  lot  variability,  combined  with  a 
variable feed stream, was resulting in serious performance issues during the purification of a 
multi component therapeutic protein from crude feed material. FDA guidance encourages 
the  application  of  mechanistic  models  to  improve  process  understanding,  based  on 
fundamental  knowledge  of  the  underlying  causes  linking  process  parameters  to  product 
CQA’s. The methodology presented in this work demonstrates that mechanistic models can 
be very useful for this task, for as well as determining the functional relationship between 
process  parameter  values  and  the  resulting  value  of  the  CQA,  they  can  quickly  and  
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efficiently determine the relationship between process parameter and CQA variances, a key 
aspect of providing assurance of product quality. This was not possible using a design of 
experiment type of approach for the HIC considered in this work, due to the impractical 
amount of resources that would be required. 
 
The model based approach combines mechanistic models and stochastic simulation, and was 
used to predict a key product CQA as function of mass challenge and wash length for two 
polar  extreme  resin  lots,  designated  high  and  low  binding  resin,  whilst  accounting  for 
uncertainty in feed stream composition and concentration. With normal process variability, 
no operating condition was found where the probability of both the low and high resin lots 
meeting  product  quality  specifications  remained  >  0.95.  The  risk  of  batch  failure  when 
operating  at the  most  favourable conditions  found in  this  work  was  16%, and  selecting 
operating conditions that were eligible for both resin lots meant that operating conditions 
were not robust. Increasing control on the inlet concentration and composition was predicted 
to improve fixed design space robustness, but we found that using an adaptive design space, 
where operating  conditions  are  changed  according  to  which  resin lot  is  in  use,  was  the 
favorable option. 
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Chapter 6. Conclusions and Future Work 
 
The overall aim of this thesis was to derive fundamental process understanding of specific 
industrial chromatographic separations currently in development or operation at Pfizer, via 
the  development  and  application  of  mechanistic  chromatography  models.  The  thesis 
contains  three  distinct  contributions:  (1)  A  platform  model  of  weak  partitioning  anion 
exchange  chromatography  was  developed  to  provide  a  link  between  high  throughput 
screening (HTS) and scouting runs conducted during early process development. (2) An 
experimental  investigation  was  conducted  into  fouling  of  the  anion  exchange  weak 
partitioning  chromatography,  providing  a  basis  for  addressing  a  lack  of  fundamental 
knowledge  and  mechanistic  understanding  of  fouling  in  industrial  bioseparations.  (3)  A 
mechanistic model was used to identify robust operating parameter ranges for an industrial 
hydrophobic  interaction  chromatography,  at  a  late  stage  of  development,  experiencing 
performance issues due to resin lot variability. The key outcome of the work is that there are 
significant advantages to be gained by the use of mechanistic models of chromatography in 
industry.  The  recommendation  for  future  work  is  to  develop  a  platform  that  brings  the 
various models, tools, procedures and expert guidance together to allow industrial users to 
efficiently and quickly implement mechanistic models within industrial constraints. The key 
areas  that  need  addressing  are  discussed  related  to  the  modelling  framework,  model 
parameters and physical properties, model calibration and model applications. 
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6.1. Review of Project Objectives 
The overall aim of this thesis was to derive fundamental process understanding of specific 
industrial chromatographic separations currently in development or operation at Pfizer, via 
the development and application of mechanistic chromatography models. The goal was to 
accelerate the development and increase the robustness of industrial protein purification 
processes, whilst following guidance regarding the implementation of Quality by Design. 
 
6.1.1. Weak partitioning chromatography 
Chapter 3 looked at developing and applying mechanistic models of chromatography at an 
early  stage  of  process  development,  focusing  on  the  platform  anion  exchange  weak 
partitioning  process.  This  key  step  in  the  purification  process  of  monoclonal  antibodies 
experienced difficulty delivering the required level of impurity removal, whilst maintaining 
product recovery, when facing challenging load material compositions. In addition, there 
was an overreliance on experimental process development and a lack of fundamental process 
understanding.  
 
A  platform  model  was  developed  that  was  applicable  at  an  early  stage  of  process 
development. This was achieved by characterising the equilibrium adsorption isotherms of 
the three key species involved in the separation: the product (monomer) and two product 
related impurities (dimer and multimer) which were not previously known. In addition, a 
new approach was taken where the adsorption was characterised as a function of the product 
partition  coefficient,  enabling  the  model  to  be  applied  to  new  candidate  monoclonal 
antibodies  without  additional  experimental  effort.  A  simple  high  throughput  screening 
experiment, which can be automated and conducted in a few hours by a trained scientist, was 
all that was needed to calibrate the model to the particular molecule. This experiment is 
routinely conducted as part of the existing experimental approach to process development, 
and as such, does not comprise any additional effort.  
 
The model was applied in concert with stochastic simulation to generate probabilistic design 
spaces which predict the probability of achieving certain purity and recovery as a function of 
operating variables. In the first of two case studies, it was possible to select robust operating 
conditions using the probabilistic design spaces that enabled the purification of previously 
impossible to purify load material with extremely challenging composition. In the second 
case study, it was shown that the probabilistic design spaces could enable the required purity 
to be reached for material with a more standard load composition with very high product 
recovery.   
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The  detailed  analysis  of  the  model  simulations  increased  fundamental  knowledge  and 
understanding  of  weak  partitioning  chromatography,  revealing  the  complex 
multidimensional design space. The impact of the mean and variance of load concentration, 
load  challenge,  pH,  counterion  concentration,  and  product  partition  coefficient  among 
others, on the mean and variance of purity and recovery will allow for significantly better 
informed process development at Pfizer. 
 
6.1.2. Resin fouling 
Chapter 4 considered a key aspect of industrial chromatographic separations, which in the 
author’s opinion, has not been given sufficient consideration in the mechanistic modelling 
literature: resin fouling. The platform anion exchange weak partitioning chromatography 
process considered in chapter 3 had experienced performance issues due to suspected resin 
fouling. In chapter 4, the location of the fouling on the resin particles, and the mechanistic 
effect of the resin fouling on the chromatographic separation over the lifetime of a column, 
was elucidated. The foulant was found to be located on the resin surface through the use of a 
number of orthogonal experimental techniques. Thus, the primary effect of the fouling was 
to limit mass transfer into the resin particle, rather than reduce the binding capacity of the 
resin itself, which was shown to be recoverable by reducing the flowrate of material during 
column  loading.  The  increased  understanding  of  resin  fouling  is  an  important  step  to 
characterising this important phenomenon mathematically, in order that model predictions 
are more applicable in an industrial setting where column aging is commonplace.  
 
6.1.3. Resin variability 
Chapter  5  considered  the  development  and  application  of  mechanistic  models  of 
chromatography  at  a  late  stage  of  process  development.  The  chapter  considered  a 
hydrophobic  interaction  chromatography  process  used  in  the  purification  of  a  complex 
multicomponent  therapeutic  protein.  The  drug  substance  produced  by  the  downstream 
processing  section  of  the  manufacturing  process  had  to  contain  a  specific  ratio  of  the 
different  forms  of  the  protein,  but  was  experiencing  serious  performance  issues  due  to 
suspected  resin  lot  variability.  Prior  to  this  work,  an  extended  range  of  resin  lots  were 
obtained from the supplier for testing within normal process operating ranges. All resin lots 
were  within  the  manufacturers  specifications  for  ligand  density  and  chloride  capacity. 
Despite this, many failed to meet product quality specifications during testing and would 
have incurred significant losses if used for the large scale manufacture of the product. 
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In chapter 5, a mechanistic chromatography model of the step was developed for the two 
most extreme resin lots which gave the highest (designated high binding resin) and lowest 
(designated  low  binding  resin)  protein  recoveries  at  normal  operating  conditions,  in  the 
experimental study conducted prior to this work. Model development revealed that the resin 
lot  variability  manifested  itself  in  the  equilibrium  adsorption  isotherms  of  the  different 
therapeutic  protein  variants,  bringing  increased  understanding  of  the  issue  at  hand.  The 
model was applied with stochastic simulation to generate probabilistic design spaces for the 
two resin lots which were designated high and low resins. These design spaces showed the 
probability of the final product meeting product specification criteria as a function of the 
load challenge and washlength, the only two operating conditions that were available for 
manipulation because the process was in late stage development. The probabilistic design 
spaces revealed that the optimum solution for a robust process was to vary the washlength 
based on the particular resin lot in use, which is a step change concept for bioprocessing that 
has not been considered before. Model predictions shows that limiting the operating space to 
conditions  that  gave  the  highest  probability  of  meeting  the  product  specification  for  all 
resins, may result in an unacceptable number of batch failures, and a variable final product. 
 
6.2. Recommendations for future work 
It is clear from this thesis that there are significant advantages to be gained by the use of 
mechanistic models of chromatography in industry. However, there is still much work to be 
done before models are used in practice. In the following section, potential directions for 
future work related to use of mechanistic chromatography models in industry are discussed. 
 
The foremost need in order for mechanistic models of chromatography to be used in industry 
is the development of an expert driven software environment that provides users with: (1) a 
library  of  rigorous  mathematical  models  based  upon  a  chromatography  modelling 
framework containing descriptions of all the key phenomena occurring in chromatography 
and supporting unit operations, (2) a database containing physical properties and parameters 
of  existing  process  models,  where  values for  new products  and  processes  can  easily  be 
added, (3)  recommended  workflows  and experimental  standard  operating  procedures  for 
calibrating model parameters for new chromatography processes, including guidelines on 
how  to  integrate  model  based  approaches  for  development,  design  and  operation  of 
chromatographic  processes  with  current  industry  procedures,  and  (4)  recommended 
workflows  and  examples  of  key  model  applications  such  as  optimisation,  experimental 
design, global sensitivity analysis and automated design space generation. 
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6.2.1. Modelling framework 
 
Mass transfer 
As  regards  to  the  availability  and  quality  of  models  of  the  various  phenomena,  the 
mathematical description of mass transport is currently the strongest part of the framework. 
This thesis has shown how even simplistic mathematical models such as the equilibrium 
dispersive  model  can  describe  complex  multicomponent  chromatographic  separations  as 
seen in the hydrophobic interaction process. More detailed descriptions of mass transport are 
available if required, such as the lumped kinetic and general rate models which account for 
intraparticlar diffusion. Greater understanding of particle level phenomena may be useful, 
especially regarding the impact of localised variations in pH and counterion concentration 
which  may  prove  important  when  modelling  non–isocratic  separations.  This  extension 
would be useful if the mass transfer of the weak partitioning anion exchange system was 
characterised and salt gradients considered, but in general, this section of the framework is 
satisfactory. 
 
Adsorption 
Continued consideration needs to be given to developing fundamental understanding and 
mathematical descriptions of protein adsorption. Although progress has been made in recent 
years (Mollerup et al., 2008), a fundamental description based on thermodynamics of protein 
adsorption has not yet been achieved, and there is reliance on empirical and semi-empirical 
models  with  parameters  fitted  to  experimental  data.  In  addition, the  complexity  of  feed 
streams and low concentrations of many species in process material means that often a great 
many  simplifications  and  dubious  assumptions  must  be  made,  as  (1)  there  are  limited 
options for modelling the adsorption equilibria seen in this type of system, and (2) accurately 
measuring the very low concentrations of species in heterogeneous material is an extremely 
difficult  analytical  challenge.  In  this  work,  the  model  of  the  anion  exchange  weak 
partitioning chromatography did not account for the impact of process related impurities in 
the load material, such as host cell protein, leached protein A, and virus, all of which would 
be expected to bind strongly to an anion exchange resin. It was assumed that the impact of 
these  species  would  be  minimal  as  they  are  typically  present  in  very  small  quantities 
compared to the product related impurities which were considered in the model. This was 
acceptable because the model was for use at an early stage of development, and the impact 
of  this  assumption  was  leveraged  by  platform  knowledge  and  subsequent  experimental 
studies. However, in the future, approaches for incorporating these species will need to be 
found as their removal from the final drug substance is considered critical to product quality.  
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Reaction 
A description of the various reactions that occur in chromatographic separations is a critical 
area of weakness that needs to be addressed. As most of the reactions produce undesired 
species, it is important that they are understood and characterised to ideally prevent them 
from  happening,  but  more  realistically  limit  the  impact  when  they  occur.  The  work 
conducted  on  the  fouling  of  chromatography  resin  demonstrated  the  importance  of 
accounting for non-ideal reaction phenomena. Although it was determined that the foulant 
itself was composed of primarily protein, thought to have been a complex including protein 
A, product, product related impurities and host cell proteins, there was little understanding 
of  the  reactions  involved  in  its  creation.  In  particular,  the  reactions  occurring  between 
different product forms and species in the load material are of great interest, as it is generally 
understood that these reactions are reversible. If it was possible to describe these reactions 
mathematically,  an  envisaged  extension  of  the  model  would  be  to  determine  operating 
conditions favourable for the formation of product rather than impurity. 
 
Ionic equilibria 
A  further  extension  to  the  model  framework  which  would  be  of  great  interest  is 
characterising the chemical equilibria in the mobile phase. Ionic reactions involving the 
product may play an important role in the chemical reactions as charge plays a large role in 
protein aggregation. However, more importantly, this addition would enable the model to 
accurately assess non-isocratic separations during the load and the wash phases. In relation 
to this thesis, this would enable operating models such as partition coefficient gradients in 
the load and/or wash to be examined for the weak partitioning chromatography process, and 
the buffer conductivity to be considered as an extra manipulated variable in the hydrophobic 
interaction chromatography process.  
 
Chromatography system  
One element of mechanistic modelling of chromatography that is rarely considered, but has 
a  large  impact  on  separations,  is  the  chromatography  system  itself.  Most  often,  system 
parameters such as column length and porosity are measured and assumed to stay constant 
thereafter.  However,  in  practice  these  parameters  will  change  over  a  chromatography 
column’s lifetime, and in some cases will differ during each phase of a separation (e.g. load, 
wash, elution etc). Resin particles of the weak partitioning chromatography are known to 
swell  and  shrink  based  upon  the  buffer  composition,  and  column  packing  is  variable, 
especially when moving from laboratory scale to manufacturing scale. This work considered 
the impact of non-ideal, variable chromatography systems in the form of resin fouling of the 
weak  partitioning  anion  exchange  process,  and  the  resin  lot-to-lot  variability  of  the  
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hydrophobic interaction chromatography. Deriving a mathematical description of the resin 
fouling in the weak partitioning chromatography system is the next logical step. Further 
experimental work is needed to understand the mechanistic effect of the other non-ideal 
phenomenon mentioned above, before mathematical descriptions can be developed.  
 
6.2.2. Physical properties and model parameters 
One of the challenges with developing mechanistic models of industrial chromatographic 
separations is that model parameters have to be determined for each process. The perceived 
experimental effort needed for finding these parameters dissuade the application of model 
based approaches in industry, as there is little guarantee that values will be found that give 
satisfactory model predictions, and it is difficult to conduct the required experiments without 
expert guidance. The makes the investment in a model based approach risky. This work has 
gone  further than  the  usual  approach  to  determining  model  parameters  by  developing  a 
“platform”  model  of  the  anion  exchange  weak  partitioning  chromatography,  utilising  an 
adsorption isotherm model that is based upon the product partition coefficient, and can thus 
be reused for new molecules with minimal experimentation. The idea of reusing models is 
very  powerful  and  one  that  should  be  explored  further.  In  the  weak  partitioning  anion 
exchange  chromatography  process,  the  next  step  is  to  validate  the  adsorption  model  by 
applying it to other monoclonal antibodies. However, in general there is a need for new 
approaches to reduce the experimental workload. One of the most important steps could be 
the  creation  of  a  physical  properties  package,  containing  a  database  where  values  for 
parameters of existing process models are stored, and where values for new processes can be 
calculated/added. In addition, emerging fields such as molecular dynamics simulations are of 
great interest for in silico calculation of model parameters. In particular, a relevant area for 
research in relation to this thesis is the use of a molecular model to estimate product partition 
contours,  which  would  theoretically  enable  completely  in  silico  process  development  of 
anion exchange weak partitioning chromatographic processes. 
 
6.2.3. Model calibration 
Although  there  are  many  different  approaches  for  model  calibration  that  have  been 
published, there is a lack of guidance or comparisons on which approach to take in specific 
scenarios. In addition, not enough consideration has been given to how to incorporate model 
calibration  approaches  into  existing  industrial  experimental  development  workflows  and 
process development timelines. This work showed how it is possible to closely integrate a 
model based approach into the existing the weak partitioning anion exchange experimental 
development process. The next step for the anion exchange process is to extend the mass  
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transfer description and calibrate mass transfer parameters so that the wash phase may be 
modelled.  
 
6.2.4. Model applications 
 
Probabilistic design spaces 
The  work  conducted  on  the  hydrophobic  interaction  chromatographic  separation  in  this 
thesis has many areas of future work that can be considered relatively easy to complete. 
Similar to the weak partitioning simulations, there are a range of simple simulation studies 
that can be run with the existing model to evaluate the impact of uncertainty in many of the 
different  factors  by  generating  further  probabilistic  design  spaces.  The  stochastic 
methodology can be easily extended to examine the impact of uncertainty in load challenge, 
column  volume,  compression  factor  etc.  An  interesting  study  would  be  to  examine  and 
compare the contribution from variability in the resin or the load material on the probability 
of meeting product quality specifications. An alternative approach to changing the wash 
length based on the resin lot in use would be to change the operating condition based upon 
the load material composition and concentration. This approach is possible in a Quality by 
Design  paradigm.  The  other  thing  that  is  of  interest  is  determining  what  the  impact  of 
relaxing  or  tightening  constraints  would  be.  In  the  case  of  the  hydrophobic  interaction 
chromatography, the recovery constraint did not play a role in choosing operating conditions 
as a recovery as low as 52% was still satisfactory. It would be of interest to tighten this 
constraint and determine how different the conclusions would be based on the probabilistic 
design spaces.  
 
Another interesting study would be to use stochastic simulations to determine an allowable 
standard  deviation  of  resin  characteristics  to  fit  into  a  defined  design  space.  In  this 
workflow, each new resin would be put through a set of experiments to characterise the 
adsorption equilibria, and then its suitability for use would be determined based on its fit to 
validated ranges. 
 
The difficulty with the probabilistic design space methodology is that it currently requires 
many simulations to be conducted and managing the generated data is very time consuming. 
The time to complete the necessary simulations was reduced by utilising multiple computers 
for the simulations, with each computer considering at a single operating condition, and the 
results imported manually to a central file. Future research into automating this process and 
possible utilisation of multi-core machines, is of great interest.  
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In this work, the statistical analysis of the results from the stochastic simulations was limited 
to determining basic parameters such as probabilities, means and standard deviations of 
critical process parameters etc. The next step in both the anion exchange weak partitioning 
chromatography  process  and  the  hydrophobic  interaction  chromatography  process  is  to 
conduct detailed global sensitivity analysis calculations. A very interesting application of 
this  would be  to  examine  interactions  between  different  variables  in  order to  determine 
where additional time and effort in process development should be targeted for the greatest 
increase in process robustness. In addition, another related area of research is to determine 
the  actual  variability  and  uncertainty  experienced  in  industrial  manufacturing  processes, 
which can indicate where to focus future work (i.e. model development in order to gain 
better description of chromatographic processes, or model application to improve process 
robustness).  
 
Evaluation of continuous processing 
One  area  of  great  interest  that  has  seen  some  work,  but  will  require  more,  is  using 
mechanistic models of chromatography to evaluate the move to continuous processing. It is 
relatively  straightforward  to  extend  a  model  that  has  been  developed  for  a  batch 
chromatography process to modelling a continuous process. Of interest with relation to this 
thesis,  is  evaluating  how  to  convert  the  batch  weak  partitioning  anion  exchange 
chromatography process to a continuous one. In particular, it will be useful to understand the 
benefits with relation to different objectives at different stages in the drug development 
lifecycle,  as it  is  possible  that  the  process  may  switch from  batch  to continuous  as the 
candidate molecule moves through the various development phases in order to leverage the 
advantages of each approach.  
 
Regulatory considerations 
Regulatory  guidance  regarding  the  implementation  of  Quality  by  Design  has  proposed 
greater use of mechanistic models (ICH, 2008a). However, there is no guidance on how this 
should  be  achieved  in  practice.  Unless  this  is  addressed,  it  is  likely  that  the  use  of 
mechanistic models in industry will remain ad hoc and only as a worst case scenario to solve 
a  particular  problem  or  scenario.  One  of  the  most  important  areas  of  future  work,  if 
modelling  approaches  are  to  be  used  in  industry,  is  that  the  regulator  authorities  are 
approached and discussion initiated into how models should, and should not, be applied. 
Formal model validation procedures need to be developed and guidance should be issued on 
how  to  communicate  models  and  results  in  filings,  in  addition  to  the  publication  of 
exemplary modelling case studies and examples by the regulatory authorities. 
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Process optimisation 
Rigorous  process  optimisation  has  been  used  extensively  for  many  years  in  traditional 
chemical engineering sectors such as oil and gas, and is a proven approach for gaining 
maximum  value  out  of  a  process.  However,  despite  optimisation  of  chromatographic 
processes  being  a  topic  that  is  often  revisited  in  the  literature,  there  is  little  uptake  in 
industry. This is because the primary objective in industry is the production of a product of 
consistent quality in amounts satisfying demand, and as a year’s supply can be produced in a 
single  manufacturing  campaign  lasting  only  a  few  weeks  for  many  products,  most 
optimisation  examples,  such  as  maximising  the  recovery  or  minimising  the  cost  of  a 
particular piece of equipment, are just not relevant. There is a real need for examples of 
optimisation  where  the  objective  function is  more relevant,  such  as  maximising  process 
robustness. In addition, chromatographic processes often experience lots of variability and 
uncertainty  (e.g.  most  have  variable  and  unknown  feed  material  compositions  and 
concentrations), and since the solution to optimisation studies is heavily dependent on the 
input variables, most solutions are easy to write off as irrelevant in all practical sense. There 
is a need for new optimisation studies which demonstrate how to account for this uncertainty 
whilst searching for a solution. 
 
6.2.5. Summary 
Future work should focus on (1) reducing the required effort to implement a model based 
approach in industry, (2) demonstrating the value of the approach using case studies and 
exemplary examples, and (3) providing relevant regulatory guidance on its implementation. 
The current state of the art in mechanistic modelling of chromatographic separations should 
be  brought  together  into  a  single  software  tool,  to  create  a  platform  that  enables  more 
straightforward  application  in  the  biopharmaceutical  industry. The tool  should  contain a 
library  of  mathematical  models  and  physical  properties,  as  well  as  guidance  on  model 
calibration, validation and application. In parallel to the development of such a tool, further 
work should be conducted on mathematical models of adsorption, reaction, ionic equilibria 
and column systems to increase the applicability of models in industry. Further work should 
also be conducted to demonstrate the industrial relevance of model applications such as 
design space generation, global sensitivity analysis and process optimisation. Lastly, and 
probably most importantly, regulators, biopharmaceutical companies, and modelling experts 
need  to  come  together  to  develop  formal  guidance  on  good  modelling  practices  which 
describe how models must be used in industry. 
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Chapter 8. Appendix A 
 
The following appendix contains a table summarising the literature reviewed in chapter 2 
with regard to the mode of chromatography, the retention mechanism, the molecules of 
interest, the impurities considered, the mass transfer model, and the adsorption model, in 
addition to brief notes on each study.  
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 Table 8.1. Studies using mechanistic models of chromatography for studies related to the purification of therapeutic proteins (part 1)   
Reference  Mode  Retention mechanism  Molecules of 
interest  Impurities  Mass transfer 
model  Adsorption model  Notes 
Charton et al., 1994  Elution  cellulose based   Ketoprofen 
enantiomers  N/A  Equilibrium 
dispersive  Bi-Langmuir   Explored recycling  
Boyer and Hsu, 1992  Pulse 
injections 
None- sepharose matrix, 
size exclusion 
Myoglobin, Beta-
Lactoglobulin, 
Ovalbumin, 
Albumin, 
Hexokinase, 
Immunoglobin G, 
Catalase 
N/A  General Rate model  N/A 
Restricted protein diffusion in 
agarose matrix. Looked at 
mass transfer correlations. 
Li et al., 1998  elution  Size exclusion  Myoglobin, 
Ovalbumin  N/A  General Rate model  N/A  Scale up and sensitivity of 
mass transfer parameters  
Gu et al., 1990 
frontal, 
elution and 
displacemen
t 
N/A  Not specific  N/A  General Rate model  Multicomponent 
Langmuir  
Displacement phenomena in 
multicomponent systems 
Gu et al., 1990  elution  N/A  Not specific  N/A  General rate model  Langmuir  Considerations of desorption 
chromatography  
Natarajan and Cramer, 
2000  N/A  Cation exchange 
alpha 
chymotrypsinogen 
A, ribonuclease 
A, nyomysin 
sulphate 
N/A  Lumped rate model  Steric mass action 
Method for identifying 
appropriate mass transport 
models  
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Table 8.2. Studies using mechanistic models of chromatography for studies related to the purification of therapeutic proteins (part 2)   
Reference  Mode  Retention mechanism  Molecules of 
interest  Impurities  Mass transfer 
model  Adsorption model  Notes 
Kaczmarski et al., 2001  elution  Anion exchange  Bovine Serum 
Albumin  N/A 
General rate, 
lumped pore, 
equilibrium 
dispersive, transport 
dispersive 
modified bi-
Langmuir  
Comparing breakthrough 
curves from different models 
of chromatography 
Teoh et al., 2001  isocractic 
elution  size exclusion 
nitrobenzene, 
naphthalene, 
flourene, 
fluoranthene 
N/A  Equilibrium 
dispersive  Langmuir  simulation and optimisation of 
a closed loop recycling HPLC  
Charton et al., 1994  Elution  cellulose based   Ketoprofen 
enantiomers  N/A  Equilibrium 
dispersive  Bi-Langmuir   Explored recycling  
Kaczmarski et al., 2002  isocractic 
elution  cellulose tribenzoate 
1-phenyl-1-
propanol 
enantiomers 
N/A 
General rate model 
with the generalised 
maxwell stefan 
equation 
competitive toth  
Developing a extremely 
detailed model of the 
enantiomer separation where 
mass transpot is relatively 
slow 
Gallant,2004  N/A  ion exchange 
alpha - 
Chymotrypsinoge
n, Cytochroma C 
N/A  Particle model  SMA 
Developing understanding of 
adsorption of protesin in 
spherical particles 
Persson et al., 2006  N/A  N/A  BSA  N/A  General rate model  N/A 
To derive methods and 
understanding of flow rate and 
bead size dependency of mass 
transfer coefficients  
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Table 8.3. Studies using mechanistic models of chromatography for studies related to the purification of therapeutic proteins (part 3) 
   
Reference  Mode  Retention mechanism  Molecules of 
interest  Impurities  Mass transfer 
model  Adsorption model  Notes 
Susanto et al., 2006  Flowthroug
h  Anion exchange  BSA  N/A  General rate model  Steric mass action 
Used insights from confocal 
microscopy for developing the 
particle model 
Bak et al., 2007  Bind/Elute  Affinity  Clarified rabbit 
antiserum  HCP, DNA  Ideal 
Lumped parameter 
approach with 
Langmuir kinetics 
Interesting as the study 
considered crude feed material 
Sun and Yang, 2007  Batch 
uptake  anion exchange  Bsa and gamma 
globulin  N/A  Maxwell stefan   langmuir  compared fickian diffusion 
with maxwelll stefan diffusion 
Chan et al., 2008 
isocratic and 
gradient 
elution 
ion exchange  Many model 
proteins  N/A 
equilibrium 
dispersive and 
general rate model 
linear 
Proposed approach for 
estimating model parameters 
using inverse method when 
feed material is unknown 
McCue et al., 2008  Bind/Elute  Hydrophobic interaction  Fusion protein  Aggregated fusion 
protein  Lumped pore model  Competitive 
langmuir binary 
Included a term in the model 
for irreversible binding 
To and Lenhoff, 2008  Isocratic 
elution  Hydrophobic interaction 
Ribonuclease A, 
lysozome,  
lactalbumin, 
ovalbumin, BSA 
N/A  General rate model 
Kinetic expression 
including 
conformational  
change on the resin 
surface 
The elution profiles of five 
model proteins were 
investigated in eight 
hydrophobic interaction resins 
Melter et al. 2008  Isocratic 
elution  Cation exchange  Monoclonal 
antibody variants  N/A  General rate model 
Langmuir with 
mobile phase 
modifiers 
characterisation of mAb 
varaints  
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Table 8.4. Studies using mechanistic models of chromatography for studies related to the purification of therapeutic proteins (part 4) 
 
   
Reference  Mode  Retention mechanism  Molecules of 
interest  Impurities  Mass transfer 
model  Adsorption model  Notes 
Muller – Spath et al., 
2011  Bind/Elute  Cation exchange  Monoclonal 
Antibody 
Aggregate, HCP, 
DNA 
Lumped kinetic 
model 
Competitive 
Langmuir  - 
Nagrath et al., 2011 
displacemen
t and 
gradient 
Hydrophobic interaction   lysozyme and 
lectin  N/A  general rate model  
preferential 
interaction quadratic 
adsorption  
characteriosation and 
mdoelling of HIC using the 
PIQ isotherm 
Sandoval et al. 2012  Gradient 
elution  Affinity  IgG, BSA, 
Haemoglobin  N/A  General rate model 
Second order 
kinetic binding 
expression 
Power law and exponential 
elution relationships were 
used to simulation gradient 
elution 
Guélat et al. 2012 
Bind/Elute 
(isocratc 
and gradient 
elution) 
Cation exchange  Monoclonal 
antibody variants  N/A  General rate model 
competitive multi 
component 
Langmuir 
Henry constants were 
calculated using a statistical 
thermodynamic model based 
on properties of the proteins. 
Borg et al., 2013  Isocratic 
elution  reversed phase  insulin  n/A  Equilibrium 
dispersive model 
Langmuir with 
mobile phase 
modulators 
analyse effects of uncertainty 
in estimation of model 
paramerers 
Gu et al. 2013  Bind/elute  Anion exchange  BSA  N/A  General rate model  Langmuir  -  
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Table 8.5. Studies using mechanistic models of chromatography for studies related to the purification of therapeutic proteins (part 5)   
Reference  Mode  Retention mechanism  Molecules of 
interest  Impurities  Mass transfer 
model  Adsorption model  Notes 
Karlsson et al., 2004  Gradient 
elution  Ion exchange  IgG and BSA  N/A  General rate model 
Langmuir with 
mobile phase 
modifiers 
Optimisation 
Jakobsson et al., 2005  Isocratic 
elution  Ion exchange  IgG, BSA and 
myoglobin  -  Equilibrium 
dispersive  Steric mass action  Robustness 
Degerman et al., 2006  Gradient 
elution  Ion exchange  IgG and BSA  -  General rate model 
Langmuir with 
mobile phase 
modifiers 
Optimisation 
Mollerup et al., 2007  isocratic 
elution  ion exchange 
BSA, Beta 
lactoglobulin A 
and B, and alpha 
lactalnumin 
N/A  Reactive dispersive  Association model  optimistaion and scale up 
Degerman et al., 2007  Isocratic 
elution  Reversed phase  Insulin  Desamido insulin  Equilibrium  
dispersive  Kinetic Langmuir  Optimisation 
Susanto et al., 2008  Isocratic 
elution  cation exchnage  lysozyme  N/A  Equilibrium 
dispersive  Kinetic langmur 
optmisation using high 
throughput screening 
development methods 
Chan et al., 2008  Isocratic 
elution  N/A  N/A  N/A  kinetic dispersive  linear  Optimisation and 
understanding of HIC  
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Table 8.6. Studies using mechanistic models of chromatography for studies related to the purification of therapeutic proteins (part 6)   
Reference  Mode  Retention mechanism  Molecules of 
interest  Impurities  Mass transfer 
model  Adsorption model  Notes 
Teeters et al., 2009  Elution  Protein A  Monomer and 
dimer mAb  N/A  Kinetic dispersice  N/A 
optmisation of recovery and 
clearance during protein A 
elution 
Degerman et al., 2009  Isocratic 
elution 
Ion exchange, 
hydrophobic interaction 
and reversed phase 
IgG and insulin  BSA, Desamido 
insulin, myoglobin 
Kinetic dispersive 
and general rate 
Langmuir with 
mobile phase 
modifiers 
Robustness  
Westerberg et al., 2010  Isocratic 
elution   Reversed phase    human insulin  kinetic dispersive 
Langmuir with 
mobile phase 
modifiers 
design and control  
Gerontas et al. 2010  Isocratic 
elution  Ion exchange  BSA and 
lactoferrin   -  General rate  Langmuir kinetics 
with phase modifier  Scale up 
Nfor et al. 2011  Isocratic 
elution  Mixed mode  BSA, ovalbumin, 
amyloglucosidase  -  Lumped kinetic 
Multi-component 
mixed mode 
formalisation 
Resin selection 
Ng et al., 2012  Bind/Elute  Affinity  IgG  BSA  Equilibrium 
dispersive 
Langmuir with 
mobile phase 
modifiers 
Optimisation 
Westerberg et al., 2012  Isocratic 
elution  Ion exchange  Therapeutic 
protein 
A strong and weak 
impurity 
Equilibrium 
dispersive 
Self-association 
isotherm  Robustness  
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Table 8.7. Studies using mechanistic models of chromatography for studies related to the purification of therapeutic proteins (part 7) 
 
Reference  Mode  Retention mechanism  Molecules of 
interest  Impurities  Mass transfer 
model  Adsorption model  Notes 
Osberghaus et al., 2012a  Gradient 
elution  Ion exchange 
Lysozyme, 
ribonuclease A 
and cytochrome C  
-  General rate  Steric mass action  Optimisation and scale up 
Osberghaus et al., 2012b  Gradient 
elution  Ion exchange 
Lysozyme, 
ribonuclease A 
and cytochrome C  
-  General rate  Steric mass action  Optimisation and scale up 
Osberghaus et al., 2012c  Gradient 
elution  Ion exchange 
Lysozyme, 
ribonuclease A 
and cytochrome C  
-  General rate  Steric mass action  Optimisation and scale up 
Gétaz et al., 2012  Isocratic 
elution  Reversed phase  Peptide 
Complex mixture 
of over 20 
impurities 
simplified by 
classification into 
3 groups 
Lumped kinetic 
Combined a 
Langmuir with  
Moreau type 
isotherm 
Design space determination 
Gétaz et al., 2013  Isocratic 
elution   Reversed phase  Peptide 
Complex mixture 
of over 20 
impurities 
simplified by 
classification into 
3 groups 
Lumped kinetic 
Combined a 
Langmuir with  
Moreau type 
isotherm 
Design space determination 
Nfor et al., 2013 
Isocratic 
and gradient 
elution 
Ion exchange, 
hydrophobic and size 
exclusion 
Monoclonal 
antibody 
Full set of 
impurities from 
HCCS cell line 
Lumped kinetic  
Multi-component 
mixed mode 
formalisation 
Process synthesis  
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Chapter 9. Appendix B 
 
The following appendix contains a description of the equations used in the general rate 
model, and the equilibrium dispersive model. 
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9.1. Equilibrium dispersive model 
The differential mass balance in the bulk mobile phase is: 
 
   
 
  
+
 1 −    
  
∙
 C 
  
  
+   ∙
   
 
  
=    ∙
    
 
    						 
      ∀				  = 1,2,…,  								  ∈  0,        [9.1]   
where   
  is the concentration of component   in the mobile phase,   is the time,    is the 
total column porosity, C 
   is the concentration of component   in the stationary phase,   is 
the  interstitial  velocity,     is  the  axial  coordinate,      is  the  apparent  axial  dispersion 
coefficient,    is the number of components in the system, and   is the column length. 
   
     ⁄  is the rate per unit volume of accumulation of component   in the mobile phase  
  1 −        ⁄   ∙   C 
      ⁄   is the rate per unit volume of accumulation of component   in 
the  stationary  phase,    ∙     
     ⁄    is  the  rate  per  unit  volume  of  mass  transfer  by 
convection down the column, and    ∙      
      ⁄   is the rate per unit volume of mass 
transfer by dispersion and particle mass transfer kinetics lumped into one term. The total 
column porosity,   , is defined as the ratio between the void volume,   , and the column 
volume,   : 
           =
   
   
          [9.2] 
 
The boundary conditions for Equation [9.10] are the following (Guiochon, 1994): 
At the inlet of the column, i.e. at z = 0, the mobile phase concentration,   
 , depends on 
convection and dispersion: 
 
        
 –  
   
 
    | 	 	  = 	   , 
 											∀				  = 1,2,…,      [9.3] 
 
where   , 
  is the inlet concentration.  
At the outlet of the column, only convective transport is considered: 
 
     
   
 
   | 	 	  = 	0										∀  = 1,2,…,            [9.4]   
 
An initial condition is also required to solve Equation [9.1] which states that the rate per unit 
volume of accumulation in the mobile phase of component   at   = 0 is zero at all points 
interior to the column: 
   
   
 
   = 0						0 <   <  		∀  = 1,2,…,          [9.14] 
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Illustrating the equilibrium dispersive model 
   
i. Accumulation in 
the mobile phase 
ii. Accumulation in 
the stationary phase 
iii. Convection 
through the column 
iv. Diffusion through 
the column 
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9.2. General rate model 
In the general rate model, a differential mass balance over the packed bed of particles in the 
column describes convection through the column, axial dispersion and transport through the 
external film at the particle surface: 
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=     ∙
    
 
    					 
    ∀				  = 1,2,…,  			   			  ∈  0,          [9.6] 
 
where   
  is the concentration of component   in the extra particular mobile phase,   is the 
time,    is the bed porosity,    is the film mass transfer coefficient of component  ,   
  is the 
concentration of component   in the intra particular mobile phase,   is the coordinate of the 
radial  dimension  through  resin  particles,      is  the  particle  radius,     is  the  interstitial 
velocity,   is the coordinate of the axial dimension along the length of the column,     is the 
axial dispersion coefficient,    is the number of components in the system,   is the column 
length.    
     ⁄  is the rate per unit volume of accumulation of component   in the extra 
particular mobile phase,  
         
  
∙    
  −   
 |      is the rate per unit volume of component   
transferred from the extra particular mobile phase, through the external film, to the intra 
particular  mobile  phase at  the  surface  of the particle,   ∙     
     ⁄    is the rate per  unit 
volume of mass transfer by convection down the column, and     ∙      
      ⁄   is the rate 
per unit volume of mass transfer by dispersion. The bed porosity,   , is defined as the ratio 
between the void volume between resin particles,   , and the column volume,   : 
 
           =
   
   
          [9.7] 
 
The boundary conditions for Equation   [9.1] are the following (Guiochon, 1994): 
 
At the inlet of the column, i.e. at z = 0, the mobile phase concentration,   
 , depends on 
convection and dispersion: 
 
        
 –  
   
 
    | 	 	  = 	   , 
 											∀				  = 1,2,…,      [9.8] 
 
where   , 
  is the inlet concentration.  
At  the  outlet  of  the  column,  i.e.  at  z  =  column  length,  only  convective  transport  is 
considered:  
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   | 	 	  = 	0										∀  = 1,2,…,        [9.4] 
 
An initial condition is also required to solve Equation 9.6 which states that the rate per unit 
volume of accumulation in the extraparticular mobile phase of component   at   = 0 is zero 
at all points interior to the column: 
 
     
   
 
   = 0						0 <   <  		∀  = 1,2,…,        [9.10] 
 
The differential mass balance over the resin particle pores in the radial dimension describes 
diffusion of components through the stagnant mobile phase within the resin pores: 
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where    is the particle porosity,    is the concentration of component   per unit volume of 
the  solid  adsorbent  phase,  and    ,   is  the  molecular  diffusivity  of  component     in  the 
intraparticular mobile phase. The boundary conditions for Equation [9.6] are the following: 
   
At the surface of the particle the mass transport is controlled by film mass transfer: 
 
 
   
 
   =	
  
    , 
∙    
  −   
 |     						∀  = 1,2,…,  							  =	      [9.12] 
 
At the centre of the particle there is no mass transfer due to the symmetrical geometry of the 
particle: 
 
     
   
 
   = 0					∀  = 1,2,…,  							  = 0      [9.13] 
 
The initial condition required to solve Equation [9.6] states that the rate per unit volume of 
accumulation in the intraparticular mobile phase of component   at   = 0 is zero at all points 
interior to the column: 
     
   
 
   = 0							∀  = 1,2,…,  										0 <   <       [9.14]  
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Illustrating the general rate model 
Mass transfer through resin pores 
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